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The aim of this study was to examine the distribution of coag-
glutination (CoA) W serogroups and cell envelope phenotypes among
gonococcal strains isolated in the Edinburgh area and to undertake
the development of a non-cultural detection method.
A total of 745 gonococcal strains acquired in the Edinburgh area
were serogrouped by CoA. Overall 41.8%, 49.9%, 8.2% and 0.1% of
these strains belonged to CoA serogroups WI, WII, WII/WIII and Will
respectively. A strong correlation (p <0.001) of CoA serogroup WII
with homosexually acquired infection was observed regardless of anatomical
site of isolation. There were no overall differences between heterosexual
men and women (p >0.5). Differences in the distribution of CoA sero¬
groups within the four six-month periods studied were observed. There
was a significant increase in the number of WII/WIII strains isolated
(p <0.001) and a decrease in the number of WI strains isolated from
heterosexual men and women. There was a correlation of the CoA sero¬
group of isolates from sexual partners but no correlation between CoA
serogroup of infecting strain and symptoms in women.
All four serogroups were represented among 24 strains acquired
in other areas of the United Kingdom and in Europe. Whereas 18, 2
and 2 of the 22.strains acquired in non-European countries, mostly
Thailand, belonged to CoA serogroups WII, WII/WIII and Will respectively.
The CoA serogrouping results are discussed in relation to the findings
of other groups.
The overall distribution of the cell envelope phenotypes of 482
gonococcal strains was examined in relation to patient group, site of
isolation and in relation to CoA serogroups. Overall 5%, 87% and 8%
of strains had an Env, wild type and Mtr phenotype respectively.
Strains with the Mtr phenotype were isolated significantly more often
from homosexual men than from heterosexual men (p <0.001) and from
women (p <0.001). There was no correlation of the Mtr phenotype
with rectal isolates but it was found more often in urethral and throat
isolates from homosexual men. Serogroup WII and the Mtr phenotype
were strongly correlated (p <0.001): 85% of the 40 Mtr strains belonged
to CoA serogroup WII. Strains isolated from heterosexual men who
had acquired their infections in non-European countries (mostly in
Thailand) belonged to CoA serogroup WII and the Mtr phenotype was
strongly correlated with these strains (p <0.05). The factor(s) involved
in the selection of the Mtr phenotype and CoA serogroup WII is discussed.
A dot-blot immunoassay using nitrocellulose membranes in the
place of conventional solid phase materials such as polystyrene beads
and wells was developed and evaluated. CoA reagents prepared with
antisera raised against MOMP E-5 and N-10 detected 99.6% and 95.8%
of the WI and WII gonococcal strains respectively. Therefore these
antisera were considered suitable for antigen detection in the dot-blot
immunoassay. The sensitivity and specificity of the test when applied
to 95 male urethral specimens were 91.5% and 89.6% respectively.
It is concluded that this study has shown that (i) the antigenic
pool of N. gonorrhoeae in Edinburgh is not static but dynamic and
changing. Therefore constant surveillance will be required to ensure
that reagents used for serogrouping and non-cultural detection and
identification remain effective; (ii) antibiotic pressure is the major
force in the selection of gonococcal strains with the Mtr and CoA WII
phenotypes; (iii) CoA serogrouping has allowed the rational choice
of antisera to be employed in the development of a non-cultural detection
xiv.
method; and (iv) the dot-blot immunoassay is acceptable at present
but could be improved. It may be a useful tool in the laboratory
detection of N. gonorrhoeae, particularly when used for detection of
antigen in specimens from women and in transported specimens.
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INTRODUCTION
1.
GENERAL INTRODUCTION AND HISTORICAL BACKGROUND
Gonorrhoea is an infection primarily of the genito-urinary tract
of humans but it may also affect the rectum, pharynx and, less commonly,
the eye. Gonorrhoea is caused by the gram-negative diplococcus Neisseria
gonorrhoeae. Occasionally the organism disseminates and gives rise to
a systemic infection.
N. gonorrhoeae is extremely fastidious and requires exact growth
conditions. It has a poor survival rate outside of its host and intimate
contact is required for transmission from one person to another.
1.1 Historical background
Gonorrhoea has been known to be of venereal origin since the
earliest recorded days of mankind. The Old Testament refers to venereal
disease as uncleanliness resulting from promiscuous acts of intercourse.
Parts of Leviticus, Chapter 15 refer to gonorrhoea, its diagnosis, manage¬
ment and aftercare and states that, "Every male that has a discharge
from his penis is to be segregated for the discharge makes him contag¬
ious" (Brim, 1936). For many centuries the symptoms of gonorrhoea
and syphilis were thought to be manifestations of the same disease,
and it was not until the 19th century that the situation was clarified.
In 1838 Philip Ricord provided proof that gonorrhoea and syphilis
were separate diseases and in 1879 Albert Neisser identified by microscopy
the causative agent Neisseria gonorrhoeae which bears his name. N.
gonorrhoeae was first cultured on artificial media by Ernst von Bumm
in 1885 (Catterall, 1984).
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1. 2 Gonorrhoea in the early twentieth century
There was no effective treatment for gonorrhoea until the introduc¬
tion of the sulphonamides in 1937 (Morse, 1979). In the period prior
to this, the social impact and personal trauma of venereal diseases
was daunting. Treatment of gonorrhoea was limited to urethral irrigation
with potassium permanganate and oxycyanide of mercury, or to very
weak antiseptics taken orally and excreted in the urine (Morton, 1966).
Ascending gonococcal infections occurred frequently, particularly after
urethral irrigation. Urethral stricture and sterility were often the
sequelae to such infections.
Sterility and disseminated infections were common in both men
and women. By the early 1900s the problems associated with venereal
diseases were finally recognised. Special clinics for the diagnosis and
treatment of patients were finally established in 1916 upon the recommenda¬
tions of the Royal Commission on Venereal Diseases (Robertson, McMillan
and Young, 1980). However, in this period and up to the 1930s much
less interest was taken in women with venereal diseases and little or
no contact tracing was undertaken (Catterall, 1984). Babies born
to women with gonorrhoea frequently developed gonococcal eye infections
known as ophthalmia neonatorum. This manifestation of N. gonorrhoeae
was the largest single cause of blindness in children during the pre-
antibiotic period (Robertson et al. , 1980).
An important part of controlling the spread of gonorrhoea in
the population is by the effective diagnosis and treatment of infected
patients and their sexual contacts. In 1938 the International Union
against Venereal Diseases and Treponematoses tried to persuade govern¬
ments to encourage the introduction of contact tracing. These suggest-
tions were met with opposition and hostility. Therefore, at the beginning
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of 1939 management of patients with venereal diseases was fragmented
with health care being undertaken by general practitioners and various
hospital specialists. The advent of the Second World War and high
rates of infection amongst the armed forces served as an impetus to
instigate contact tracing within the civil population. With the introduc¬
tion of penicillin in the early 1940s it was predicted that gonorrhoea
would be eradicated. A decline in the number of cases did occur for
a while and interest in gonococcal research diminished. The number
of public clinics and funds available for treatment and research also
diminished (Catterall, 1984).
The fall in the incidence of gonorrhoea was short-lived. The
number of cases of gonorrhoea reached epidemic levels in the early
1960s and remains prevalent today.
4.
CLINICAL ASPECTS OF GONORRHOEA
1. 0 Uncomplicated genital infections
Acute anterior urethritis is the most common manifestation of
gonococcal infection in the male resulting in purulent discharge. The
incubation period is on average 3-4 days with a range of 2-14 days.
Prior to availability of effective antimicrobial agents most patients had
symptomatic resolution within eight weeks and 95% were free of symptoms
within six months (Holmes, 1974).
The columnar epithelium of the endocervix is the primary site
of infection in women. The cervix is involved in 85-90% and the urethra
in 65-75% of cases (Robertson et al. , 1980). The most common symptoms
among women infected with N. gonorrhoeae are abnormal or increased
vaginal discharge, abnormal uterine bleeding, dysuria and urinary
frequency and urgency (Handsfield, 1977). However, the majority
of women with endocervical gonococcal infections remain asymptomatic
or develop very slight or non-specific symptoms and do not seek medical
attention.
1.1 Asymptomatic genital infections
The prevalence of asymptomatic infections in women is estimated
at 70 per cent or more (Robertson et al. , 1980). Asymptomatic urethral
infections in men are also found. Overall, 10% of men acquire infections
in which few or no symptoms develop (Judson, Miller and Schaffmit,
1977; Handsfield et al. , 1980). Therefore they may not recognise
that they have been infected and fail to seek medical attention.
Handsfield et al. ( 1974) detected urethral gonococcal infections in
40% of asymptomatic men who were known contacts of women with gonorrhoea.
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In a survey of servicemen returning from SE Asia, it was found that
a large proportion (68%) had asymptomatic gonococcal infections
(Handsfield et al. , 1974). John and Donald ( 1978) found that 17% of
203 cases of urethral gonorrhoea were asymptomatic and a further 7%
of cases had symptoms so mild that they failed to seek medical attention.
All of these cases were brought to attention by contact tracing. There¬
fore, the prevalence of asymptomatic urethral infections in men vary
depending on whether one examines the figures for male patients overall
or of specific groups of male patients. The figures may also vary
geographically.
Patients with asymptomatic infections may well be more efficient
at transmitting gonococcal infections because they are unaware of having
contracted the disease and therefore continue with their normal pattern
of sexual behaviour.
1. 2 Complications of local genital infections in men
Local spread of urethral gonococcal infections in men have been
reported to result in prostatitis, seminal vesiculitis, epididymitis, inflam¬
mation and abscess formation in the glands of the urethra (Robertson
et al. , 1980). Urethral strictures and fistulae may occur but nowadays
these are very rare in the western world. However, in the pre-antibiotic
period these were not uncommon. In West Africa and probably also
in other developing countries where medical facilities are inadequate
and improper self-treatment with antibiotics occurs, all of the above
complications are frequently seen (Osoba and Alausa,. 1976).
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1.3 Complications of local genital infections in women
Local complications in women include involvement of the para¬
urethral and Bartholin's glands (Bartholinitis). Ascending cervical
infections result in salpingitis or pelvic inflammatory disease and occurs
in approximately 10% of untreated women. Approximately 20% of such
women subsequently have impaired fertility (Eschenbach and Holmes,
1975). Therefore, this manifestation of gonorrhoea continues to present
serious consequences to infected women.
1.4 Disseminated gonococcal infections
Disseminated gonococcal infections (DGI) arise from the spread
of N. gonorrhoeae from the initial site of infection to the blood stream
and is rare, occurring in approximately 1% of untreated cases (Gruber,
Sandeford and Ziff, 1960). DGI is more likely to arise in patients who
have had asymptomatic genital infections (Holmes, Weisner and Pederson,
1971). DGI has two phases: a bacteraemic and a septic joint stage.
The bacteraemic stage is characterised by polyarthritis, dermatitis
and an increased likelihood of positive blood cultures. The septic joint
stage is characterised by monarticular arthritis, negative blood cultures
and frequently culture positive synovial fluid (Handsfield, 1977).
Occasionally the two overlap (Brogadir, Schimmer and Myers, 1979).
It has been shown that the overall incidence of septic gonococcal derma¬
titis in patients with gonorrhoea was 1.9%; 3% for women and 0.7% for
men (Barr and Danielsson, 1971). In 23 patients with DGI the common
presenting symptoms were arthritis or arthralgia and bouts of fever.
Characteristic skin lesions served as early clues to diagnosis. N. gonor¬
rhoeae was usually isolated from the genito-urinary tract or from blood cultures
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(Barr and Danielsson, 1971). Occasionally gonococci can be observed .
in smears prepared from skin lesions using immunofluorescence micro¬
scopy. Lesions occur on the extremities and most patients have from
5 to 30 lesions. Individual lesions often progress from petechiae or
papules to pustular haemorrhagic or nercrotic lesions (Handsfield,
1977). Occasionally gonococcal endocarditis results from DGI (Rosoff,
Cohen and Jacquette, 1983).
1.5 Rectal infections
Rectal infections occur in both men and women. Ano-rectal infec¬
tions in men result from passive anal intercourse. In 1977, 10.9% of
men with gonorrhoea had acquired their infection as a result of homo¬
sexual contact (British Co-operative Clinical Group, 1980). The majority
of male patients with rectal gonorrhoea produce no symptoms (McMillan
and Young, 1978; Bygdeman, 1981a) and the proctoscopic appearance
of the rectal mucosa is normal in 84% of cases (McMillan et al., 1983).
In women with gonorrhoea the rectum is involved in approximately
25-50% of cases (Handsfield et al. , 1980; Willcox, 1981). Rectal gonor¬
rhoea in women is thought to result partly from infection due to rectal
coitus (Cornthwaite et al. , 1974; Kinghorn and Rashid, 1979) but
mostly due to contamination of the anus by infected vaginal discharge
(Willcox, 1981).
1.6 Pharyngeal infections
Gonococcal pharyngeal infections occur in both sexes. Lack
of correlation between pharyngeal colonisation and symptoms of pharyn¬
gitis (Wiesner, 1975; Young and Bain, 1983), combined with the
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reluctance of many patients to admit to orogenital contact (fellatio and,
less commonly, cunnlingus), makes it difficult for the clinician to use
these criteria in selecting patients from whom to take throat cultures.
The prevalence of pharyngeal infection in patients with gonorrhoea
in Edinburgh has been shown to be 4.3% for all men, 7-9% for women
and 11% for homosexual men (Young and Bain, 1983). There have been
reported cases of oral-genital transmission of N. gonorrhoeae (Soendjojo,
1983), although such events are probably rare in most locations. However,
having said this, pharyngeal infections do constitute a possible source
for the spread of infection and the possibility of developing DGI from
an initial pharyngeal infection also exists.
1.7 Gonococcal infection in infants and children
Gonococcal infections in infants
Gonococcal conjunctivitis of the newborn (ophthalmia neonatorum)
in the pre-antibiotic era was the single largest cause of blindness.
Ophthalmia neonatorum results from the passage of the baby through
its mother's infected cervix. The infection is usually apparent within
48 hours and up to one week after birth. Symptoms are conjunctivitis
with purulent discharge and has dangerous consequences if treatment
is delayed with the end result of keratitis with corneal scarring which
may result in blindness. Nowadays this condition is very rare but
remains a notifiable disease (Robertson et al. , 1980).
Gonococcal infections in children
Orapharyngeal, genital, rectal and eye infections in older children
have often been considered to be due to non-sexual transmission (Nelson
et al. , 1976). Proponents of this theory suggest that transmission of
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gonorrhoea to children results from sleeping in the same bed as an
infected parent, using damp towels contaminated with fresh pus and
even from contaminated toilet seats. However, gonococcal transmission
in adults by such modes is considered to be unlikely. Gonococcal infec¬
tions in children resulting from sexual contact and abuse probably
occurs much more frequently than is generally supposed (Sgroi, 1982;
Alexander et al. , 1984).
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EPIDEMIOLOGY
After the decline in the incidence of gonorrhoea in the 1950s
an upsurge in the number of reported cases occurred in the 1960s
(Figure 1). This rise coincided with changing attitudes towards sexual
behaviour, the availability of oral contraception and a much greater
degree of population mobility. The incidence of gonorrhoea in a number
of countries (Figure 1) has continued to increase in the last 25 years.
1.0 Incidence of gonorrhoea in England
In England the number of new cases of post pubertal gonorrhoea
reported in 1980, was 54,388 (117.04 per 100,000 population). Whereas
in 1981 the number of reported cases was slightly lower at 52,200 ( 111.52
per 100,000 population). Overall the number of new cases reported
has dropped from the peak of 126.64 cases per 100,000 population in
1977 (Extract of Annual Report of the Chief Medical Officer for the
year 1982).
1.1 Incidence of gonorrhoea in Scotland
A similar trend has been observed in Scotland. In 1977, 5,528
( 106.39 per 100,000 population) new cases of gonorrhoea were reported,
whereas in 1979 the number of new cases had declined to 4,938, a rate
of 95.96 per 100,000 population (Communicable Diseases Scotland, Summary
of Sexually Transmitted Diseases 1972-79).
1. 2 Incidence of gonorrhoea in America
In the United States of America over one million new cases were
reported to the US public Health Services in 1976. These figures did
not include those cases seen by private physicians or those for the
year
FIGURE 1: Reported gonorrhoea incidence per 100,000 population,








armed services. It has been estimated that the true incidence of gonor¬
rhoea in the USA for 1976 was 3.4 million cases (Roberts, 1977).
1. 3 Incidence of gonococcal PIP
Coincident with the rise in sexually transmitted diseases, the
incidence of PID in women has also risen sharply. Approximately one
million women are treated annually for PID in the United States where
this disease accounts for 250,000 hospital admissions and approximately
150,000 surgical procedures each year (Sweet, 1981). It has been
estimated that the direct annual cost for treatment of PID is greater
than 600 million dollars and that the total cost of the disease is upwards
of three billion dollars (Curran, 1980). In addition to the economic
consequences, salpingitis is a major cause of infertility with infertility
rates of approximately 20% and a six- to ten-fold increase in the rate
of ectopic pregnancies following the disease (Sweet, 1981). In his
review of PID, Sweet (1981) noted that although N. gonorrhoeae may
be the causative agent in 31-81% of cases of salpingitis, other organisms
such as anaerobic bacteria and Chlamydia trachomatis may also be im¬
plicated.
1.4 The worldwide incidence of gonorrhoea
There is great difficulty in obtaining reliable figures for the
incidence of gonorrhoea in developing countries, but the incidence
of gonorrhoea worldwide is estimated to be 70-200 million cases per
year (Roberts, 1977). The World Health Organisation considered gonor¬
rhoea to be the major underlying cause for the high prevalence of in¬
fertility in parts of Africa (WHO, 1978). Therefore, today, gonorrhoea
remains the most prevalent communicable disease exacting huge
12.




1.0 Deoxyribonucleic acid - chromosomal
The chromosomal deoxyribonucleic acid (DNA) of N. gonorrhoeae
has 1.5 x 106 nucleotide pairs and molecular weight of 9.8 x 108 daltons
(Kingsbury, 1969). It has a guanine plus cytosine ( GC ) ratio of 50-53
which is similar to that of other neisserial species which range from
46-53 (Bdvre, 1984). Other pathogens such as Salmonella typhimurium
and Escherichia coli have larger chromosomes, 2.8 x 109 d and 2.5 x 109
d respectively (Morse, 1979). It has been suggested that the gonococcus
because of the smaller size of its chromosome may have a limited genetic
potential and this may be reflected by the fact that it is a host specific
pathogen. Despite this, N. gonorrhoeae is a very successful pathogen
and is able to colonise all mucosal surfaces of its human host and cause
a wide range of clinical syndromes.
1.1 Plasmid DNA
Plasmids are extrachromosomal genetic elements that are capable
of autonomous replication and are not required for the survival of the
host bacterium under most conditions. Bacterial plasmids may carry
information for the production of a large variety of different determin¬
ants such as multiple antibiotic resistance, surface antigens such as
pili, production of bacteriocins, toxins and resistance to toxic ions
(Elwell and Falkow, 1977). These additional determinants may give
the bacteria carrying such plasmids a greater ability to survive in
certain circumstances or to compete successfully with other bacteria.
In addition to plasmids for which a known phenotype is expressed,
there are many plasmids carried by bacteria for which there is no known
function. These plasmids are called phenotypically "cryptic".
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1. 2 Gonococcal plasmids
The search for plasmids in gonococci was stimulated by the observa¬
tions that certain features such as the loss of pili on subculture and
multiple antibiotic resistance were plasmid coded in other bacteria.
The first two plasmids to be characterised in the gonococcus were a
small 2.6 x 106 d (2.6 Md) multicopy plasmid (Mayer, Holmes and Falkow,
1974) and a large 24.5 x 106 d (24.5 Md) plasmid (Stiffler et al. , 1975).
The 2.6 Md plasmid comprised 6 to 8% of the total gonococcal DNA,
equivalent to approximately 24 to 32 copies per cell (Mayer et al. , 1974).
The GC ratios of the 2.6 Md and 24.5 Md plasmids are 50 and 46 respec¬
tively (Mayer et al. , 1974; Roberts and Falkow, 1977).
1.3 Function of gonococcal plasmids
Initially no phenotype could be ascribed to the presence of either
plasmid (Mayer et al., 1974; Stiffler et al., 1975). However, it is
now known that the 24.5 Md plasmid is involved in conjugation (Baron
et al., 1977; Roberts and Falkow, 1977). Recently two genes encoding
for production of polypeptides have been identified on the 2.6 Md plasmid
(Hagblom, Korch and Normark, 1984). These 2.6 Md, previously cryptic,
plasmids are found in nearly all gonococcal strains whereas the 24.5 Md
plasmid is found rarely (Elwell and Falkow, 1977).
1.4 Gonococcal plasmids coding for g-lactamase production
Penicillinase-producing N. gonorrhoeae (PPNG) were reported
for the first time in the United Kingdom and United States of America
in 1976 (Philips, 1976; Percival et a!., 1976; Ashford, Golash and
Hemming, 1976). 6-lactamase production was shown to be plasmid
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mediated by Elwell et at. ( 1977). They showed that PPNG strains isolated
from American army personnel, who had acquired their infections in
the Far East, harboured a 4.5 Md plasmid coding for 3-lactamase produc¬
tion as well as the 2.6 and 24.5 Md plasmids. In contrast, the PPNG
strain from London (Philips, 1976) contained a 3.2 Md plasmid coding
for 6-laetamase production, the 2.6 Md plasmids but not the 24.5 Md
plasmid (Elwell et al. , 1977).
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METHODS OF GENETIC EXCHANGE IN THE GONOCOCCUS
The gonococcus has two methods of genetic exchange: transforma¬
tion and conjugation. Transduction has not been reported and bacterio¬
phages have not been isolated.
1.0 Transformation
Genetic transformation is the process by which one bacterium
takes up, integrates and expresses (and is thereby transformed by)
naked DNA from another organism. Transformation in Neisseria spp
whose normal habitat is the human nasopharynx was first described
by Catlin and Cunningham (1961). They showed that nearly all Neisseria
spp were transformable and that intraspecific and interspecific trans¬
formation occurred. However, it was not until 1966 that Sparling showed
that gonococci can also be transformed (Sparling, 1966).
Transformation involves binding and uptake of DNA by competent
cells and integration and expression of DNA.
1.1 Competence
In N. gonorrhoeae transformation frequencies (number of trans¬
formed bacteria/number of bacteria exposed to DNA) are at least 1000
times higher ("TO-2 to 10-4) in pilated colony types 1 and 2 than in
non-pilated strains (10-7) (Sparling, 1966). A similar finding has
been observed in N. meningitidis (Frdholm, Jyssum and Bdvre, 1973).
Therefore, gonococcal non-pilated strains are not used for transformation
assays.
Transformation of N. gonorrhoeae, like most other transformation
systems, requires an energy source, the presence of cations, particularly
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Mg2+ or Ca2 + , and the correct temperature and pH (Biswas et at. ,
1977; Sparling, 1966). The optimum temperature for transformation
is 35 to 37°C (Sparling, 1966) and the optimal pH range is 7.5 ± 0.5
(Biswas et at. , 1977).
1. 2 Soluble competence enhancing factors
Unlike most other transformation systems where the bacteria
excrete a soluble factor which enhances competence in other cells and
where they are only competent for a part of their growth cycle, N.
gonorrhoeae is competent throughout all phases of its growth cycle
in nutrient broth (Sparling, 1966; Biswas et at. , 1977). This suggests
that gonococci do not require a soluble competence-enhancing factor.
However, there has been one report of competence factor in N.
gonorrhoeae (Siddiqui and Goldberg, 1975). Siddiqui and Goldberg ( 1975)
reported that washing competent pilated cells with phosphate-buffered
saline resulted in a 1000-fold decrease in transformation frequencies.
Resuspension of these washed cells in culture supernate restored normal
transformation frequencies. However, these results have not been
confirmed by other workers carrying out similar experiments (Biswas
et al. , 1977; Sparling, Biswas and Sox, 1977).
1.3 The effect of proteolytic enzymes on transformation frequencies
The treatment of competent gonococcal cells with proteolytic
enzymes such as pronase and trypsin, while reducing viability of cells
by approximately ten-fold, did not decrease transformation frequencies
and in some cases slightly increased them (Biswas et a!., 1977; Sparling
et a!., 1977). However, the inhibition of protein synthesis by addition
of 10 Mg/ml of chloramphenicol to competent T1 cells of gonococcal strains
FA 19 and F 62 prior to the addition of DNA resulted in a ten-fold decrease
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in transformation efficiencies (Biswas et at., 1977). When the chloram-
phenicol-treated cells were washed and allowed to resume normal growth
in fresh medium, transformation efficiencies gradually returned to normal.
Therefore, concentrations of chloramphenicol that had minimal effects
on viability had a much greater effect on phenotypic development of
competence, presumably due to the interruption of synthesis of one
or more proteins essential to the transformation process (Biswas et al •,
1977).
1.4 The role of Pili in transformation
So far attempts to determine the role of pili in transformation
have been unsuccessful. Pili do not appear to act as receptors for
DNA. Experiments utilising radiolabeled DNA and pili have failed
to show an affinity of DNA to pili (Sparling et at., 1977). However,
it is possible that some other constituent such as a cell-wall component
present only in pilated cells affect transformation. Biswas et al. (1977)
showed small increases in the transformation efficiencies of FA 19 T4
non-pilated cells by increasing cell envelope permeability by treating the
gonococci with EDTA or lysozyme and EDTA. However, both treatments
resulted in marked decreases (>90%) in viability (Biswas ef al., 1977).
Attempts to produce competent mutants of T4 cells have also been unsuc¬
cessful (Biswas et al., 1977). Recent work suggests the site for DNA
uptake may not be pili and although the nature of this site is unclear
the receptor appears to recognise a specific nucleotide sequence (Sparling
et al. , 1980).
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1. 5 Uptake of DNA
The uptake of DNA during transformation is affected by the
physical state of the DNA used. Sparling et al. ( 1977) showed that
single-stranded (ss) DNA is approximately 1% as active in transforma¬
tion as double-stranded (ds) DNA. Gonococci do not take up covalently
closed circular (plasmid) DNA very efficiently (Roberts and Falkow,
1977). Rapid uptake occurs in the first few minutes after the addition
of donor-DNA with continued uptake up to 30 to 45 minutes. The effect
of incubation periods of greater than 30 minutes were found to be variable
and thus an optimum of 30 minutes is generally used (Sparling, 1966).
At this point, saturation of DNA binding sites occurs. Saturation is
reached with 5 to 10 jig /ml of DNA with a cell density of less than 108
gonococci (Sparling, 1966). It has been shown that DNA binds equally
well to competent and non-competent gonococcal cells (Biswas et al.,
1977). This initial binding of DNA to cells is deoxyribonuclease (DNase)
sensitive. This step is followed by DNase resistant uptake and this
occurs only in competent cells. DNase resistant uptake was found
to be 0.5% of the DNA added with saturation at 0.5 |ig/ml of DNA (Biswas
et al., 1977).
1.6 Integration and expression of transforming DNA
Although DNA uptake is nearly completed after 30 minutes, it
takes considerably longer for the DNA to be integrated and expressed
by the recipient organisms. Gonococci being transformed to streptomycin
resistance showed increased transformation frequencies with extended
periods of time being allowed prior to the addition to the plates of the
streptomycin overlay. The optimum time period was 6 to 7 hours (Sparling,
1966). However, very little is known about what actually happens to
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the DNA during and after uptake by N. gonorrhoeae. In other systems
donor DNA is converted from its initial double-stranded form to a single-
stranded form and strand length may also be reduced (Sparling et
at. , 1977). During this period of conversion of donor dsDNA to ssDNA,
prior to integration into the recipient chromosome, transforming activity
of the donor DNA is lost (eclipsed). However, when DNA is extracted
from DNase treated, washed gonococci at short intervals and assayed
for transforming activity of donor and recipient markers, no change
in donor DNA activity is observed (Sparling et at., 1977). Therefore
N. gonorrhoeae appears to lack an eclipse period. Lack of an eclipse
period is also seen in N. meningitidis (Jyssum, Jyssum and Gunderson,
1971).
1. 7 Transformation of DNA between Neisseria spp and transformation
in vivo
Transformation can occur between N. gonorrhoeae and other
Neisseria spp. Transformation efficiencies are affected by both the
species and the particular marker studied (Sparling et al. , 1977). The
most efficient heterologous cross was between N. gonorrhoeae and N.
meningitidis which approached the efficiency of homologous gonococcal
to gonococcal crosses with respect to most markers studied.
Sarubbi and Sparling ( 1974) demonstrated that genetic exchange
took place when two strains of N. gonorrhoeae carrying different anti¬
biotic resistance markers were co-cultivated in liquid medium. However,
the direction of gene transfer was dependent on the colony types of
the two strains. It has been estimated that of patients with gonorrhoea,
25% will have infections with more than one strain (Short et al. , 1977).




Conjugation in N. gonorrhoeae had not been reported prior to
plasmid mediated penicillinase production in 1976. The first report
of the conjugal transfer of the gonococcal penicillinase plasmid (R plasmid)
occurred in 1977 (Eisenstein et a!., 1977). Donor g-lactamase strains
were able to transfer B-lactamase activity to other gonococci and E. coli
in culture and on membranes in the presence of DNase. Phage-mediated
transduction was eliminated after cell-free filtrates of the donor strains
and chloroform treated donor cultures were unable to transfer of the
R plasmids to either N. gonorrhoeae or E. coli recipients (Baron et al. , 1977).
Transformation as the method of genetic exchange of 6-lactamase act¬
ivity was eliminated by the addition of DNase ( ~50 pg/ml) to the mating
mixtures (Eisenstein et al. , 1977; Baron et al. , 1977). Roberts and
Falkow also demonstrated that transformation was not likely to be the
mechanism of 3-lactamase transfer since purified gonococcal covalently
closed circular (ccc) plasmid DNA could not transform other gonococci
to penicillin resistance but could be used to transform E. coli to resistance
in transformation experiments. They concluded that N. gonorrhoeae was
refractory to transformation by ccc plasmid DNA (Roberts and Falkow,
1977). Additional evidence for conjugation as the method of R plasmid
transfer came from the observations that the transfer efficiencies were
similar regardless of whether pilated or non-pilated recipient gonococci
were used (Eisenstein et al. , 1977). In transformation experiments, pilated
recipients are required to attain efficient levels of transfer of genetic
material.
Baron et al. ( 1977) demonstrated that the transfer frequency
of the R plasmid was related to the donor : recipient ratio; at 100 : 1 the
frequency was approximately 10~3 and at 1000 : 1 the frequency was 10~5.
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2.1 The mediator of R plasmid transfer
On analysis of the plasmids carried by donor, recipient and trans-
recipient gonococci, it was shown that only strains carrying the 24.5 Md
plasmid could transfer the R plasmid to another gonococcal or E. coli
strain (Baron et al., 1977; Roberts and Falkow, 1977). However,
the 24.5 Md plasmid was not found in the donor strain in all cases.
It was suggested that because only ccc plasmid forms and no intermediary
open circular forms were detected that the 24.5 Md transfer plasmid
DNA was rapidly converted into a linear form and was therefore not
detected (Baron et al. , 1977). Therefore it was proposed that the
24.5 Md plasmid of N. gonorrhoeae possesses sex factor activities and
is able to mobilise or promote the transfer of the smaller coexisting R
plasmid by conjugation. However, conjugal (sex) pili, have not been
observed on donor gonococci (Sparling et al., 1980).
The efficiency of conjugation has been shown to be affected by
the composition of the outer membrane. A 10- to 15-fold decrease in R
plasmid transfer has been observed in crosses with opaque x opaque
cells compared with crosses with isogenic transparent x transparent
cells (Sparling ef al. , 1980). Transparent colony types lack the approxi¬
mately 28,000 dalton outer membrane proteins associated with gonococcal
colony opacity (Walstaad, Guymon and Sparling, 1977; Swanson, 1978b).
Therefore it is thought that one of these colony opacity associated
proteins inhibits conjugation possibly by interfering with the formation
of mating pairs (Sparling et al., 1980). The composition of the outer
membrane does not appear to be controlled by the 24.5 Md plasmid
(Sparling et at. , 1980).
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2. 2 Conjugal transfer of chromosomal genes
There has been one report that the 24.5 Md plasmid is capable
of promoting the transfer of chromosomal genes at a low frequency:
lO-5 to 1(T7 per recipient cell (Roberts and Falkow, 1978). However,
a number of workers have been unable to confirm these results (Norlander,
Davis and Normark, 1979; Steinberg and Goldberg, 1980; Sparling
et al., 1980). Sparling ef al. ( 1980) suggested that chromosomal transfer
was actually the result of concurrent transformation at low frequencies
probably caused by the deterioration of the DNase in the mating mixture.
Therefore, although conjugation occurs in the gonococcus for
experimental purposes, transformation remains the most important system.
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ANTIBIOTIC RESISTANCE OF THE GONOCOCCUS WITH
SPECIAL REFERENCE TO PENICILLIN RESISTANCE
The introduction of sulphonamides in 1937, to which N. gonorrhoeae
was highly susceptible, revolutionised the treatment of gonorrhoea
(Catterall, 1984). However, resistance to sulphonamides quickly
developed and it was extremely fortunate that penicillin came into general
use as the sulphonamides were becoming ineffective.
1.0 Development and epidemiology of gonococcal penicillin resistance
Gonococci were initially extremely sensitive to penicillin. Gonococcal
strains isolated in 1944 and tested for penicillin sensitivity in 1957
had a six-fold 50% inhibition range to penicillin: 0.0038- 0.024 pg of
penicillin/ml, with a peak at 0.01 pg/ml, the MIC or 100% inhibition
levels were two-fold higher (Reyn, Korner and Bentzon, 1958). However,
it was possible to select laboratory mutants with an MIC to penicillin
S2 units/ml ( ~ 1.2 pg/ml) (Bahn, Ackerman and Carpenter, 1945) and
one strain was found to have an MIC of up to 21 units/ml (-12 pg/ml)
(Miller and Bohnhoff, 1945).
By the mid-1950s there were several reports from various parts
of the world of gonococci with reduced sensitivity to penicillin (Sparling,
1977). Strains isolated in 1957 had a wider 50% inhibition range than
those isolated in 1944: an 80-fold range from 0.005- 0.45 (ig/ml of
penicillin with two peaks at 0.01 and 0.2 Mg/ml (Reynef at. , 1958).
Therapy with a single injection of 150,000 units of penicillin produced
cure rates of 90% or more. However, the increases in resistance to
penicillin were accompanied by evidence of increased rates of treatment
failure with standard single-dose therapies (Curtis and Wilkinson, 1958;
Thayer et al. , 1957).
25.
Nowadays gonococcal strains which have reduced sensitivity
to penicillin are usually defined as strains with an MIC of SO.06 ug/ml
with a normal upper limit of 2.0 pg/ml (Sparling, 1977). These levels
of resistance are over 100 times greater than those which prevailed
when penicillin therapy was introduced in the 1940s, but are still much
lower than resistance found in staphylococci and enteric bacteria
(Sparling, 1977).
1.1 Development of resistance to other antimicrobials
Along with the development of low-level resistance to penicillin,
gonococci also developed low-level resistance to other antibiotics such
as tetracycline, chloramphenicol and erythromycin.
Gonorrhoea was also frequently treated with streptomycin to
which gonococci developed a single-step high level resistance (Sparling,
1977). These levels were far in excess of achievable serum levels of
the drug.
1. 2 Geographical variations in gonococcal penicillin resistance
Resistance to penicillin varies in different geographical areas
of the world and indeed within one country. Although results of anti¬
biotic testing varies from laboratory to laboratory, the trends of penicillin
resistance have been confirmed when gonococci from various areas
of the world have been tested in one laboratory (Reyn, 1969; Sng,
Lim and Yeo, 1984). Strains from countries in SE Asia tend to be most
resistant to penicillin. In Singapore, 64% of non-PPNG strains have
MICs to penicillin of SO.5 ag/ml (Sng et a!., 1984).
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Differences occur in antibiotic sensitivities within one country.
In the United States it has been suggested that strains isolated from
patients in rural areas are less likely to be resistant than those isolated
from patients living in urban areas (Gump and Berry, 1975). However,
greater differences are likely to be caused by the influx of gonococcal
strains from other geographical areas. The most dramatic demonstration
of this was the emergence of PPNG strains in Britain and America in
1976 (Philips, 1976; Percival et al., 1976; Ashford etal., 1970).
Sparling (1977) reported an increase of antibiotic sensitive strains
in North Carolina which coincided with an influx of strains with nutritional
requirements for arginine, hypoxanthine and uracil (auxotype AHU-).
These strains tend to be highly penicillin sensitive (Catlin and Pace,
1977). However whether N. gonorrhoeae carrying particular resistance
mutations persist and become endemic among the indigenous gonococcal
population, depends on the ability of such strains to survive and compete
successfully. Therefore, if drug resistance has an adverse effect
on virulence, such strains will not be successful. Although there are
problems with resistance to penicillin single dose therapy remains the
drug of choice for treatment of gonorrhoea (WHO, 1970). However,
there are alternatives to penicillin such as the cephalosporins and speetino-
mycin. There are reports however of PPNG acquired in SE Asia which
also have high levels of spectinomycin resistance (Gunby, 1983).
2.0 Chromosomally mediated low level penicillin resistance
Low level penicillin resistance is the result of chromosomal mutations.
The loci involved in this are penA, pen B and mtr (Sarubbi, Blackman
and Sparling, 1974; Sparling, Sarubbi and Blackman, 1975). The
locus pen A confers resistance to penicillin alone and is not linked to
27.
genes which confer resistance to other antimicrobials such as streptomycin,
spectinomycin, tetracycline and chloramphenicol (Sarubbi et al., 1974).
Mutation at pen A results in an eight-fold increase in penicillin resistance.
Mutation at mtr results in a two- to four-fold increase in resistance
to penicillin and to other antibiotics, dyes and detergents and is not
linked to any of the other groups of antibiotic resistance genes (Sparling
et a!., 1975; Maier, Zubrzycki and Coyle, 1975). Mutation at pen B2
results in a four-fold increase in resistance to penicillin and tetracycline.
However pen B2 is only expressed phenotypically when a mutation at mtr
is present within the same cell. The cumulative' effect of these three
mutations was a 128-fold increase in penicillin resistance (Sparling et al.,
1975). Modifier genes for penicillin and tetracycline resistance, pem
and tem, have been reported (Warner, Zubrzycki and Chila, 1980).
The pem gene enhances penicillin resistance expressed by the pen and
mtr loci. A strain containing a permutation, with an MIC of 0.05 ug/ml
of penicillin, was transformed to contain both the pen and pem mutations.
The MIC of the resulting transformants was 0.1 |ig/ml (Warner et al.,
1980).
There was no evidence that gonococcal strains carrying pen and
mtr mutations produced g-lactamases or acylases (Sparling et al. , 1975;
Rodriquez and Saz, 1975). It was proposed that these mutations effect
resistance to penicillin by altering the permeability of the gonococcal
cell envelope (Maier et a!., 1975).
3.0 Penicillin resistance mediated by plasmid coded g-lactamase
Percival et al. ( 1976), using isoelectric focussing, showed that
PPNG isolates had two bands of g-lactamase (penicillinase) activity
which focussed at pH 5.5 and pH 5.4. One of these bands focussed at
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the same point (pH 5.4) as the TEM 8-lactamase from E. coli. It has
been shown in DNA-DNA homology studies that gonococcal strains contain¬
ing either the 4.4 Md or 3.2 Md R plasmids contain approximately 40%
of the transposable DNA sequence TnA. This sequence contains the
gene Tn2 encoding for TEM g-lactamase production (Elwellef al .,
1977; Roberts et al., 1977). The 4.4 and 3.2 Md plasmids were found
in gonococci which originated from the Far East and West Africa respec¬
tively (Ashford et al., 1976; Barrow and Philips, 1977).
The TnA sequence is commonly found in the R plasmids of enteric
bacteria such as E. coli (Heffron etal 1975).
3.1 Origin of gonococcal R plasmids
Reports of g-lactamase producing Haemophilus influenzae (Khan
et al., 1974) prior to the appearance of PPNG lead to the suggestion
that gonococci acquired their R plasmids from H. influenzae. It has
been shown that the two gonococcal R plasmids have approximately
70% of their DNA sequence in common and are in turn closely related to
a 4.1 Md R plasmid from a g-lactamase producing strain of H. influenzae
(Roberts et a I., 1977). If the gonococcal R plasmids had arisen as
a result of a transposition of TnA to an indigenous gonococcal plasmid,
it would have been expected that the R plasmids would have had a GC
ratio similar to that of the chromosome (-50) . However, it was shown
that the R plasmids had a much lower GC ratio in the range of 40-41
(Roberts et a I. , 1977). Therefore it appeared that gonococci acquired
their plasmids from another species. It was suggested that N. gonorrhoeae
acquired R plasmids from gram negative enteric bacteria and not from
H. influenzae. It seemed probable that H. influenzae acquired their
R plasmids coincidentally from the same source.
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It has been shown in transformation experiments that DNA deletions
may occur resulting in reduction of plasmid size (Sox, Mohammed and
Sparling, 1979), and it was postulated that the 3.2 Md plasmid may
have naturally arisen as a result of such a deletion.
Although the first PPNG strains were carried into Europe and
America and many are still isolated from people who have been overseas,
reports suggest that in some areas these isolates are now endemic (Embden
et al., 1980; McCutchan, Adler and Berrie, 1982). McCutchan et al.
(1982) reported that the incidence of PPNG in Great Britain has increased
exponentially since 1977. In 1977 there were 15 reported cases of PPNG
and in 1981 there were 443 PPNG isolated. Between 1978 and 1980,
62-68% of the isolates were acquired abroad and 20-26% acquired in the
UK. However, in 1981 only 48% of PPNG were acquired directly or
indirectly from abroad, and 37% were acquired from indigenous sources.
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THE OUTER MEMBRANE COMPONENTS OF N. GONORRHOEAE
The cell envelope of Gram-negative bacteria including N. gonorrhoeae
is composed of three macromolecular components, the outer membrane, the
cytoplasmic membrane and the rigid peptidoglycan layer.
The outer membranes of Gram-negative bacteria, particularly those
of E. coli and Salmonella typhimurium, have been studied for many years.
The knowledge gained from these studies form the models for research
into the outer membranes of other Gram-negative pathogens.
The outer membrane of the gonococcus is undulating, approximately
8.4 nm thick and appears to be a bilayered structure (Morse, Miller
and Hebler, 1977). It is composed of lipopolysaccharide, phospholipids
and proteins.
1. 0 Colony types of N. gonorrhoeae
Kellogg et ai (1963) described four colonial types of the gonococcus
based on size and shape of the colonies. He termed these T1 to T4.
Colony type T1 predominated in primary cultures of clinical specimens.
T1 and T2 gonococci were associated with pilus production whereas
T3 and T4 were associated with non-pilated gonococci. There have
been two additional colony types described, T5 and Tl1 (Jephcott and
Reyn, 1971; Chan and Wiseman, 1975). Colony types Tl, T2 and Tl1
have been associated with gonococcal virulence in infection studies with
human volunteers and with chick embryos (Kellogg et al., 1963; Chan
and Wiseman, 1975). Colony types T3, T4 and T5 were essentially
avirulent.
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1.1 Instability of colony types
Maintenance of colony types Tl, T2 and Tl1 depend upon selective
subculturing at daily intervals. Non-selective subculture leads to
the appearance of types T3, T4 and T5. Chan and Wiseman (1975)
observed colony changes from Tl to T4, T2 to T3, T3 to T4 and Tl1 to
T5.
The colony types still remain a fundamental means of describing
gonococcal strains. However, the description and division of gonococci
into distinct colony types has often complicated studies of the gonococcal
surface structures.
2.0 Gonococcal capsules
The presence or absence of a gonococcal capsule has been a matter
of some controversy. However, in recent years there have been a
number of reports on the presence of capsules on gonococci (Hendly
et at., 1977; James and Swanson, 1977; Richardson and Sadoff, 1977;
De Hormaeche, Thornley and Glau«rt, 1978).
2.1 Definition of bacterial capsules
The criteria for the presence of bacterial capsules is reviewed
by Hendly et at. (1978). Basically, it is defined as being a covering
layer on the organism which is outside the cell wall and has a definite
external surface. The presence of capsules can be demonstrated under
light microscope in wet films stained with India ink and by the quellung
reaction. Both of these methods depend upon the capsule being at
least 0.2 urn in width in order to differentiate it from the cell wall and
from a diffraction halo (Hendly et al. , 1978).
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2. 2 Gonococcal capsules
Gonococcal capsules have been demonstrated on fresh clinical
isolates with wet India ink, methylene blue and in electron microscope
studies with hyperimmune antisera (Hendly et a!., 1977). The width
of the capsular material was determined to be 0.3 pm. Capsules were
found on all gonococcal colony types and were disassociated easily from
the cells by shearing forces (James and Swanson, 1977; Richardson
and Sadoff, 1977).
Capsular production could be stimulated by addition of casein
hydrolysate to the growth media and by co-cultivation with 'viridans'
streptococci (Hendly et a!., 1977; Richardson and Sadoff, 1977).
2. 3 Characterisation of capsular material
The appearance of the capsules was not affected by treatment
with heat, proteolytic enzymes or RNase (James and Swanson, 1977).
The capsules stained with alcian blue and with Ruthenium Red suggesting
that capsules consisted of acidic polysaccharide (James and Swanson,
1977; Hendly et al., 1981). However, gonococcal capsules have not
been isolated and chemically characterised. It is possible that the
material described as being capsular in origin is actually the gonococcal
lipopolysaccharide (LPS) in the process of being shed. Therefore,
the LPS would form a loose layer on the outside of the gonococcal envelope
resembling a capsule.
3.0 Lipopolysaccharide
Information concerning the lipopolysaccharide (LPS) of N. gonor¬
rhoeae has only become readily available in the last 10 years and much
remains to be clarified.
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LPS, also termed endotoxin, appears to play a significant part
in meningococcal disease (Devoe, 1980) and efforts have been made
to characterise and determine the role of gonococcal LPS in gonorrhoea.
3.1 Basic structure of LPS
In enterobacteria LPS is composed of three parts, an O- or somatic
antigen which extends out from the bacterial surface, a core oligosac¬
charide and Lipid A. The O-antigen is a high molecular weight antigenic
polysaccharide made up of species specific oligosaccharide repeating
units with as many as eight monosaccharides per unit. This is linked
by its reducing end to the core oligosaccharide which is composed of
different monosaccharides such as heptose, glucose, mannose, glucosamine
and an eight carbon sugar acid 3-deoxy-D-manno-octulosonic acid (KDO).
Lipid A is bound to the core usually by the KDO residues. Lipid A
is composed of a low molecular-weight D-glucosamine residue which is
acylated with long chain fatty acids usually g-hydroxymyristic acid and
linked by phosphate groups.
The O-antigen and core oligosaccharides are hydrophilic while
Lipid A is hydrophobic (Luderitz, Staub and Westphal, 1966).
3. 2 Smooth and rough LPS
LPS which is composed of all three components is called smooth
LPS (S-LPS) (Figure 2). Occasionally mutants arise which are deficient
in certain enzymes resulting in either the loss of the O-antigen or loss
of some of the core oligosaccharide. Therefore even if the O-antigen
is produced it cannot be attached to the core. This type of LPS is








FIGURE 2: Schematic representation of S- and R-type LPS.
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3. 3 Loss of LPS from the membrane
LPS is found on the outermost part of the gram-negative outer
membrane (Shands, 1965; 1966) and can be spontaneously lost (Crutchley,
Marsh and Cameron, 1968; Rothfield and Pearlman-Kothencz, 1969).
In the neisseriae this loss of LPS has been visualized as a process
of outer membrane 'blebbing' (Devoe and Gilchrist, 1973; Johnston
and Gotschlich, 1974). Free endotoxin which is found in meningococcal
culture supernates (Zollinger et al., 1972; Devoe and Gilchrist, 1973 )
has been shown to be identical to cell bound LPS (Zollinger et al., 1972).
Stead et al. ( 1975) have reported observing long projections
extending from the surface of N. gonorrhoeae which broke up into
vesicles analogous to blebbing seen in N. meningitidis.
Both serological and chemical analyses have been attempted to
characterise gonococcal LPS.
3.4 Serological characterisation of gonococcal LPS
Maeland et al. (1971a,b) were the first to describe carbohydrate
antigens on the surface of N. gonorrhoeae. They called these antigens
a-factors and using specific antisera they could identify six determinants
from three different gonococcal strains. They proposed that these
antigens were immunologically analogous to the O-antigens of the Entero-
bacteriaceae
Later, Apicella ( 1974, 1976) described four serologically distinct
populations of N. gonorrhoeae. These serotype antigens termed Gc i
to Gc k were shown to be acidic polysaccharides and shared similar
core determinants. It was considered that the a factors (Maeland et al.,
1971a,b) were probably attached to and part of the Gc serotype antigens.
Latterly, two other Gc antigens, Gc 5 and Gc 6 were described (Apicella
et al., 1981).
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Further serological analysis of LPS has shown that in addition
to the six serotype antigens, Gci to Gcs, there are also two sets of
antigenically distinct non-serogroup determinants (Apicella and Gagliardi,
1979). One of these is common to gonococci of all six Gc serogroups,
whereas the other is variable and shared by gonococci of only three
serogroups. These variable non-serogroup antigenic determinants
are thought to be analogous with the core oligosaccharides of E. coli
which have been shown to be heterologous (Joklik and Willet cited by
Apicella and Gagliardi, 1979).
3. 4. 7 Characterisation of gonococcal LPS with monoclonal antibodies
Recently monoclonal antibodies have been raised against gonococcal
LPS (Apicella et al., 1981; Morse and Apicella, 1982) and these have
been used to characterise LPS. The two monoclonal antibodies used
were 3F11 and 5B9a.
Monoclonal antibody 3F11:
Monoclonal antibody 3F11 recognises a common region on the LPS
from all six gonococcal serotypes (Apicella et al., 1981). Inhibition
studies with various sugars were undertaken to determine the binding
specificity of this monoclonal. It was found that D-galactosamine completely
inhibited binding of 3F11. Partial inhibition occurred with a-lactose,
g-lactose and with meningococcal LPS and LPS-derived polysaccharides.
LPS isolated from E. coli 0 : 111 and its J-5 mutant, and S. minnesota
R595 failed to inhibit binding of 3F11 to gonococcal LPS.
These results suggest that the antibody recognises a common
core moeity which is composed in part of D-galactosamine-O-D-galacto-
pyranosyl-( l-4)-D-glucopyranose, the 1-4 linkage playing an important
part in recognition. Partial inhibition of 3F11 binding by meningococcal
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LPS suggests that N. meningitidis contains part of this moiety (Apicella
et at., 1981). It has been suggested that the missing part is glucosamine
because meningococcal LPS has been shown to contain little or no glucos¬
amine (Apicella, 1979).
It was thought that additional specificity of monoclonal 3F11 may
depend on the steric relationship of the determinant on intact native
gonococcal LPS (Apicella et al., 1981).
Monoclonal antibody 5B9a:
This antibody reacted with gonococci from all six Gc serotypes
and with LPS from a wide range of gram-negative bacteria. Binding
of this antibody was partially inhibited by N-acetyl-D-glucosamine
and completely inhibited by Lipid A isolated from either gonococci or
from E. coli J-5 (Morse and Apicella, 1982). Therefore, monoclonal
antibody 5B9a seems to recognise Lipid A.
It has been hypothesised that a common portion of the core oligo¬
saccharide containing glucosamine-glucose-galactose-heptose-KDO found
in the rough mutant E. coli J-5 (Elbein and Heath, 1965) is common
to all enterobacteria and other gram-negative bacteria including the
Neisseria (Davis ef at., 1975; Zollinger and Mandrell, 1977). However,
the studies with the monoclonal antibodies 3F11 and 5B9a suggest that
the LPS antigens shared by the enterobacteria and neisseriae reside
in the Lipid A structure and not in the core oligosaccharides (Apicella
et al. , 1981; Morse and Apicella, 1982).
3. 5 Chemical analysis of gonococcal LPS
Chemical analysis has produced some conflicting evidence for
and against the presence of O antigens and about the chemical composition
of gonococcal LPS.
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Stead et al. ( 1975) showed that LPS from five gonococcal strains
extracted by phenol-water and purified by ribonuclease and multiple
washes all contained glucose, galactose, glucosamine, heptose, KDQ,
Lipid A and phosphate. They were unable to detect N-acetylated,
deoxy- or dideoxy-sugars which are characteristically found in Cl¬
an tigens of enteric bacteria. They were unable to detect significant
differences in the LPS isolated from virulent (T1 and T2) and avirulent
(T3 and T4) gonococci. However, it appeared that they did not use
isogenic variants and used cultures of T1 and T2 colony types which
may have reverted in high numbers to T3 and T4 colony types. They
concluded that all gonococci produce an R-type LPS (Stead et al., 1975).
In a similar study, Perry et a I. ( 1975) examined the LPS from T1 and
T4 colony types. Lipid A and a core oligosaccharide composed of 2-amino-
2-deoxy-D-glucose, D-glucose, D-galactose, L-glycero-D-manno-heptose
and KDO were common to all colony types. Unlike Stead et al. (1975),
they found that T1 colony types produced a high molecular weight O
polysaccharide. However, yields of this S-type LPS were inconsistent
and frequently T1 colonial variants only produced an R-type LPS or
occasionally a mixture of S- and R-type LPS (Perry et aI., 1975). They
showed that the high molecular weight O polysaccharide material from
different gonococcal strains varied considerably in its glycose composition
and identified sugars such as rhamnose and fucose. They proposed
that T1 cells produce an S-type LPS with structurally different O-
polysaccharide side chains and that T4 cells produce a common R-type
LPS (Perry et al. , 1975) .
Wiseman and Caird ( 1977) using isogenic variants also found
that virulent T1 and T2 colony types and avirulent T3, T4 and T5 colony
types produced different types of LPS. They found that glucose,
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mannose and galactose were common to all colony types. N-acetylneur-
aminic acid, KDO, glucosamine and galactosamine were also invariably
present. Avirulent T3 to T5 gonococcal variants, N. sicca and N.
lactamica all had rhamnose in their LPS whereas the virulent T1 and
T2 gonococcal colonies did not. However, Perry et at. ( 1975) found
rhamnose only in T1 colonies.
Wiseman and Caird ( 1977) found that the main difference between
LPS from virulent and avirulent gonococci was a quantitative difference
in the glycose-KDO ratios. Virulent strains contained approximately
four-fold more mannose-KDO and galactose-KDO than avirulent strains.
They did not confirm the variability of the glycose composition of LPS
from T1 gonococci reported by Perry et at. (1975).
It was suggested that the increased glycose-KDO ratios in virulent
gonococcal strains might represent the presence of an O-antigen poly¬
saccharide (Wiseman and Caird, 1977). Therefore although Perry et al.
( 1975) and Wiseman and Caird ( 1977) came to similar conclusions that
gonococci may produce an O polysaccharide they found quite different
chemical compositions.
3. 5. 7 Polyacrylamide gel electrophoresis analysis of gonococcal LPS
Recently efforts have been made to clarify the presence or absence
of gonococcal O-antigens. LPS from N. gonorrhoeae and N. meningitidis
have been compared with LPS from S. typhimurium by SDS-PAGE stained
with silver stain of Tsai and Frasch (1982) (Parr and Bryan, 1984;
Mintz, Apicella and Morse, 1984). Although different extraction proced¬
ures were used essentially similar observations have been made.
Parr and Bryan ( 1984) used proteinase K-digested whole-cell
lys ates of a number of gonococcal strains isolated from uncomplicated
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and disseminated gonococcal infections. They observed that the banding
patterns produced on silver-stained gels indicated that gonococcal
LPS was essentially composed of short low molecualr weight molecules
but with a few high molecular weight molecules corresponding to Cl¬
an tigens .
Mintz et al. (1984) used hot phenol water and phenol-chloroform
petroleum ether (PCP) which extract smooth and rough LPS respectively.
In addition to examining the pattern of bands produced by different
LPS preparations following gel electrophoresis, they examined the anti¬
genic composition of the LPS preparations in an ELISA inhibition system.
3. 5. 2 Banding patterns obtained with different LPS preparations
No differences could be observed in the banding patterns of
the two LPS preparations (Mintz et al., 1984). Silver-stained gels
of PCP-extracted gonococcal LPS showed multiple low molecular weight
bands. The banding patterns produced were unaffected by treatment
with pronase, DNase and RNase and were similar in size heterogeneity
to those patterns obtained with S. typhimurium. LPS from S. typhimurium
produced multiple finely stained bands on the gels. The size heterogeneity
of smooth enterobacterial LPS results from differences in the number of
O-repeating units in the side chains of S-LPS molecules (Goldman and
Lieve, 1980). However, it was considered possible that the banding
patterns exhibited by gonococcal LPS might represent aggregates of
LPS rather than differences in the number of repeating oligosaccharides
in the O-antigen (Mintz et al. , 1984). This proved to be the case.
Sodium hydroxide treatment of extracted LPS resulted in a reduction
in the number of bands observed. Only two or three low molecular
weight bands (Mwt 3000-5000) were observed compared with approximately
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20 observed with untreated LPS. Addition of 4 M urea to the gels also
resulted in a similar reduction in the number of LPS bands. However,
EDTA treatment had no effect, suggesting that hydrophobic LPS-LPS
interactions are important.
3. 5. 3 LPS banding patterns in relation to Gc serogroup antigens
Comparison of the banding patterns of LPS extracted from different
Gc serotypes of N. gonorrhoeae showed that there were significant
differences in the structure of the LPS produced by these strains.
Serological analysis of PCP-extracted LPS showed that it contained
very little or none of the serotype antigens compared with hot-phenol
extracted LPS. However, because no differences could be observed in
the banding patterns of the two LPS preparations it was concluded
that the structural heterogeneity of gonococcal LPS may arise due to
small differences in the composition of the basic core structure and/or
in the gonococcal serotype antigens. The results also suggested that
the Gc serotype antigens may represent a single repeat unit or a further
modification of the basic core structure. Therefore, if the Gc serotype
antigens represent the addition of single sugars to or the modification
of the core structure, it is not surprising that no differences could
be observed between PCP and hot-phenol water extracted LPS on SDS-
PAGE gels.
3.6 Factors affecting the composition of gonococcal LPS
The chemical composition of gonococcal LPS may be affected by
a number of factors including different LPS purification procedures
and gonococcal growth conditions. Stead ef al. ( 1975) reported that
longer periods of hydrolysis resulted in increased yields of Lipid A
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and core oligosaccharide. Mintz et al. ( 1984) found that hot-phenol
water extraction gave greater yields of LPS than PCP extraction. There¬
fore it is quite likely that different LPS isolation and purification proced¬
ures affect the components yielded for chemical analysis.
Gonococcal growth conditions:
Variations in gonococcal growth may be another important cause
of discrepancies in the chemical analysis of LPS.
Perry et al. ( 1975) suggested that the production of S-type LPS
was dependent upon some unidentified nutritional requirement. It
has been shown that the LPS isolated from N. sicca cultured with high
growth rates was different from that isolated from the same strain grown
at low growth rates (McDonald and Adams, 1971). Similar observations
have been made with N. gonorrhoeae (Morse et al., 1983). N. gonorrhoeae
FA 171 colony type T4 grown in continuous culture with glucose as the
limiting nutrient showed a growth-rate dependent change in LPS. This
was demonstrated by an alteration in the mobility of purified alkali-
treated LPS in SDS-PAGE, quantitative differences in the amount of
the Gc serotype antigen and changed sensitivity of the strain to the
bactericidal activity of normal human serum (NHS).
The LPS from cells grown at low dilution rates (low glucose con¬
centration) showed one band on SDS-PAGE gels stained with silver.
These cells were also serum-sensitive. Those cells grown at high dilution
rates (high glucose concentration) were serum-resistant and showed
three bands on SDS-PAGE. One of these bands was common to cells
grown at high and low growth rates (Morse et al., 1983). Serological
analysis of the LPS revealed that cells grown at a high dilution rate
contained eight- to nine-fold more serotype antigen.
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3.7 Lipid A composition
Stead et al. (1975) found that Lipid A contained a number of
long chain (10-18 carbon) fatty acids and glucosamine. The composition
of Lipid A from colony types T1 to T5 was found to be essentially the
same and similar to that described by Stead et al. ( 1975) (Wiseman
and Caird, 1977).
3.8 Summary
In summary, gonococci have antigens which are serologically
analogous to O somatic antigens, show structural heterogeneity of their
LPS which appears to be composed of short LPS molecules without the
long somatic antigens of the enterobacteria. The chemical composition
of gonococcal LPS requires to be clarified especially if the serotype
antigens result from minor changes in the basic structure. However,
efforts may be hampered by a number of factors such as the growth
conditions and LPS extraction procedures used.
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4.0 Outer membrane proteins
There are three major classes of protein in the outer membrane
of N. gonorrhoeae and they account for over 60% of the total protein
of the membrane (Johnston and Gotschlich, 1974). They are character¬
ised primarily by their migration following SDS-PAGE and by the modifica¬
tion in their mobility after treatment with heat and reducing agents
(Johnston, 1978; McDade and Johnston, 1980). The three proteins
are termed protein I, protein II and protein III.
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4.1 Protein I
Protein I has previously been called by a variety of names, such
as principal outer membrane protein (POMP) and major outer membrane
protein (MOMP). However, at the EMBO workshop of 1980 it was
proposed that it should be termed protein I or PrI to prevent any con¬
fusion arising with the outer membrane proteins of E. coli (Swanson
and Heckels, 1980). Protein I accounts for 50-60% of the total membrane
protein (Johnston and Gotschlich, 1974; Johnston, Holmes and Gotschlich,
1976), and the subunit molecular weight varies between 32,000 and
39,000 daltons (32-39 K) (Johnston et al., 1976).
4. 7. 7 Early development of protein I research
Initially 14 strains of N. gonorrhoeae isolated from the New York
area could be assigned to five classes according to the electrophoretic
profile of their membranes following SDS-PAGE (Johnston et al. , 1976).
By extending the study to a further 57 clinical isolates the number
of groups were extended to seven on the basis of the molecular weight
of protein I and a minor protein which appeared to covary with protein I.
Outer membrane complexes containing protein I were isolated and antisera
prepared. Using these antisera and extending the number of strains
examined to include isolates from Taiwan, Denmark, Ethiopia, the
Philippines, Vietnam and a further 203 strains isolated from New York,
16 distinct serogroups could be identified. Each serogroup represented
strains with protein I and minor covariant protein of a distinct molecular
weight (Johnston et al. , 1976). No difference could be seen in the
molecular weights of protein I isolated from Tl, T3 and T4 colonial
variants (Johnston et al. , 1976). Protein I is not responsible for the
variations in colony opacity described by Swanson ( 1978a) (Swanson,
1978b; Lambden and Heckels, 1979).
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4. 7. 2 Characteristics of protein I
Protein I is a heat stable protein and its migration on SDS-PAGE
was not altered by boiling (Heckels, 1977; Johnston, 1978; McDade
and Johnston, 1980). Protein I is partially solubilised by treatment
with sodium deoxycholate. The molecular weight of both the soluble
and insoluble protein I are identical (Johnston, 1978).
The envelope proteins of N. gonorrhoeae can be labelled with
125I and lactoperoxidase. Tryptic peptide maps of labelled outer membranes
have indicated that protein Is produce maps quite distinct from those
produced by protein lis or protein-III (Swanson, 1979; Heckels, 1981;
Judd, 1982a).
Amino acid analyses have shown that there are no large differences
in the amino acid composition of proteins I and II, both containing similar
amounts of hydrophobic amino acids (Heckels, 1981). However, Blake
and Gotschlich ( 1983) determined that protein I contains fewer basic
amino acids.
4. 7. 3 Subgroups of protein I
Protein I was subdivided into two subgroups on the basis of
peptide mapping patterns and sensitivity to proteolytic enzymes (Swanson,
1979; Blake, Gotschlich and Swanson, 1981). One group consisted
of protein I molecules with molecular weights of 34 and 33 K and the
second of protein I of 32 K. On the basis of these results it appears
that there are two distinct subgroups of protein I. These have been
termed protein IA and protein IB. The protein IA subgroup contains
the protein I molecules of a lower molecular weight, which are resistant
to in situ proteolysis as described by Blake et al. (1981) and have
approximately 11 peptides in common when examined by peptide mapping
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(Sandstrom, Chen and Buchanan, 1982a). Protein IB subgroup contains
those protein I molecules with a higher molecular weight, with differing
degrees of sensitivity to proteolytic enzymes as described by Blake et
al. (1981) and have approximately 10 common peptides (Sandstrom et al . ,
1982a). Only three of the peptides produced on peptide maps are shared
by both protein IA and IB (Sandstromef a/., 1982a).
4. 7. 4 Orientation of protein I within the gonococcal membrane
Early experiments using 3H-chloride-cycloheptaamylose indicated
that protein I and II are exposed at the gonococcal surface whereas
protein III is blocked or not exposed on the surface (McDade and Johnston,
cited by Johnston, 1978). These results were confirmed by Heckels
(1978).
Recently it has been demonstrated that protein IA and IB have
different orientations within the gonococcal membrane (Blake et at.,
1981; Barrera and Swanson, 1984).
Whole cells of three gonococcal strains were treated with chymo-
trypsin and trypsin (Blake et al., 1981). Two of the strains contained
protein IB molecules with molecular weights of 33 and 34 K respectively.
The third strain contained protein IA of a molecular weight of 32 K.
The 34 K protein I was completely sensitive, the 33 K protein I was
partially sensitive and the 32 K protein I was completely resistant to the
in situ proteolytic activity of these enzymes. Treatment of the 33 and
34 K protein Is with chymotrypsin resulted in cleavage at one site, leaving
two membrane associated fragments. Trypsin cleaved these proteins
at two sites leaving two membrane associated fragments and one much
smaller fragment which was lost to the supernate. From these results
it was proposed that the 33 and 34 K protein Is (PrIB) had a looped
structure with both termini embedded within the membrane (Figure 3).
FIGURE 3: Proposed structure of protein IB and the effect of
chymotrypsin and trypsin treatment (Adapted from
Blake et al. , 1981).
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It was hypothesised that the resistance of the 32 K protein I to
these enzymes may have been due to either the lack of the peptide sequences
required for chymotrypsin and trypsin activity or to this molecule having
a different structure within the membrane (Blake et al., 1981).
Treatment of whole gonococcal cells with proteinase K has con¬
firmed that protein IB has a looped structure. In situ cleavage resulted
in two membrane associated fragments (Barrera and Swanson, 1984).
Protein IA which was insensitive to chymotrypsin was cleaved by protein¬
ase K. In situ cleavage resulted in a single membrane associated fragment
of a slightly smaller size than the intact protein IA subunit with a small
fragment being lost to the supernate. This suggested that protein IA
molecules have one of their termini exposed at the surface of the membrane
but with most of the molecule embedded within it (Figure 4) (Barrera
and Swanson, 1984).
4. 7. 5 Interaction of protein I molecules with protein III within the outer
membrane
Protein I has been shown to have the ability to form multimers
with both itself and with protein III (McDade and Johnston, 1980; Newhall,
Sawyer and Haak, 1980). It was shown that protein I multimers isolated
from gonococcal membranes had a molecular weight of approximately
200 K and that multimers composed of one molecule of protein I and two
of protein III had a molecular weight of approximately 100 K (McDade
and Johnston, 1980). The interactions of protein I with itself and protein
III were examined by cross-linking studies using diimidoesters, which
interact with primary amino acids at pH 8.0, as cross-linking agents.
Initially experiments using ^10 mM concentrations of the cross-linking
agents with whole cells and membrane vesicles resulted in the production
of very large protein complexes. These were too large to enter a 3%
PrIB PrIA
inside
FIGURE 4: Proposed orientation of protein IA and IB within the
gonococcal outer membrane.
(adapted from Barrera and Swanson, 1984)
OM - outer membrane
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polyacrylarnide gel (McDade and Johnston , 1980). This indicated that
the gonococcal surface consists of very large areas rich in protein-
protein interactions. Similar results were obtained by Newhall et al.
(1980).
At concentrations of 1 mM the cross-linking agents produced trimers
of protein I and a dimer of protein I and III. Both reagents used form
cross-links of approximately 1.1 nm suggesting that protein I and III
are very closely associated within the outer membrane (McDade and
Johnston, 1980). It is possible that both these proteins have an important
role in the integrity of the outer membrane.
Protein I can be cross-linked to the peptidoglycon layer (Johnston,
1978). This also suggests that protein I is involved in the structural
rigidity of the gonococcal outer membrane.
4. 7. 6 Functional properties of protein I
Protein I is primarily a porin which forms channels in the outer
membrane through which hydrophilic molecules and ions are taken up
(Greco et al. , 1980; Douglas, Lee and Nikaido, 1981; Young et al. ,
1983).
This was determined by the use of artificial planar lipid bilayers
(Montal, Darszon and Trisel, 1977) which showed that gonococcal protein
I behaved as a cation-selective voltage-dependent gating channel or
pore (Greco et al., 1980). The enzymes trypsin and chymotrypsin when
added to the chamber containing protein I inhibited this activity (Greco
et al. , 1980). Young et al. ( 1983 fusing a different method of preparing
the artificial planar bilayers showed that the porin was cation-selective.
They were unable to confirm anion-selectivity of gonococcal porin reported
by Greco et al. ( 1980) .
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Similar porin structures are found in S. typhimurium and E. coli
(Nikaido and Nakae, 1979). In E. coli trimers of the major outer membrane
protein form pores. Young et at. ( 1983bJconfirmed that gonococcal pores
are formed by protein I trimers, each molecule in the trimer contributing
a pore. They estimated that the diameter of the pores was 11 X.
Recently pores formed by protein IA and protein IB have been reported
to have different sizes (Blake, personal communication, cited by Barrera
and Swanson, 1984).
4. 7. 7 Insertion of gonococcal protein I into non-gonococcal membranes
Protein I on whole gonococci were shown to insert into artificial
lipid bilayers (Blake and Gotschlich, 1983). Protein I was also shown
to be capable of inserting into the membranes of red blood cells. Results
of cleavage with chymotrypsin suggested that the loop of protein I was
localised in the interior of the red blood cells (Blake and Gotschilch,
1983).
Proteins intrinsic to one type of cell membrane have been shown
to transfer to another membrane and this process seems to depend on
the recipient membrane being more fluid than that of the donor (Cook,
Bouma and Huestis, 1980). Changes in the membrane potential of human
macrophages due to the action of the complement C5, C5a complex have
been shown to precede membrane spreading, ruffling and pseudopod
formation (Galin and Galin, 1977). Therefore it is possible that the
insertion of gonococcal protein I into epithelial cell membranes may alter
the membrane potential of the epithelial cells and possibly trigger phago¬
cytosis and internalisation of gonococci by these cells.
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4.2 Protein II
Protein II is associated with the colony opacity variants described
by Swanson ( 1978a). Two types of colony variation were observed on
translucent solid media; colonies which were opaque and tended to be
light tan to dark in colour and colonies which were transparent and
light in colour (Swanson, 1978a). On numerous serial passages gonococcal
colonies were observed to become darker and more opaque. The optical
properties of the gonococcal colonies were independent of pilation and
appeared to be related to the degree of aggregation of gonococci comprising
the colonies. The smallest recognisable unit observed at the edge of
the opaque colonies was clumps of gonococci in chains whereas in trans¬
parent colonies gonococci were usually in pairs.
Gonococci from the different colonies were I125 surface labelled and
treated with trypsin. Trypsin treatment had a greater effect on opaque
colonies. Opaque colonies had greater zones of inhibition to trypsin
discs, a greater decrease in the number of viable organisms and a greater
amount of the surface I125 label was solubilised and released to the super¬
natant (Swanson, 1978a). These observations suggested that opaque
colonies had a glue-like aggregation promoting surface component which
was probably a protein or glycoprotein.
4. 2. 7 Characteristics of protein II
The molecular weight of protein II molecules ranges from 24-30 K
(Lambden and Heckels, 1979; Swanson, 1980). Protein II is a heat
modifiable protein. The migration of protein II on SDS-PAGE gels is
altered by solubilising at 37°C compared with 60°C and 100°C (Heckels,
1977; Johnston, 1978; McDade and Johnston, 1980; Swanson, 1980).
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Protein II is solubilised by treatment with deoxycholate and cannot
be sedimented by centrifugation at 150,000 x g for 60 min (Heckels,
1977; Johnston, 1978).
Amino acid analyses of various protein II molecules have shown
that they contain very similar amino acids and have an almost identical
proportion (~23%) of hydrophobic amino acids (Heckels, 1981). Protein II
is exposed on the surface of the gonococcal outer membrane and can
be surface labelled with 125I and lactoperoxidase (Heckels, 1978; Swanson,
1980). Proteolytic digestion of protein II with trypsin and chymotrypsin
has indicated that it has one terminal (amino) embedded in the membrane
and the other terminal and a large part of the molecule exposed at the
surface (Blake et al. , 1981).
4. 2. 2 Variation in protein II
There are a number of different protein II species and gonococcal
strains may express one or more of these (Lambden and Heckels, 1979;
Swanson, 1982). Gonococcal transparent colonies are generally considered
to contain no protein II. However Swanson (1982) reported finding
a protein II species in an isogenic transparent variant of N. gonorrhoeae
JS3.
Gonococcal isogenic opacity variants of strain P9 have been shown
to contain protein lis of a different molecular weight. These proteins
have been termed protein Ila-IIf (Lambden et al., 1979). These different
protein II's have been associated with a variety of biological properties
such as increased resistance to bactericidal activity of normal human
serum (NHS) and resistance to low molecular weight antimicrobial agents
and Cu2+ and Zn2+ ions.
51.
All strains which produced extra protein lis showed increased
binding to human buccal epithelial cells but showed decreased binding
to red blood cells compared with parent strain or strains not producing
protein II. Strains producing protein Ha showed increased association
with polymorphonuclear leukocytes (PMNs) whereas another variant
producing protein lib* showed decreased association with PMNs (Lambden
et al. , 1979).
Protein Ha* which has a molecular weight of 28.5 K (Lambden
et al. , 1979) may be the same or similar to the previously reported protein,
the leukocyte association factor (LA), with a molecular weight of 28-29 K
(Swanson and King, 1978).
The contribution of protein II to adhesion has been confirmed
by studying the attachment of 125I labelled outer membranes to buccal
epithelial cells (Heckels and James, 1980).
4. 2. 3 Primary structure of protein II species
Although these proteins appear to be correlated with different
virulence properties of the gonococcus, analyses by peptide mapping
has shown that they are remarkably similar in structure (Swanson, 1980;
Heckels, 1981; Judd, 1985).
Swanson ( 1980), Heckels (1981) and Judd ( 1985) examined protein
II species from isogenic gonococcal variants. Swanson ( 1980) also exam¬
ined protein II species from different gonococcal strains. Swanson ( 1980)
and Judd (1985) found that the various protein II molecules had 50-70%
of their peptides in common whereas Heckels (1981) found that nearly all
peptides produced were common to all protein II species with only a few
peptides being unique. Heckels (1981) found that the unique peptides
corresponded to those which were hydrophilic in nature and were
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therefore probably located on the bacterial surface. Judd ( 1985) in¬
dicated that variation in protein II was likely to be in the surface exposed
part of the molecule but that changes in non-exposed parts of the molecule
might cause conformational changes in the protein II resulting in new
domains being exposed at the surface. Structural differences have
been confirmed by Draper et al. (1984). Tentative linear peptide maps
have been generated from V8 protease cleavage studies of protein II
species. These show that protein II molecules have conserved domains
of ~10 K and variable domains of -20 K.
The structural differences in protein II have also been confirmed
by serological studies. Antiserum, raised in rabbits, to protein II is
highly specific for the homologous protein II species and lacks reactivity
with other protein II species produced by isogenic variants of the same
gonococcal strain (Diaz and Heckels, 1982).
4.3 Protein III
Protein III has a molecular weight in the range of 30-31K (Judd,
1982a,b) and is not a heat modifiable protein (Johnston, 1978; McDade
and Johnston, 1980). It is resistant to the effect of in situ proteolysis
(Blake et al., 1981; Swanson, 1981).
Protein III is not readily visualized on SDS-PAGE but can be demon¬
strated by Iodogen-catalyzed radioiodination and autoradiography (Blake
et al. , 1981; Swanson, 1981). It exhibits retarded electrophoretic
migration after treatment with 2-mercaptoethanol (McDade and Johnston,
1980; Judd, 1982a,b), probably as the result of the disrutpion of an
intrachain disulphide band (McDade and Johnston, 1980).
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4. 3. 7 Protein III structural studies
The structural similarity of protein III molecules has been demon¬
strated by Judd ( 1982a,b). 125I-peptide mapping of protein III isolated
from four different gonococcal strains showed that all four protein III
molecules produced peptide-maps that were virtually identical differing
in only a few peptides (Judd, 1982a).
An earlier study indicated that protein III was not exposed or
was blocked at the gonococcal surface (McDade and Johnston, cited
by Johnston, 1978). However, Judd has shown that it is exposed at
the gonococcal surface (Judd, 1982b). Peptide maps of surface labelled
protein III in whole gonococci or in outer membrane preparations indicated
that it has the same portion of its molecule exposed at the surface regard¬
less of which gonococcal strain is examined (Judd, 1982b).
4. 3. 2 Antigenicity of protein III
Initial studies indicated that protein III was antigenically identical
in a number of different gonococcal strains (Johnston, 1978). Recently
a monoclonal antibody, 2E6, has been produced against gonococcal protein
III (Swanson, Mayer and Tarn, 1982). Studies with monoclonal 2E6 have
shown that protein III from three different gonococcal strains all have
the same antigenic determinant (Swanson et al., 1982). Studies with
this monoclonal antibody have shown that protein III retains its anti¬
genicity after treatment with Iodogen and 2-mercaptoethanol and has
confirmed that it is a surface exposed protein (Swanson et al. , 1982).
Swanson et at. ( 1982) have also confirmed the association of protein
III with protein I in heteropolymers. McDade and Johnston ( 1980)
previously reported that protein III and protein I associate to form multi-
mers and suggested that protein III may play an important role in the
54.
structural integrity of the gonococcal membrane. The conserved nature
of the protein III molecules from different gonococcal strains (Judd,
1982a, b) increases the evidence for this role.
4.4 Minor gonococcal envelope proteins
Recently attention has turned towards some of the minor gonococcal
proteins. Zak et al. ( 1984) observed that the sera from four patients
with gonorrhoea reacted with a 43 K gonococcal protein. These sera
reacted equally well with this protein from homologous and heterologous
gonococcal strains. This protein failed to be detected in whole cells or
outer membrane preparations on SDS-PAGE gels stained by Coomassie
blue but showed up as faint lines on autoradiographs after SDS-PAGE of
whole cells labelled with Iodogen. It has been proposed that this protein
be termed protein IV (Zak et al •, 1984).
Cannon et al. ( 1984) recently described a protein antigen, using
a monoclonal antibody (H-8), which was common to N. gonorrhoeae, N.
meningitidis and N. lactamica but not to non-pathogenic neisseriae.
This antigen termed H-8 antigen was heat-modifiable with a molecular
weight of 30 and 20 K after heating at 100°C and 20 K after heating at
37°C. It did not stain with Coomassie blue but did stain with silver
staining. The H-8 antigen was not thought to be a protein II species
and was present in pilated and non-pilated gonococci.
The gene for the H-8 antigen has been cloned in the bacteriophage
lambda (Black and Cannon, 1985). The cloned gonococcal DNA was
approximately 15 kilobases in size. One clone S6H-8 which produced
the H-8 antigen was used to construct a DNA probe. The DNA from
neisseriae which reacted with H-8 and produced the H-8 antigen were
shown to hybridize to the S6H-8 probe (Black and Cannon, 1985).
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A number of other workers have described other protein antigens which
are similar to H-8. Virji, Zak and Heckels ( 1984) have shown that mono¬
clonal antibody SM70 detects an antigen varying in size from 20.5- 26. 5 K
found in pathogenic but not in non-pathogenic neisseriae. This protein
could not be detected on SDS-PAGE gels stained with Coomassie blue
but could be after silver staining (Virji et al., 1984). Zollinger et al.
(1984) described a protein termed CA2 (26-28 K) which was slightly
larger in size than H-8 described by Cannon et at. (1984). However it
shared the property of not staining with Coomassie blue following SDS-
PAGE. Antibody was detected to CA2 in the convalescent sera of patients
with meningococcal infections and in sera from individuals vaccinated
with a meningococcal outer membrane protein vaccine (Zollinger et al.,
1984). On further analysis all of these antigens may be found to be
identical.
5.0 Pili
Pili were first described on N. gonorrhoeae in 1971 (Swanson,
Kraus and Gotschlich, 1971; Jephcott, Reyn and Birch-Anderson, 1971).
These two groups examined the ultrastructure of the gonococcus by
electron microscopy and discovered extracellular fibrous bundles resemb¬
ling pili. Negative staining revealed pili on the surface of gonococci
(Swanson et al. , 1971). The number of pili per gonococcal cell was
difficult to establish but appeared to vary from as few as two to six
or to as many as 25-50. Pili varied in length. However, the majority
appeared to be 0.5-2 pm in length with a few as long as 4 gm. The
diameter of the pili was estimated to be approximately 8 nm (Swanson
et al. , 1971). Pili were found on gonococci of colony types 1 and 2 but
not on types 3 and 4 (Swanson et al., 1971; Jephcott et al., 1971).
Therefore pilation appears to be related to gonococcal virulence.
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Pili have been shown to adhere to a wide variety of human cells
such as epithelial cells, spermatozoa and fallopian tube in organ culture
(Punsalang and Sawyer, 1973; James-Holmquest ef al., 1974; Ward,
Watt and Robertson, 1974).
5.1 Ultrastructure of pili
Each pilus filament is composed of thousands of protein subunits
(pilin) which polymerise to form a linear structure (Brinton, 1965).
The molecular weight of gonococcal pilin subunits varies from approxi¬
mately 17,000-21,000 in pili from different strains (Buchanan, 1977;
Robertson, Vincent and Ward, 1977; Lambden, Robertson and Watt,
1981a).
5.2 Interstrain variation in pili
Pili from different gonococcal strains are antigenically distinct
(Buchanan, 1975). However, it has been shown that there is approxi¬
mately 10% shared antigenicity between pili from three different gonococcal
strains with rabbit antisera and 50% shared antigenicity with human
sera (Buchanan, 1978; Brinton ef al., 1978). Therefore, gonococcal
pili appear to contain regions of shared antigenicity and regions which
are antigenically distinct.
5. 3 Intrastrain variation in pili
In addition to inter-strain variation, intrastrain variation of
gonococcal pili has been described (Lambden, Robertson and Watt, 1980;
Salit, Blake and Gotschlich, 1980). Both groups studied pili from isogenic
gonococcal opacity variants. Salit ef al. ( 1980) examined 14 different
gonococcal strains and found that the opaque variants of 10 of these
strains produced pili with a higher subunit molecular weight than the
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pili from corresponding transparent variants. In addition there were
differences in the buoyant density and isoelectric points of the two types
of pili (Salit et al., 1980).
Lambden et al. ( 1980) examined isogenic variants of N. gonorrhoeae
strain P9, and found similar results to those of Salit et al. ( 1980). A
transparent P9 variant produced pili with subunit molecular weights
of 19,500 whereas the opaque isogenic P9 variant produced pili with
subunit molecular weights of 20,500. These pilus types were termed a
and 8 respectively. These pili were shown to have different buoyant
densities and isoelectric points (Lambden et al., 1981a).
In electron micrographs of gonococci producing the different pili
it was observed that a- pili occurred in large aggregated bundles and
appeared to be produced from a few widely spaced sites on the gonococcal
surface. The 3—pili were well separated, wavy structures which appeared
to radiate from the whole gonococcal surface (Lambden et al., 1981a).
The a-pili showed 45% attachment to human buccal epithelial cells
compared with 13% attachment of 3—pili - The a-pilus attachment was
pH dependant with an optimum at pH 6.5 and appeared to be mediated
by pilus receptors on the epithelial cell surface composed of sialic
acid plus other sugar residues (Lambden et a!., 1980). The binding of
a-pili to epithelial cells could be reduced to the same level as that of
3-pili by removing the sailic acid/sugar receptors by treating epithelial
cells with neuraminidase and exoglycosidase. Both pilus types bound
to human erythrocytes at the same level of 7%. It was postulated that
in addition to receptor specific binding that non-specific hydrophobic
interactions also play a part in pilus binding.
It was observed that on SDS-PAGE gels that 3—pili were always
accompanied by a minor band of a slightly higher molecular weight.
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It was postulated that this band may represent aggregates of g-pili or
possibly a third pilus type (Lambden et a!., 1980). The inoculation
of P9 gonococcal strains producing a- and g-pili into subcutaneous guinea
pig chambers resulted in the in vivo selection of P9 variants producing
two quite distinct pili. These pili were different from a- and g-pili
and were termed y and 6 . They had molecular weights of 21,000 and
18,500 respectively and had different isoelectric points (Lambden et al.,
1981b; Lambden, 1982). Therefore one gonococcal strain is capable
of producing a variety of different pilus types.
Biochemical analysis of the a-, g-, y- and 6-pili have indicated
that the amino acid composition of all four types was very similar (Lambden,
1982). However, there were some individual differences. The low
molecular weight 6 -pili contained less aspartate and serine whereas the
g- and y-pili contained more alanine residues. Tryptic peptide mapping
revealed all four pilus types shared nine common peptides and therefore
there was a certain amount of structural homology. However, each of
the four pilus types produced a number of peptides which were unique
to that particular pilus. In addition some peptides appeared to be common
to 6- and a-pili and others were common to y- and g-pili. Hence it
appeared that <5- and a-pili and y- and g-pili may represent two groups
of structurally related pili (Lambden, 1982).
However, although there appears to be considerable structural
homology it was shown in an ELISA that there was only 10-20%
cross-reactivity between these four pili (Virji, Everson and Lambden,
1982). These results confirm that pili contain common and variable peptide
regions.
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5.4 Chemical analysis of pilin
Chemical analysis of gonococcal pilin subunits has revealed that
the amino acid composition is similar but not identical in pili from different
strains (Robertson et al., 1977; Hermodson, Chen and Buchanan, 1978).
The amino acid composition appeared to be 55% hydrophilic and 45% non-
polar amino acids (Robertson et al., 1977; Hermodson et al., 1976).
Carbohydrate, mostly galactose but also traces of glucose, and phosphates
were also detected (Robertson et al., 1977). It was thought that these
components might be the result of tightly but non-covalently bound
contaminating material. Contamination with carbohydrates has been
reported for pili of E. coli (Armstrong et al., 1981). Carbohydrate
could be completely removed by gel filtration chromatography in the
presence of SDS from one pilus type and approximately 65% from the
other pilus type. Investigation of the phosphate content of these pili
indicated that these groups were involved in phosphodiester linkages
(Armstrong et al., 1981). Similar results have been reported recently
for gonococcal pili (Schoolnik et al., 1984). Approximately 1.5 mol of
galactose and 0.2 mol of glucose were detected per pilin subunit. However,
these were not covalently bound. The phosphate residues detected, two
per pilin subunit, were covalently bound to serine residues. It was
concluded that gonococcal pilin is not a glycoprotein (Schoolnik et al.,
1984) .
5. 5 The primary structure of pilin
Early sequencing studies of the N-terminus of pilin subunits from
four antigenically distinct gonococcal strains showed that all had an
identical amino acid sequence up to and including the 29th residue
(Hermodson et al., 1978). The N-terminal residue in all of these strains
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was the unique amino acid N-methyl phenylalanine. All except two of
the 29 residues in this sequence were hydrophobic in nature. Therefore
it would appear that the N terminus of gonococcal pilin is hydrophobic
and highly conserved in nature. It was suggested that this part of
the pilin polypeptide may play an important structural role in the integrity
of the pilus either by maintaining the conformation of the pilin subunit
or the polymeric pilus structure by subunit-subunit interactions. The
N-terminal sequence contains most of the hydrophobic amino acids of
pilin. Therefore the remainder is hydrophilic in nature and is likely
to be surface exposed (Hermodson et at., 1978).
5.6 Primary structure of pilin subunits in relation to function
Cyanogen-bromide (CNBr) cleavage studies on gonococcal pilin
have indicated receptor binding and antigenic domains (Schoolnik, Tai
and Gotschlich, 1982). Cyanogen-bromide cleavage of pilin subunits
produces three fragments: CNBr-1 N-terminal to residue 7, CNBr-2
residues 8 to 84, and CNBr-3 residues 85 to 160, the carboxy-terminal
portion of the molecule (Figure 5). 1 . Binding studies to human erythro¬
cytes indicate that the CNBr-2 fragment of pilin contains the cell binding
domain. CNBr-2 pilin fragments were able to inhibit the haemaglutination
of both CNBr-2 fragments and whole pili from the opacity variants of
both homologous and heterologous gonococcal strains. The CNBr-2
fragment also binds to Chinese hamster ovary cells (Gubish et at.,
1982). The amino acid composition of CNBr-2 fragments from a number
of different gonococcal pili are very similar and tryptic peptide mapping
show that they have 87% of their peptides in common. N-terminal amino
acid sequencing of different CNBr-2 fragments show that they are identical
in structure (Schoolnik et al., 1982). Therefore it would appear that the cell
CNBr-1 CNBr2 CNBr-3
H.N V J COOH
I 1 1 i L 1'~ To 5 ,CyS CyS. 160I
y > I ' \/
Polymerisation Receptor Binding Type-specific
and determinants
Common determinant
FIGURE 5: Functional and antigenic domains of the gonococcal pilus
subunit (Adapted from Schoolnik et al. , 1982).
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binding domain is highly conserved among pili from different gonococcal
strains. As each pilin subunit contains a cell receptor binding domain,
when assembled the pili would have a linear array of binding regions
along the longitudinal axis of the pilus filament.
In contrast CNBr-3 pilin fragments from different gonococcal pili
indicate that they are chemically diverse. There are differences in
amino acid composition and CNBr-3 pili fragments only share 50% of peptides
on tryptic peptide maps. Therefore the primary structure of the carboxy
terminal region of pilin is variable. This section of pilin did not appear
to be involved in cell binding (Schoolnik et al., 1982). Rabbit antibody
prepared to antigenically distinct pili from two strains of gonococci and
to their CNBr-2 and CNBr-3 fragments revealed that anti-CNBr-2 antisera
could bind to CNBr-2 fragments and intact pili from homologous and
heterologous gonococcal strains. Thus it was shown that this region in
addition to containing the cell receptors also contains a common gonococcal
antigenic determinant. Anti-CNBr-3 antibody bound only to CNBr-3
fragments and whole pili from homologous gonococcal strains. Therefore
this region which is chemically diverse contains the type specific antigenic
determinant of gonococcal pili. CNBr-3 fragments contain a disulphide
bridge and when this is reduced and alkylated the type-specific antigenic
determinant is destroyed (Schoolnik et al., 1982). Although both of
these fragments are antigenic in native pili it appears that CNBr-2 frag¬
ment containing the cell receptors and common antigenic determinants
is less immunogenic than the CNBr-3 fragment. This fragment contains
the region which determines type-specific antigenicity and confers diversity
in gonococcal pili (Schoolnik et a!., 1982).
62.
5.7 Structural analysis of gonococcal pili with monoclonal antibodies
Recently monoclonal antibodies have been prepared to the four
pilus types of N. gonorrhoeae P9 (Virji, Heckels and Watt, 1983). Studies
with these monoclonals confirm that gonococcal pili contain a common
antigenic region and a type specific region. Both antigenic sites contain
more than one epitope (Virji et al., 1983). Type-specific and cross-
reacting monoclonal antibodies used in immunoblotting showed differences
in their reactivity with pili treated with SDS. Cross-reacting monoclonals
SMI and SM2 bound efficiently to the SDS-unfolded pilin from a-, g-,
y- and 6- pili whereas the specific antibodies bound poorly to their
appropriate pilus types under identical experimental conditions. This
suggested that the cross-reacting antibodies recognised the conserved
primary sequence in unfolded pilin subunits whereas the type specific
monoclonals require the variable pilin region to be intact for recognition
(Virji et al., 1983). This confirms the previous observations of Schoolnik
et at. ( 1982) who showed that destruction of a disulphide bridge in the
variable domain (Figure 5) removed type-specific antigenicity.
Monoclonal SMI binds to the conserved CNBr-2 fragment of pili
(Figure 6) (Virji and Heckels, 1983).
Recent studies with these monoclonal antibodies indicate that the
variable type-specific pilus antigenic domains may also be involved in
binding of pili and virulence of gonococci to human epithelial cells (Virji
and Heckels, 1984). The cross-reacting antibodies SMI and SM2, at
high concentrations, were not able to or only partially able to inhibit
binding of a- and y—pili to buccal epithelial cells. Three a-specific and
four y-specific monoclonals were able to inhibit the binding to epithelial
cells of a- and y-pili respectively.
SMI Type-specific monoclonal
[ [ |^ anfibodies
NH CN Br2 f CN BrB COOH
v v '
Conserved epithelial and Variable domain
erythrocyte binding domain -antigenic specificity
Possible cell binding receptor?
I 1
TC-2
Binding to cervical cells
but not HeLa or buccal
epithelial cells
FIGURE 6: Schematic representation of the functional domains and
antigenic sites on gonococcal pilus subunits.
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Previous studies showed that a- and 3-pili adhered to buccal
epithelial cells differentially suggesting that the variable domain of gono¬
coccal pili contained a receptor for epithelial cell binding (Lambden et al.,
1980). However, Schoolnik et al. ( 1982) were unable to demonstrate
cell binding receptors in the variable antigenic pilin domain encompassed
in the CNBr-3 fragment (Figure 5). However, it is possible that
cleavage with cyanogen bromide destroys a receptor site. Tryptic digests
of gonococcal pilin liberated a fragment termed TC-2 which encompassed
part of the CNBr-2 and CNBr-3 fragments (Figure 6). This fragment
was shown to bind to endocervical cells but not to HeLa or buccal epithelial
cells (Schoolnik et al., 1984). It would appear that the cell binding
receptors may confer tissue specificity. The exact site of cell binding
receptors awaits clarification of the structure of pilin subunits and the
conformational arrangement of pilin molecules within intact pili.
5. 8 Examination of clinical isolates with pilus monoclonal antibodies
Pili from a number of gonococcal clinical isolates were examined
using 10 pilus monoclonal antibodies to determine if they produced pili
of the a-, 6-, y- or 6-type found on P9 (Virji and Heckels, 1983).
It was shown that the monoclonal antibodies SMI (specific for
the conserved pilin domain) and to a lesser extent SM2 reacted with
all gonococcal isolates. However, of the eight type-specific monoclonal
antibodies only two showed any cross-reactivity with pili from clinical
isolates. These two antibodies were specific for epitopes on P9 a-pili.
This suggests that gonococci have the capacity to produce a large range
of antigenically diverse pili. Virji and Heckels ( 1983) also showed that
SMI reacted with pili from a large number of meningococcal strains.
Hermodson et at. ( 1978) demonstrated that one strain of N. meningitidis
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shared the same N-terminal amino acid sequence up to residue 29. There¬
fore it is likely that areas of the pilin molecule involved in pilus inter-
subunit interactions and possibly in binding to human cells are conserved
among heisserial species.
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GENETICS OF THE GONOCOCCAL CELL SURFACE COMPONENTS
The components of the gonococcal cell surface are controlled by
chromosomal genes. Mutations at these sites may alter the components
produced by a particular strain and thus affect a number of gonococcal
cell functions.
1.0 Penicillin resistance mutations
The molecular basis of low-level penicillin resistance controlled
by the mutations penA, penB and mtr is now beginning to be understood.
Once the production of enzymes which inactivate penicillin were ruled
out (Sparling et al., 1975; Rodriguez and Saz, 1975), it became clear
that resistance may occur by preventing the binding of penicillin to
the cell wall/membrane and or by altering the permeability of the cell
wall. Rodriguez and Saz ( 1975) first reported observing a reduction
of penicillin binding to gonococcal strains with a reduced MIC to penicillin.
However the exact site of penicillin binding was not clearly characterized.
1.1 Gonococcal penicillin-binding proteins
Penicillin-binding proteins (PBP) are penicillin-sensitive bacterial
enzymes (carboxypeptidases or transpeptidases) situated in the cyto¬
plasmic membrane of bacteria and are involved in peptidoglycan-cross-
linkage during the terminal stages of cell wall synthesis (Davis and
Salton, 1975). The gonococcus has three major PBPs: PBPx, PBP2 and
PBP3 with molecular weights of 90,000, 63,000 and 48,000 respectively
(Dougherty, Roller and Tomasz, 1980). Barbour (1981) confirmed the
presence of three PBPs in the cytoplasmic membrane. However, he
observed slight differences in the molecular weights of these proteins.
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1. 2 The relationship of the penicillin mutations with PBPs
The penA mutation was shown to result in a 30% increase in the
cross-linkage of peptidoglycan and it was suggested that this mutation
might affect a carboxypeptidase or a transpeptidase (Sparling et al. ,
1978). Acquisition of the mtr mutation which confers resistance to peni¬
cillin, to a variety of other antibiotics, dyes and detergents (Sparling
et al., 1975), results in a seven-fold increase in the amount of a minor
outer membrane protein with an approximate molecular weight of 52,000
and a 32% increase in the extent of peptidoglycan cross-linkage (Guymon,
Walstaad and Sparling, 1978a). The relationship of the penicillin resistance
mutations to the PBPs was examined by transformation experiments
(Dougherty et al., 1980). It was found that acquisition of the penA
mutation resulted in decreased binding of penicillin to PBP2 and the
modifier genes pem and term (Warner et al., 1980) were associated with
changes in PBPi (Dougherty et al., 1981). Whereas the transformants
containing the mtr and penB mutations appeared to contain more PBP3
than their penicillin sensitive parents (Dougherty et al., 1981). It has
been recently shown that PBP2 is related to O-acetylation and PBPi with
transpeptidation of peptidoglycan (Dougherty, 1983).
1. 3 Mutations which increase envelope permeability
There is another set of gonococcal mutations termed en v. Strains
carrying these mutations are much more sensitive (hypersensitive) to
antibiotics, dyes and detergents than comparative wild type strains
(Maness and Sparling, 1973; Sarubbi et at., 1975). The env mutations
suppress the phenotypic expression of the mtr mutations if the two
occur within the same strain (Sarubbi et al., 1975). They have been
shown to cause a decrease in the amount of the 52,000 Mwt membrane
67.
protein and the extent of peptidoglycan cross-linkage when compared
with mtr mutants (Guymon et al., 1978a). Therefore the env and mtr
mutations result in the cell envelope being more and less permeable respec¬
tively.
Gonococcal strains containing the env mutations have been shown
to account for 15% of clinical isolates in North Carolina (Eisenstein and
Sparling, 1978).
1.4 Mutations affecting gonococcal LPS
Gonococcal serum-resistance is determined by the loci sac (resist¬
ance to serum antibody and complement) and these genes are thought
to affect the structure of the LPS in the outer membrane (Guymon et al.,
1978b). There are three distinct loci, soc-1, sac-2 and soc-3+ and
each confer distinct levels of serum resistance (Shafer, Guymon and
Sparling, 1982).
Gonococcal strains which are isolated from patients with dissemin¬
ated infections are usually serum-resistant and are highly susceptible
to antibiotics (Eisenstein, Lee and Sparling, 1977). Gonococci containing
the penA and mtr mutations have been shown to have an increased sus¬
ceptibility to killing by one or more PMN proteins (Cannon et al., 1980b;
Daly et al., 1982). This may explain why gonococcal strains isolated
from DGI seldom carry these mutations (Eisenstein et al., 1977).
1.5 Protein I
There are two loci associated with control of protein I production,
nmp-1 and nmp-2 (new membrane protein) (Cannon et al., 1980a,b).
The gonococcus has two distinct protein I molecules, protein 1A and
protein IB (Sandstrom et al., 1982a). It has been suggested that nmp-1
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and nmp-2 could represent different alleles of a structural gene for
production of protein I or alternatively each could represent a distinct
gene determining which form of protein I is synthesized and inserted
into the outer membrane (Cannon et al., 1980b).
These loci were discovered after observations that gonococcal
strains transformed independently to penicillin resistance by penB and
serum resistance by sac acquired the same protein I type as the donor
strains (Guymon et al., 1978a,b; Sparling ef al., 1978). Initially it
was thought that these genes conferred changes on protein I, however
it was shown that penB was genetically linked to nmp-1 (Cannon et al.,
1980a) and sac to nmp-2 (Cannon et al., 1980b) and thus these genes
could be co-transformed.
1.6 Protein II
Little is known about the genetic control for the production of
the various protein II species found in isogenic variants of one strain
or indeed in other strains of gonococci. However, recent work suggests
that protein II species within a single strain are products of similar
but distinct structural genes (Schwalbe, Klapper and Cannon, 1984).
Meyer et at. (1984) have identified one such gene termed opaE 1.
1. 7 Genetic control of pilus production
Genetic analysis of pilus expression using specially constructed
DNA probes (Meyer, Mlawer and So, 1982) indicated that the gonococcal
genome contains a number of pilus-related sequencies. Transition from
the pilated (P+) to non-pilated (P~) state was shown to result in chromo¬
some rearrangement. This chromosomal rearrangement is reversible.
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Recent chromosomal mapping has identified three major chromosomal
pilus genes within a 5% fragment (80 kbp) of the gonococcal chromosome
(Meyer et a!., 1984). These studies also indicate that there are many
other pilus-related sequences scattered throughout the gonococcal chromo¬
some.
The three loci described have been termed pilEi, pilEz and pilS i.
The loci pilE i and pilE 2 code for pilus production. It is not known whether
one or other or both are expressed simultaneously. However, in the
gonococcal strain (MS 11) studied both of these sites were found to be
identical (Meyer et at., 1984). PilEi and pilEz are both found within
the region of the chromosome which undergoes rearrangement during P +
to P~ transition.
The third locus pilS 1 was designated as a silent region because
it does not contain a promotor sequence. It is found in a region which
does not undergo rearrangement during P+ to P" transition. PUS 1 appears
to contain genetic information for part of the pilin structure, probably
for a variable region of the pilin molecule. It is possible that the other
areas of the gonococcal chromosome which contain pilus-associated regions
may contain other silent regions like pilS 1 and possibly promotor sequences.
However these sequences await characterization.
It has been hypothesized that genetic control of pilin production
in gonococci might be analogous to genetic control of immunoglobulin
production in B lymphocytes. A gonococcal strain would thus be able
to alter its pilus structure by switching on one of the variable sequences
such as PilSi coding for a different variable pilin region (Meyer et al.,
1984). Therefore gonococci could change their pilus structure in response
to changing environmental conditions in a completely flexible manner.
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The conserved part of the pilin molecule is thought to be coded
by DNA sequences in completely different parts of the chromosome.
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METHODS OF CLASSIFICATION OF N. GONORRHOEAE
A method of classifying gonococcal isolates is required for epidemio¬
logical and research purposes. For a number of years a non-serological
classification system, auxotyping, was the primary method used for
distinguishing different gonococcal strains. Recently methods for the
serological classification of N. gonorrhoeae have been developed.
1.0 Auxotyping
Auxotyping was developed in 1973 by Carifo and Catlin. It is
based upon the nutritional profile of gonococcal isolates on chemically
defined media. Thirty-five auxotypes have been identified (Catlin,
1978). These range from gonococci which are prototrophic and are
thus able to grow on media lacking one or more nutrients to those strains
which require the addition of up to six nutrients. The auxotype charac¬
teristics are stable during subculture (Carifo and Catlin, 1973).
Differences in the geographical distribution, differences in the
antibiotic sensitivities, association with site of infection and clinical
syndromes have been associated with particular gonococcal auxotypes
(Knapp and Holmes, 1975; Catlin and Pace, 1977; Crawford et a!., 1977;
Knapp et al., 1978). Gonococcal strains of auxotype 14 requiring arginine,
hypoxanthine and uracil for growth (AHU-) have been associated with
disseminated gonococcal infections and with asymptomatic urethral infec¬
tions in men (Knapp and Holmes, 1975; Catlin and Pace, 1977; Crawford
et al. , 1977; Turgeon and Granger, 1980).
Auxotyping has provided valuable information about N. gonorrhoeae.
However it is a laborious and expensive technique and nowadays only
gonococcal reference laboratories are likely to use auxotyping routinely.
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2.0 Serological classification of N. gonorrhoeae
Since the early 1970s attempts have been made to find an acceptable
system for serogrouping gonococci. A number of gonococcal outer mem¬
brane components have been examined for this purpose.
2.1 Gonococcal lipopolysaccharide and pili
Antigenic differences in gonococcal LPS and pili have been investi¬
gated as the basis of serological classification systems.
Gonococci have been divided into six serogroups (Gc 1-6) on the
basis of antigenic differences in the acidic polysaccharides of LPS
(Apicella, 1974, 1976; Apicella et al., 1981). However this classification
system has been used mostly for determining differences in gonococcal
LPS and has not been widely used for epidemiological purposes.
Pili are antigenically heterogeneous and there are a large number
of serologically distinct pilus types (Buchanan, 1975, 1977). However,
because pili are lost on subculture serotyping of gonococci based on
pili is not suitable for epidemiological purposes.
2. 2 Serological classification based on protein I
Any system for typing bacteria must be based upon stable charac¬
teristics and the impetus for the development of serogrouping systems
based on protein I stemmed from the work of Johnston et al. ( 1976).
These workers divided gonococci into 16 serogroups on the basis of
differences in the molecular weight of protein I (then termed MOMP)
and a covariant minor protein. This study gave rise to the MOMP ref¬
erence strains (Johnston et a!., 1976).
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2. 2. 7 Development of serogrouping by coagglutination
Sandstrom and Danielsson ( 1980a) developed a system of sero¬
grouping by coagglutination (CoA). This system is based upon the
attachment of anti-gonococcal I gG to protein A on whole killed staphylo¬
coccal cells (Figure 7). The addition of gonococcal cells which have
determinants that react with the I gG attached to the staphylococci results
in agglutination which is visible to the eye. CoA was first used as a
confirmatory serological test in the identification of N. gonorrhoeae
(Danielsson and Kronvall, 1974).
Antisera raised to the MOMP reference strains (Johnston et al.,
1976) were characterised by line-rocket immunoelectrophoresis (L-RIE)
and CoA (Sandstrom and Danielsson, 1980b). It was demonstrated by
both these methods that rabbit hyperimmune antigonococcal antisera
contained reactivity against common as well as strain specific and cross-
reactive antigens. On the basis of these results the MOMP reference
strains were initially divided into two groups. These groupings were
confirmed by CoA carried out with antisera absorbed with strains from
within the same antigenic group and with absorption with a cross-reacting
and non-cross-reacting strain from the other antigenic group (Sandstrom
and Danielsson, 1980b). These results formed the basis for producing
reagents for the CoA classification system.
Using antisera raised to and selectively absorbed by the MOMP
reference strains, Sandstrom and Danielsson (1980a) described three
classes of reactions, W, J and M.
The W class could be further subdivided into three serogroups,
WI, WII and Will. Each of the MOMP reference strains belonged to only
one of these groups. Some of these reactions were sensitive to pronase
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FIGURE 7: Schematic
reaction.
representation of the coagglutination (CoA)
74.
to be based upon protein antigens (Sandstrom and Danielsson, 1980a).
These reactions were stable during subculture and did not vary with
colony morphology.
Some of the class J reactions were sensitive and some were resistant
to pronase. All were resistant to periodate. Although some of the
reactions were thought to resemble the W reactions, the J reactions
often varied with colony morphology (Sandstrom and Danielsson, 1980a).
Only seven of the MOMP reference strains reacted with the five reagents
for this group and it was thought that these reagents recognized strain
specific antigens. It is possible that they may represent serological
reactions with protein II.
Group M reactions were periodate sensitive, were inhibited by
lactose and varied with subculture. It would appear that these reactions
recognized LPS or acidic polysaccharides (Sandstrom and Danielsson,
1980a).
The W reactions were used for serogrouping N. gonorrhoeae
because they were stable. Using CoA W reagents, Sandstrom and
Danielsson (1980a) serogrouped a number of clinical isolates and refer¬
ence strains. They found that there was a sharp antigenic demarcation
between WI and WII serogroups and that there appeared to be a gradual
order of relatedness within each serogroup. It was thought that strains
in serogroup Will might be related to those in serogroup WII. It was
proposed that serogroup WI and WII represented antigenic differences in
two different alternative structures.
2. 2. 2 Serotyping based on protein I
Hildebrandt and Buchanan ( 1978) using an enzyme linked immuno¬
sorbent assay (ELISA) determined that serum-resistant gonococcal strains
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isolated from patients with disseminated infections (DGI) contained a
particular type of protein I. They found that this protein I was present
in only 30% of serum sensitive gonococcal strains from localized infections
(Hildebrandt and Buchanan, 1978). From these initial observations
they developed an antigen-specific serotyping system based upon protein
I in an inhibition ELISA (Buchanan and Hildebrandt, 1981). Purified
protein I was used to coat ELISA tubes and either purified protein I or
whole untreated gonococcal cells were reacted with a constant amount of
protein I specific antisera. Gonococcal strains were considered to belong
to a particular serotype if they caused S30% inhibition of antibody binding
in the ELISA.
Using purified protein I from a variety of gonococcal reference
strains a total of nine different protein I serotypes were described.
Eight of the nine protein I serotypes were antigenically distinct. Sero¬
types 1 and 2 were shown to be antigenically closely related. These
two serotypes were kept as separate groups because they frequently
typed the more invasive gonococcal strains and because 40% of the salpin¬
gitis and DGI strains contained protein I which reacted with only one of
the two serotypes. 94% of gonococcal isolates from DGI and 60% isolated
from patients with salpingitis belonged to serotype 1 compared with
40% of strains isolated from localized infections. The majority of these
serotype 1 strains were also typed as serotype 2 (Buchanan and Hildebrandt,
1981). The MOMP reference strains were typed by one or more of the
protein I serotypes.
3.0 CoA W serogroups detect protein I antigens
Initial studies on gonococcal strains isolated from patients with
DGI and PID suggested that CoA serogrouping and protein I serotyping
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by ELISA detected similar antigens (Sandstrom and Buchanan, 1980).
This was confirmed in further studies (Sandstrom, Knapp and Buchanan,
1982b). A total of 224 strains were analysed by both the CoA W sero-
grouping and ELISA protein I serotyping systems. Included were 197
clinical isolates and 27 gonococcal reference strains. Once antisera
used in the ELISA serotyping system had been absorbed to remove anti¬
bodies to LPS it was shown that CoA W serogroups and the protein I
serotypes detected protein I. Strains of CoA serogroup WI were shown
to correspond to protein I serotypes 1, 2 and 3. CoA serogroup WII
strains corresponded to protein I serotypes 4, 5, 6 and 7 exclusively.
Some of the WII strains also reacted with serotypes 8 and 9 as did CoA
Will strains (Sandstrom et al., 1982b).
A few if any antigenic sites are shared between strains of CoA
serogroup WI (serotypes 1 to 3) and strains of CoA serogroups WII and
Will (serotypes 4 to 9). However, within these two groupings there is
some antigenic variation. These results suggested that there were two
different biochemical forms of protein I. One which is detected by CoA
serogroup WI reagents and the other detected by serogroup WII reagents.
It was proposed that the CoA serogrouping system which utilized boiled
cells may recognize less exposed shared antigenic determinants in addition
to variable protein I antigenic determinants. Whereas the protein I
serotyping, utilising untreated whole cells, may in general recognize
the more variable and surface exposed antigenic determinants. It was
proposed that the CoA serogroups WI and WII/Will recognize two different
groups of protein I molecules and the ELISA protein I serotyping charac¬
terizes one or more variable antigenic determinants on these molecules
(Sandstrom et at., 1982b). It would appear that CoA serogroup Will
represents a prominent antigenic determinant of the protein I molecule
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which is analogous to serotype 9 rather than a third group of protein I
molecule (Sandstrom et at, 1982b). Direct evidence for this has come
from 1125-labelled tryptic peptide maps of protein I from gonococci charac¬
terized by the CoA W serogrouping system (Sandstrom et al., 1982a).
Gonococcal strains of CoA serogroup WI tend to have protein I molecules
of a lower molecular weight than those of serogroups WII and Will. 125I
labelled peptide maps of protein I from 13 WI strains, 16 WII strains
and 4 Will strains are quite distinct in pattern. Protein I molecules
from serogroup WI and WII/Will strains were named protein-IA and protein-
IB respectively. Protein IA was shown to have 11 peptides in common,
4 acidic, 4 neutral and 3 basic. PrIBs shared 10 common peptides, 5
acidic, 1 neutral and 4 basic (Sandstrom et al., 1982a). Only 3 peptides
are common to both protein IA and IB molecules.
The CoA W serogrouping system is very easy to carry out and
has been widely accepted. Recently monoclonal antibodies have been
produced to protein I. These correspond to the three CoA W serogroups
(Tam et al., 1982). CoA reagents prepared with these monoclonal anti¬
bodies are now beginning to be used for serogrouping of N. gonorrhoeae.
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PATHOGENICITY AND IMMUNITY
Pathogenicity is dependent on the interaction of both the infecting
organism and the host defence mechanisms for production of symptoms,
severity, limitation and eradication of infection. The development of
gonorrhoea depends upon three stages: attachment of gonococci to
the host mucosal surfaces, gonococcal penetration into the subepithelial
tissue and lateral spread and dissemination of organisms. Gonorrhoea
is a specific infection of humans and pathogenicity studies have been
hampered by the lack of a suitable infection model.
1.0 Attachment
The importance of adherence of N. gonorrhoeae to human mucosa
in the pathogenesis of gonorrhoea is not known. It is reasonable to
expect that some form of anchoring would be required to prevent the
gonococcoci being washed off the mucosal surfaces by urine and genital
secretions. Microscopic examination of urethral exudate from men with
symptoms of gonorrhoea for less than 24 hours demonstrated that gonococci
appeared to be in very close contact with epithelial cells and that the
microvilli of the epithelial cells appeared to wrap themselves round the
gonococci (Ward and Watt, 1972). Similar observations were made in
cervical biopsies taken from women with cervical gonorrhoea (Evans,
1977). Gonococcal-gonococcal adhesive interactions may also be important
in maintaining multiplying cells at the mucosal surface.
Protein II and pili are the main gonococcal surface structures
implicated in adhesion to host cells.
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1.1 Pili in attachment
The exact role of pili in the pathogenesis of gonorrhoea is not
clear. Pili have been demonstrated to adhere to a variety of human
cell types such as epithelial cells, erythrocytes, spermatozoa and fallopian
tubes in organ culture (Punsalong and Sawyer, 1973; James-Holmquest
et al. , 1974; Ward et al., 1974).
Gonococci produce a wide variety of different pilus types and
these may bind differentially to different cell types (Lambden et al.,
1980). Binding may be mediated by specific ligand-receptor and/or
by non-specific hydrophobic interactions (Lambden et al., 1980). Recent
structural analysis of gonococcal pili indicate that certain domains on the
gonococcal pilus may be involved in these interactions (Schoolnik et al.,
1982; Virji and Heckels, 1984; Schoolnik ef al., 1984). However,
observations that non-pilated gonococci of colony type 4 bind to fallopian
tube mucosa and to different types of epithelial cells (McGee et al.,
1978; James et al., 1980) indicate that factors other than pili are involved
in the interaction of gonococci with the host cell surface. It has been
postulated that the initial role of pili is to overcome the repulsive negative
charges on the gonococcal and host cell surfaces (Heckels et al., 1976).
By overcoming repulsive negative charges, pilus-host cell non-specific
hydrophobic interactions may come into play bringing the two cell types
closer together. The closer association of gonococci and host cells may
in turn allow specific pilus ligand-receptor interactions to come into
force. The closer association of the organism to the host cell surface
may allow other gonococcal surface structures such as protein II to come
into effect. However, the relevance of pili in the pathogenesis of natural
infections is not clear. Examination of gonococci in pus from patients
with gonorrhoea have indicated that these organisms possess very few
or no pili (Novotny, Short and Walker, 1975; Evans, 1977).
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1. 2 Protein II in attachment
The production of various protein II molecules has been associated
with increased gonococcal binding to buccal epithelial cells, red blood
cell and to polymorphonuclear leukocytes (PMNs) in vitro (Lambden
et at., 1979). Attachment experiments utilising different host cell lines,
cultured tissues and gonococcal isogenic colony opacity/pilated variants
indicated that certain proteins may bind specifically to particular host
cell lines (James et al., 1980). The attachment of a non-pilated opaque
variant to human embryonic lung fibroblasts was shown to be equal to
that of pilated transparent (lacking in protein II) variants. The trans¬
parent colony variants appeared to attach more to cultured cervical
and fallopian tube tissue (James et at., 1980). Gonococcal transparent
variants are commonly isolated by laparoscopy from fallopian tubes and
cul de sacs of patients with salpingitis (Draper et al., 1980). Colony
type 4 transparent variants lacking in protein II and pili have been
shown to attach to fallopian tube mucosa in much greater numbers than
pilated commensal neisseriae (McGee et al., 1980). Therefore it would
appear that some other additional factor other than protein II and pili
may also be involved in attachment.
2.0 Invasion
Invasion and damage of the mucosal surface are an integral part
of the development of gonorrhoea. Without these two aspects gonococci
would be little different from commensal bacteria found in the urogenital
tract. In the classical study of gonorrhoea, Harkness ( 1948) observed
that gonococci reached the subepithelial connective tissue on the third
or fourth day post infection. Penetration was accompanied by capillary
dilation with exudation of serum and cells. The dense cellular infiltrates
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consisted of PMNS with small numbers of lymphocytes, plasma and mast
cells. There was patchy involvement of the epithelium where the inter¬
cellular spaces were enlarged and contained large numbers of leukocytes.
The epithelial cells in these patches were destroyed and desquamated
to leave small areas in which the subepithelial connective tissue was
completely exposed. PMNs, many containing gonococci, eventually found
their way into the lumen of the urethra in large numbers. These together
with serum and desquamated epithelial cells form the diffuse yellow dis¬
charge which is characteristic of gonorrhoea. Harkness ( 1948) described
gonorrhoea in women to be similar to that in men. However the extent
to which invasion and damage occurs may vary in patients with symptomatic
and asymptomatic infections.
2.1 Penetration of the subepithelial tissue
Penetration studies have been carried out using mainly human
fallopian tubes in vitro. Studies have shown that 3 to 8 h after challenge,
gonococci had attached to columnar epithelial cells of fallopian tubes.
By 24 h gonococci had penetrated the mucosal surface and foci of gonococci
were visible in the subepithelial connective tissue (Ward et aI., 1974).
Some mucosal cells contained very large numbers of gonococci and this
suggested that intracellular multiplication occurs. The cytoplasmic mem¬
brane adjacent to adherent gonococci excluded collodial thorium suggest¬
ing that penetration did not occur by erosion of the cytoplasmic membrane
(Ward et al., 1974). Intercellular penetration also seemed unlikely since
8 h after challenge, by which time gonococci were visible intracellularly,
the tight junctions between epithelial cells remained intact excluding
electron dense colloids (Watt and Ward, 1977). Therefore it was proposed
that the mechanism of penetration was phagocytosis of gonococci by
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the host cell (Watt et at. , 1978). Later experiments (McGee et at. , 1983)
showed that approximately 20 h after infection the microvilli of non-
ciliated human fallopian tube mucosal cells to which gonococci were attached,
began to retract pulling the gonococci to the surface of the cell. Other
microvilli appeared to surround the gonococci and entrap them against
the cell surface. The cell surface then retracted pulling the gonococci
into a membrane-bound vesicle in a manner similar to phagocytosis of
bacteria by PMN leukocytes. These phagocytic vesicles then appeared
to be rapidly transported to the base of the cell. There the gonococci
either multiplied with enlargement of vesicles and/or fusion of multiple
vesicles occurred. Approximately 40 h post infection the vesicles appeared
to rupture with release of gonococci into the subepithelial layers of the
fallopian tubes. This appeared to occur by a process of exocytosis
(McGee et a/., 1983). Infecting gonococci appeared viable at all stages.
2.2 Protein.I
Gonococcal protein I has been shown to insert into red blood cell
membranes. In other systems the disruption of membrane potentials
by an inserting protein has been shown to trigger phagocytosis (Galin
and Galin, 1977). Therefore protein I may play a similar role in the
pathogenesis of gonorrhoea.
Invasion of the subepithelial tissue allows the gonococcus the
chance to spread laterally within the submucosa, to enter the blood
stream and possibly also the lymphatic system to cause complicated local
gonococcal infections and DGI. Particular gonococcal strains have been
associated with invasive infections. These generally have the charac¬
teristics of belonging to serogroup WI, have an AHU~ auxotype, are
resistant to the bactericidal activity of normal human serum and are
usually very sensitive to penicillin.
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Women are particularly at risk of developing invasive gonococcal
infections at the time of menses (Harriman et al., 1982). Gonococcal
transparent colonial variants are frequently isolated from women during
this phase of the menstrual cycle (James and Swanson, 1978a).
2.3 Lack of invasion of subepithelial tissue in asymptomatic infections
Ward and Watt ( 1972) proposed that gonococci may be able to adhere
to and multiply at the epithelial surface without invading the mucosal
surface. Organisms able to do this may be responsible for asymptomatic
infections. Evans ( 1977) observed that gonococci were primarily found
on squamous epithelial cells rather than on columnar epithelial cells of
the cervix. He suggested that gonococcal association with these cells
which are quickly desquamated might also be a reason for asymptomatic
infections in women (Evans, 1977). This association with non-columnar
epithelial cells in women may account for the observations that over
60% of women have asymptomatic genital infections compared with approxi¬
mately 10% of men. However asymptomatic infections may also be attributed
to a lack of inflammatory response by the host towards particular gonococcal
strains.
3.0 Inflammatory response
Penetration of the subepithelial connective tissue, the multiplication
of gonococci and damage of the epithelial cells results in products which
stimulate an intense inflammatory response.
3.1 Tissue damage
Epithelial cell damage may be mediated by the release of endotoxin
(LPS) from multiplying gonococci and by gonococcal peptidoglycan.
Endotoxin has been shown to be toxic for human fallopian tubes in cell
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culture (McGee ef al. , 1978; Gregg et al. , 1981; Melly, Gregg and
McGee, 1981). Peptidoglycan also has been shown to cause toxic damage
to fallopian tubes in organ culture (Rosenthal et al. , 1980). Damage
to mucosal surfaces by endotoxin and peptidoglycan may also occur in
vivo. Novotony et al. ( 1977) have reported that blebbing of the gonococcal
envelope occurs in vivo. Tissue damage may also be mediated by products
released from dead phagocytes.
The inflammatory response results in the infiltration of mononuclear
(MN) and PMN leukocytes into the mucosal tissue.
3. 2 Interaction of gonococci with phagocytes
Earlier studies indicated that non-pilated gonococci of colony
types 3 and 4 in the presence of normal human sera ( NHS ) were ingested
and killed by PMN leukocytes whereas pilated gonococci of colony types
1 and 2 attached to but were not ingested or killed by PMNs (Thongthai
and Sawyer, 1973; Ofek, Beachy and Bisno, 1974; Dilworth, Hendly
and Mandell, 1975). Novotony et al. ( 1977) examined the pus from men
and women with acute gonococcal infections. They observed that clumps
of gonococci were surrounded by cellular debris or granules which were
of phagocytic, probably mononuclear leukocyte (MN), origin which they
termed infectious units. They proposed the following model for the
pathogenesis of gonorrhoea. The host is infected with free non-multi¬
plying gonococci and multiplying gonococci within infectious units. In¬
fectious units make contact with the epithelial cells and can be found
intracellularly. Multiplying gonococci within the infectious units are
presumbed to be highly leukotoxic and stimulate the infiltration of PMN
and MN leukocytes. The free gonococci are rapidly phagocytosed. Those
in PMNS are destroyed whereas those phagacytosed by MN leukocytes
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multiply, break down the monocytes and are coated in the debris forming
new infectious units. As the gonococci multiply in the infectious units
the host cell components are used up and liberate free non-multiplying
gonococci. These are then rephagocytosed by either PMN or MN leukocytes
and the cycle is repeated (Novotny et al ., 1977). They found no evidence
that infectious units were formed with PMN leukocytes. However the
cellular debris was shown to be of human origin using antisera raised
against PMNs. Other workers in studies of urethral pus have shown
that gonococci found within PMN s appear morphologically intact and some
even appear to be in a state of division (Novotny et al., 1975; Ovcinnikov,
Delektorskij and Dmitriev, 1976; Ovcinnikov and Delektorskij, 1977;
Evans, 1977). Others have indicated that gonococci can survive or
that there is a delay in killing by PMNS during in vitro experiments
(Veale, Smith and Witt, 1975; Witt et al. , 1976). Experiments conducted
in vitro and in guinea pig chambers have indicated that although a large
proportion of gonococci are killed by PMN and mononuclear phagocytes
a proportion are able to survive and multiply within these host cells
(Veale, Penn and Smith, 1978). These workers proposed that survival
within PMN leukocytes may be important in acute infections whereas
survival in the longer lived MN leukocytes may be important in the lateral
spread of infection and in chronic gonococcal infections (Veale, Penn
and Smith, 1977).
4.0 Gonococcal components involved in survival within PMN phagocytes
Some of the gonococcal surface structures may be involved in
promoting protection from killing by PMN leukocytes.
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4.1 Protein II
Analysis of the outer membrane vesicles isolated from N. gonorrhoeae
BS4 which shows resistance to killing by PMNs and its isogenic variant
which is sensitive to killing by PMNs have indicated the involvement
of surface proteins in the resistance to phagocytic killing (Parsons et al.,
1982). Antiserum raised to whole gonococci resulted in promotion of
phagocytosis and drastically reduced the ability of BS4 to survive within
PMNs. Antisera raised to pili did not promote phagocytic killing of BS4 .
Antiserum absorbed with gonococcal outer membrane vesicles ceased
to promote phagocytic killing (Parsons et al., 1982). Analysis of the
proteins in the outer membrane preparations isolated from BS4 and its
isogenic variant have indicated the possible involvement of three proteins
A, B and C in resistance to phagocyte killing. Protein A was classified
as a species of protein II. Previous work has shown that the presence
of protein lib on variants of N. gonorrhoeae P9 results in decreased
association of the organism with PMN phagocytes (Lambden et al., 1979).
Proteins B and C shared the characteristic of staining poorly with
Coomassie blue on polyacrylamide gels (Parsons et al., 1982). A number
of minor gonococcal proteins which share this feature are now beginning
to be characterised (Cannon et a!., 1984; Zak et al., 1984; Virji et al.,
1984). The role of these proteins in gonococcal resistance to killing
phagocytes remains to be elucidated.
4. 2 Protein I
Protein IA molecules and protein I from patients with DGI, which
usually have protein I of this type (Cannon et al., 1983), are more efficient
at inserting into lipid bilayers than those strains from localized infections.
Treatment of PMN leukocytes with protein I appears to prevent polymorph
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degranulation but has no effect on the morphology of these cells (Blake,
ML, presented at the 4th International Conference on Pathogenic Neisseria,
Asilomar, California, October 1984). Therefore it is possible that gonococcal
strains isolated from patients with DGI with a particular type of protein I
molecule may be more effective at thwarting the activities of PMN leukocytes.
Protein I and II can be degraded by PMN phagolysosomal enzymes.
Protein II molecules are more susceptible to these enzymes than protein I
(Eaton and Rest, 1983). Therefore the role of protein 1 may be in prevent¬
ing engulfment by PMNs. However, once engulfed, protein I may aid
intracellular survival by preventing the release of PMN enzymes.
An increase in the degree of peptidoglycan cross-linkage has
been shown to increase the sensitivity of N. gonorrhoeae FAI9 to 02-
independent killing by human PMN leukocyte mixed or isolated azurophilic
granule extracts (Daly et aI., 1982). This was demonstrated by the
increased sensitivity of FAI9 when containing the penA 2 and mtr mutations
which increase peptidoglycan cross-linkage. Gonococcal strains containing
these mutations are seldom isolated from patients with DGI. However,
much more evidence is required to ascertain the exact role played by
these structures in survival within phagocytes.
4.3 Leukotaxic activity produced by gonococci
Neisseria gonorrhoeae of colony types 1, 2 and 3 have been shown
to produce a soluble chemotaxin which stimulates the migration of PMN
leukocytes towards gonococcal cells producing this component (Rank
and Holmes, 1984). Chemotactic activity was reduced after treatment
with trypsin, pronase, aminoglucosidase and lipase suggesting that
the factor was a glycopeptide. The molecular weight of the molecule
was estimated to be between 10,000 and 12,000 daltons. This factor
stimulated chemotaxis in the absence of serum factors. James and
Williams ( 1978) previously reported serum-independant PMN chemotaxis
stimulated by cell-free culture filtrates of 13 out of 16 clinical gonococcal
isolates. They suggested that chemotactic activity might be generated
by gonococcal cell lysis products (James and Williams, 1978).
Gonococcal strains producing this low molecular weight glycopeptide
chemotactic factor stimulate the inflammatory response and may be more
prevalent in patients with symptomatic gonorrhoea. Gonococcal strains
not producing this factor may possibly be associated with asymptomatic
infections. Although Tl, T2 and T3 colonial variants produced a chemo-
taxin (James and Williams, 1978; Rank and Holmes, 1984), differences in
production between opaque and transparent variants were not investigated
(Rank and Holmes, 1984).
5.0 The role of complement in polymorph chemotaxis and killing of
gonococci
Invasion of the genital tract mucosal surface early in infection
(Harkness, 1948) brings the gonococcus into contact with plasma. I gG
and complement components are also found in cervical secretions (Price
and Boettcher, 1979) and may constitute a primary defence system.
Activation of the complement system results in the generation of powerful
leukotaxins. In addition the activation of the early components of com¬
plement aids opsonisation of bacteria while the sequential activation
of the terminal components results in the formation of the membrane
attack complex C5b-9 which kills bacteria. Complement can be activated
by the classical pathway (involving antibody antigen complexes and
CI, C4 and C2) or by the alternate pathway or by both.
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5.1 Complement and the inflammatory response
Watt and Medlen ( 1978) suggested that the acute inflammatory
response induced in localised gonococcal infections was in part mediated
by the interaction of invading gonococci with natural antibody and com¬
plement. These interactions generate chemotaxins which attract phago¬
cytes to the site of infection.
Gonococci, isolated from uncomplicated and disseminated infections,
incubated with normal human serum for 60 minutes stimulated both com¬
plement consumption and PMN migration to a similar degree (Densen,
McKeen and Clark, 1980, 1982). Chemotactic activity was generated
by the complement cleavage product, C5a. However, when time related
complement consumption studies in NHS were undertaken, it was shown
that there was a delay in the generation of chemotactic activity by gonococci
isolated from patients with UGI. When hypogammaglobulinaemic serum
was used isolates from UGI showed similar kinetics for chemotactic genera¬
tion. In C2 deficient serum there was a specific impairment of chemotactic
activity generated by UGI but not DGI strains (Densen et al., 1980,
1982). These differences suggested that although gonococcal isolates
activate complement by the classical pathway strains from patients with
DGI preferentially activate the alternate pathway (Densen et al-, 1980,
1982). Schiller ( 1980) has also demonstrated that this occurs: studies
on the susceptibility of gonococci to phagocytosis and killing by PMNs in
serum deficient in C8 indicated that gonococci from patients with UGI
were killed to a greater extent and this appeared to correlate with the
rapidity of chemotactic factor generation in serum by particular strains.
Strains isolated from DGI appeared to preferentially activate the alternate
complement pathway (Schiller, 1980). The ability of N. gonorrhoeae to
activate the alternate pathway and initiate a local Schwarzman response in
rabbits has been reported by other workers (Sveen and Maeland, 1982).
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5. 2 Gonococcal surface components involved in the stimulation of
complement
It has been reported that the porins of S. typhimurium with molecular
weights of 34 K and 36 K stimulate complement activity via the classical
pathway (Galdiero et al., 1984). Gonococcal cell envelope components
may also be involved in the activation of complement and the inflammatory
response. The molecular weight of protein I (porin) has been shown
to be associated with serum sensitivity and resistance of gonococcal
strains (James et al., 1982). Gonococcal strains with low molecular
weight protein I were more resistant to the bactericidal activity of NHS.
Transparent isogenic colonial variants (lacking in protein II) were also
shown to be more resistant to bactericidal activity (James et al., 1982).
Transparent gonococcal strains are generally isolated from the urethra
of men with asymptomatic infections (Tight and James, cited by James
et al., 1982) and from the cervices of women at the time of menstruation
and women with salpingitis (Draper et al., 1980; James and Swanson,
1978a,b).
Gonococci with low molecular weight protein I of IA subclass have
been associated with DGI (Cannon et al., 1983). Moreover, most patients
who develop DGI have asymptomatic local gonococcal infections. Therefore,
it would appear that the surface protein make up of gonococci isolated
from these infections may be directly involved in their ability to dissem¬
inate . It is tempting to hypothesize that these structures interfere
with the serum bactericidal activity and with complement activation, thereby
slowing down the production of chemotaxins and affecting the production
of an inflammatory response. This may allow these organisms to dissem¬
inate more easily by evading the host's primary defence mechanism.
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Endotoxin also stimulates the complement system. Therefore the
endotoxin released in the form of blebs from gonococci in pus (Novotny
et al., 1977) may also have a stimulatory effect on the inflammatory
process. However, Novotny ef al . ( 1977) only examined the exudate
from patients, mostly men and a few women, with symptomatic infections.
Evans (1977), who examined cervical biopses from women, reported
that gonococci did not produce blebs of endotoxin. Therefore under
certain circumstances in vivo gonococcal endotoxin blebbing may be
inhibited. A recent case report of an inflammatory skin response to
urethral exudate contaminating a male patient's thigh was thought to
be mediated by gonococcal endotoxin present in the exudate (Fiumara
and Kahn, 1982). Gonococcal peptidoglycan has also been shown to
stimulate complement consumption in NHS (Peterson and Rosenthal, 1982).
The inflammatory response and opsonisation of N. gonorrhoeae
in women may be affected by seminal plasma (Brooks et al. , 1981). It
has been shown that the bactericidal activity of serum and the opsonisation,
phagocytosis and killing of gonococci was inhibited by seminal plasma.
The addition of seminal plasma to the serum resulted in a 500-fold reduction
in bactericidal activity. The inhibitory effect of the seminal plasma
component was lost by heating at 100°C for 10 minutes. The component
had a low molecular weight (<20,000 daltons) and was thought to be
a protein, possibly a protease or protease-inhibitor acting on the complement
activation and hence opsonisation and killing of gonococci (Brooks et al. ,
1981).
5.3 The role of complement in systemic gonococcal infections
The role of complement in serum bactericidal activity has been
shown to be important in preventing systemic neisserialinfections (Lim
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etal., 1976; Petersen, Graham and Brooks, 1976; Lee et al., 1978).
Patients with hereditary deficiencies in the complement system resulting
in the lack of the terminal components C6, C7 or C8 are susceptible
to repeated attacks of bacteraemic neisserial infections. These patients
have normal opsonisation and PMN chemotaxis functions but lack serum
bactericidal functions produced by the terminal complement membrane
attack complex (Lee et al. , 1978).
6.0 Natural antibody and immune antibody response to gonococcal
infections
Natural gonococcal bactericidal antibody is present in the serum
of most normal adults and arises without obvious immunisation or specific
infection (Schoolnik, Buchanan and Holmes, 1976). These antibodies
may arise due to pharyngeal carriage of non-gonococcal neisseriae. Natural
antibody of IgG, „IgM and IgA classes reactive with gonococcal heat-
labile and heat-stable antigens were detected by an indirect immuno¬
fluorescence test (Cohen, 1967).
6.1 Natural IgG: blocking and opsonising
McCutchan et al. ( 1978) examined the mechanism by which N.
gonorrhoeae isolated from cases of DGI resisted the bactericidal activity
of NHS. They concluded that NHS contains natural blocking IgG. They
proposed that natural IgG-blocking antibody binds to gonococci possess¬
ing the appropriate receptor and protects them from killing by bactericidal
antibody and complement by preventing bactericidal antibody binding
to the gonococcal cells (McCutchan et al., 1978). Natural IgG has been
ascribed the role of a heat-stable opsonin promoting phagocytosis of
gonococci by human PMN leukocytes (Schiller, Friedman and Roberts,
1979).
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The targets for natural IgG have been investigated. Natural
IgG in NHS acting as an opsonin inhibited the attachment of monoclonal
antibodies to protein I (Sarafian, Tarn and Morse, 1983). However,
the natural IgG did not appear to react with protein III.
Natural JgG antibodies present on the mucosal surface of the
urogenital tract and acting as opsonins may promote phagocytosis of
gonococci prior to the development of a specific host antibody response.
As such it may constitute a part of the host's early defence mechanisms
prior to the development of a specific antibody response.
6. 2 Natural I gM and serum bactericidal activity
Natural I gM in conjunction with complement is responsible for
the bactericidal activity of normal human sera (Schoolnik, Ochs and
Buchanan, 1979; Rice, McCormack and Kasper, 1980). The role of
natural I gM was demonstrated by the loss of bactericidal activity upon
treating NHS and IgM with the reducing agent 2-mercapthoethanol,
the lack of bactericidal activity in cord serum, and the lack of bactericidal
activity in the serum of patients who lacked I gM due to agammaglobulinemia
(Schoolnik et al., 1979).
The development of natural antibody is age dependent attaining
adult levels at approximately two years of age (Schoolnik et al., 1979).
The bactericidal activity of NHS does not vary with differences in ABO
blood groups or sex of the donor (Schoolnik et al., 1976; Schoolnik
et at., 1979). Rice and Kasper ( 1977) showed that the bactericidal activity
of NHS could be inhibited by gonococcal endotoxin but not by gonococcal
protein. It was proposed that natural IgM reacts with lipopolysaccharide
(Schoolnik et al., 1979). Gonococcal strains isolated from DGI are resist¬
ant to the serum bactericidal activity of NHS (Schoolnik et a!., 1976).
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However, Rice et al. ( 1980) have reported that gonococcal strains from
patients with DGI may vary in their susceptibility to the bactericidal
activity of NHS and that there are degrees of resistance. Strains isolated
from patients with suppurative arthritis were significantly more sensitive
to the bactericidal activity of NHS than gonococcal isolates from patients
with dermatitis and arthralgia. Gonococcal strains isolated from women
with severe PID were more susceptible to bactericidal activity than those
isolated from mild or moderate cases of PID (Rice et al., 1980). These
observations, although subjective, may reflect differences in the target
antigens for natural IgM and/or different responses of the individual
hosts.
6. 3 Mechanism of resistance to NHS
Serum resistance is determined by the sac genes. These genes
alter the structure of gonococcal LPS (Shafer et al., 1982). Recent
evidence shows that the mechanisms by which different gonococci resist
the bactericidal activity may be different and depend upon the type
of LPS they produce (Shafer et al., 1984). In addition to activating
the classical complement pathway in the presence of antibody it was
proposed that a serum-sensitive mutant RA5100 may also activate the
classical pathway without the presence of antibody. The ability of RA5100
LPS to inhibit the killing of its homologous and a heterologous strain
by NHS suggested that a common antigenic site on the LPS of serum
sensitive gonococci may be involved (Shafer et a I., 1984). Results also
indicated that the parent strain of RA5100, FA 19 which is serum resistant,
may also contain this antigenic site but that bactericidal antibody may
not be able to bind to it. This may be due to differences in the conforma¬
tion of the LPS or to an increase in the number of receptor sites made
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available to blocking IgG. This may result in a greater degree of
IgG blocking antibody binding to the LPS of serum-resistant strains
inhibiting the binding of natural I gM by steHc hindrance. Other workers
have proposed that serum-resistance may be due to conformational changes
in LPS rendering the complement membrane attack complex C5b-9 ineffec¬
tual (Harriman et a!., 1982). These workers showed that C5b-9 complex
bound to the surface of both serum sensitive and resistant gonococci
but was unable to penetrate the membrane and kill serum resistant
gonococci. It has been reported that gonococci isolated from urethral
pus and examined without subculture are resistant to the bactericidal
activity of NHS (Ward, Watt and Glynn, 1970). This ability to resist
bactericidal activity was lost upon subculture and is different from the
stable serum resistance shown by strains isolated from DGI. It has
been demonstrated that cervical secretions and seminal plasma from un¬
infected clinically healthy persons and vaginal exudates from women
with non-gonococcal infections converted serum-sensitive gonococci to
serum resistance after three-hour incubation at 37°C (Martin et at.,
1982). The chemical nature of the serum resistance inducer is not known.
The acquired serum resistance was lost upon subculture (Martin et aI.,
1982).
7. 0 Local antibody response
IgA antigonococcal antibodies were found in the urethral secretions
of 9/11 men with first and 20/24 men with a history of multiple gonococcal
infections (Kearns et a!., 1973a). These antibodies were shown to
be predominately of the secretory type (Kearns et a/., 1973b). The
antibody response to N. gonorrhoeae in the urogenital tract of men and
women has been examined (McMillan et a!., 1979a; McMillan, McNeillage
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and Young, 1979b). Antigonococcal antibody was detected in 97% of
75 women with gonorrhoea. These antibodies were predominately of
IgG and IgA class. I gM was detected in 29 women and was associated
with infections of less than 15 days duration (McMillan et al., 1979a).
IgA appeared to be mainly secretory IgA. Antigonococcal IgG, but
not IgA or IgM, was found in 33% of women with either non-gonococcal
cervicitis or with no sign of any infection. Successful treatment resulted
in the rapid decline of I gA and a gradual decrease in I gG reactivity
(McMillan et a/., 1979a). An increase in the levels of IgA and IgG
in cervical secretions of women with cervical infections has been previously
reported (Chipperfield and Evans, 1976). Similar findings were reported
for men with gonococcal urethritis (McMillan et at., 1979b). Of 132
men with gonorrhoea, 129 had antibodies to the gonococcus in their
urethral secretions. IgA was found in all 129, IgG in 119 and IgM
in 64 of the men. IgG reactive with N. gonorrhoeae was found in 26%
of 50 men with non-gonococcal urethritis but none was found in men
with no sign of infection. The levels of I gA and I gM declined rapidly
whereas IgG levels declined gradually after successful treatment (McMillan
et al., 1979b). Therefore a measurable antibody response at the genital
mucosa can be detected. Antibodies reactive with gonococcal antigens
can also be detected on extra-genital surfaces (McMillan, Young and
McNeillage, 1980).
The finding of antigonococcal IgA and IgG in the secretions of
12 women who had no evidence of infection but were contacts of men
with gonorrhoea (McMillan et al., 1979a) suggests that an antibody res¬
ponse produced at the mucosal surface may be involved in limiting and
eradicating infection. The gonococcal components which antibody reacted
was not determined. In women using oral contraception (oestrogen/
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progesterone pill) the levels, particularly of IgA and I gG but also
of IgM in cervical secretions, is higher than in those women not taking
oral contraceptives regardless of whether they had a current cervical
infection (Chipperfield and Evans, 1976). In patients with cervical
infections the increase in I gA levels was thought to involve increased
production of secretory IgA at the mucosal surface whereas in women
taking oral contraceptives the increase in IgG and IgA was thought
to be a result of increased transudation of immunoglobulins into cervical
mucus. . Results also indicated that there was a variation in the response
produced by each individual. McChesney et at. (1982) showed that
an antibody response occurred on the genital secretions of men and
women vaccinated with a pilus vaccine. Although immunoglobulin of
all three classes was detected, secretory IgA predominated. However,
N. gonorrhoeae is able to render secretory IgA of the A1 subclass inef¬
fective. It produces an extracellular proteolytic enzyme ( IgA protease)
which cleaves IgAi at proline-threonine residues in the hinge region
separating the molecule into its Fab and Fc components (Plaut et al.,
1975).
8.0 Humoral antibody response to gonococcal infections
Various studies have indicated that humoral antibody responses
may vary in different gonococcal syndromes and antibody produced
detects different gonococcal antigens (Rice et al., 1980; Hadfield and
Glynn, 1982; Hook, Olsen and Buchanan, 1984). Rice et al. ( 1980)
showed that among patients with DGI, 91% with suppurative arthritis
developed bactericidal antibody in the convalescent phase compared
with only 18% of those with dermatitis and arthralgia. Some patients
with uncomplicated gonococcal infections also produced a serum
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bactericidal response (Rice et al., 198 0). Kearns et al. ( 1973a) found
that men with uncomplicated gonococcal infections were much more likely
to produce a humoral antibody response if they had a history of repeated
gonococcal infection.
In one study using SDS-PAGE derived antigen in an ELISA it
was demonstrated that humoral IgG from patients with uncomplicated
gonococcal infections detected protein II and carbohydrate, possibly
LPS, antigens (Hadfield and Glynn, 1982). Hadfield and Glynn ( 1982)
also demonstrated that humoral IgG from patients with DGI detected
protein I and pili antigens. In another study of patients with DGI, PID
and gonococcal epididymitis it was shown that there was a mixed response
to gonococcal LPS and protein I (Hook et al., 1984). IgG from four
patients reacted with protein I alone, IgG from one patient reacted
with LPS and IgG from eight patients reacted with both protein I and
LPS. Results also indicated that in the mixed response antibody to
both LPS and protein I may be bactericidal for N. gonorrhoeae.
Buchanan et al. ( 1980) demonstrated that antibody produced can
be protective against recurrence of complicated gonococcal infections.
Women with pelvic inflammatory disease (PID) who produced an antibody
response to protein I were protected from subsequent attacks of PID
with gonococci of the same protein I serotype. However, these antibodies
were unable to protect women from repeated local genital infection by
strains with homologous protein I serotypes.
9.0 Cell mediated immunity
The existence of cell-mediated immune response in humans infected
with N. gonorrhoeae has been reported (Esquenazi and Streitfeld, 1973;
Wyle, Rowlett and Blumenthal, 1977; Kraus, Perkins and Geller, 1970;
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Landolfo et al., 1981). Cell mediated responses were found more
frequently in patients with a history of multiple infections with greatest
blastogenic transformation in those with three or more gonococcal infec¬
tions (Kraus et aI., 1970; Landolfo ef aI., 1981). Stimulation of a
cell mediated response appeared to be generated by a non-pilus 23,000
MWt protein (Landolfo et al., 1981). It is possible that this protein
might represent a protein II species. Wyle et al. ( 1977) also indicated
a blastogenic response to a partially purified gonococcal antigen. Peri¬
pheral lymphocytes from women with uncomplicated gonorrhoea responded
better to this protein mixture than those from men with uncomplicated
infections. A wide range in degree of lymphocyte response in men and
women was noted (Wyle et al., 1977).
10.0 Gonococcal antigenic shift in response to host immune response
Recent studies involving gonococcal protein II and pili indicate
that antigenic shift may occur in natural infections.
The ability to select gonococcal strains with different protein II
molecules and different pilus types in vitro (Lambden et al., 1979;
Lambden et al., 1980; Salit et a!., 1980) suggested that the potential
existed in vivo for similar structural and antigenic changes in protein II
and pili. It was shown that variants of N. gonorrhoeae P9 inoculated
into guinea pig subcutaneous chambers changed their protein II composition
from protein II a, b and c to predominately protein II d, e and f (McBride
et al., 1981). The pilus composition was altered similarly in vivo from
the original inoculum containing a and 3 pili to y and 6 pili (McBride
et al. , 1981; Lambden et at., 1981b). The protein II and pilus composition
of clinical isolates of N. gonorrhoeae isolated from the urethras of male
patients and from the cervix and urethra of their female contacts were
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examined. On the basis of identical protein I serotyping and auxo-
typing results all isolates from each set of sexual partners were deter¬
mined to be the same strain (Zaket al., 1984; Duckworth et al., 1983).
It was found that pili expressed by isolates from the female cervix
and urethra differed in subunit molecular weight and were usually
distinct from the pili expressed by the isolate from the male partner,
although some men had the same pilus banding pattern as their female
contacts (Duckworth et al., 1983). In most cases a single pilus type
predominated in each isolate.
However, the urethral and cervical isolates from one woman showed
more than one pilus band on SDS-PAGE. This was possibly due to
infection with variants of the same strain expressing different pilus
types. No correlation could be made with menstrual cycle as all women
were taking oral contraceptives (Duckworth et at., 1983). Similar
variations in protein II expressed by different isolates were also observed
(Duckworth et al., 1983). Antibodies to protein II and pili in the serum
of patients were then examined (Zak et al., 1984). However, only
33% of patients examined produced antibody to a protein species other
than protein I. Antibodies to pili when present, gave cross-reactions
among isolates from patients within each contact group but to a variable
extent.
Serological studies using sera obtained from patients indicated
that different protein II molecules could be detected within contact
groups (Zak et al., 1984). Thus in one group of patients, a male and
his two female contacts, serum from female 1 reacted with a 31 K protein
II from her urethral isolate and a 29 K protein II molecule from the
cervical isolate of female 2. The serum failed to react with a 29. 5 K
protein II produced by her own cervical isolate or with a 32 K protein II
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produced by the isolate from her male partner. It was noted that although
this women's serum reacted with the 29K protein II produced by the
isolate from female 2, neither her own urethral or cervical isolate produced
this protein. The isolate from the male patient did not produce this
protein either (Zakef al., 1984). This suggests that when woman 1
was initially infected her isolate did produce a 29 K protein II and that
her male consort was also infected at one time with an isolate producing
this protein II species.
A model of antigenic shift has been proposed. An infecting gonococ¬
cal strain has the capacity to produce isogenic variants containing one
or more possible protein II molecules. A specific host immune response
to protein II produced by these variants would result in the elimination
of variants bearing that particular protein II molecule. The high rate of
transition associated with protein II production would ensure the presence
of a significant minority population with an antigenically distinct protein
II profile which would then overgrow the original variant to establish
a new majority population.
11.0 Summary
Although the host is capable of mounting both antibody and cell
mediated immune responses, the ability of these to eradicate and prevent
gonococcal infections appears variable. The ability of the host to produce
an immune response seems to depend upon the number of exposures
to the gonococcus. It is quite likely that most patients are treated
before an adequate immune response can be generated. However, in
complicated gonococcal infections there may be some protection against
reinfection with the same strain. The host immune response also appears
to be directed against a bewildering array of gonococcal antigens and
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varies from patient to patient. The gonococcus in turn appears to
have a formidable battery of virulence determinants which enable it to
evade the host immune response and is thus a very successful host
specific pathogen.
The variable immune response, lack of protection against reinfec¬
tion and the large number of gonococcal antigens makes the selection of
an antigen(s) for a gonococcal vaccine very difficult.
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LABORATORY PROCEDURES FOR THE DIAGNOSIS
OF GONORRHOEA
The clinical diagnosis of gonorrhoea must be supported by micro¬
biological tests. Because of the short incubation period and high infec-
tivity of the disease, rapid diagnosis followed by immediate treatment
is important in the control of infection within the community.
N. gonorrhoeae is a very fastidious organism with poor survival
outside of its host. Therefore very careful techniques are required
for the collection of specimens and their transport to the laboratory for
culture and investigation. Ideally, the patient should be seen at a
clinic with an adjacent or closely situated laboratory. However, in
many areas, particularly the United States, a great number of cases
are seen by general practitioners and not in sexually transmitted disease
(STD) clinics.
1.0 Immediate diagnosis
Immediate diagnosis is extremely important as it enables a presump¬
tive diagnosis to be made in the clinic so that appropriate treatment can
be given without delay. This is especially important for prevention
of spread of infection, to prevent the progression of the disease to
its more serious sequelae and for treatment of those patients who default
and therefore do not attend for follow-up treatment.
1.1 The gram-stain
Gram-staining of genital secretions remains the only widely accepted
routine procedure for making an 'on-the-spot' diagnosis of gonococcal
infections (Young, 1981).
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7. 7. 7 Gram-stained smear results from men
The gram-stain is a sensitive and specific test for preliminary
diagnosis of urethral gonorrhoea in men. A positive or negative gram-
stained smear of urethral discharge has been reported to provide an
immediate differential diagnosis between gonococcal and non-gonococcal
urethritis in 85 to 89.2% of cases (Jacobs and Kraus, 1975; Oxtoby et
at., 1982). Others report its sensitivity as being higher. Goodhart
et al. (1982) reported that the probability of gonorrhoea in men with
urethral discharge and/or dysuria whose urethral smears contain intra¬
cellular GNDC is 94.8%. Absence of intracellular GNDC from smears of
the same men is associated with a 92.6% probability that they have non¬
gonococcal urethritis. One group reported that the sensitivity of the
gram-stain was as high as 99.1% for a group of 113 symptomatic male
patients (Luciano and Grubin, 1980).
However, others have observed that the sensitivity of the gram-
stain is lower (40-60%) in asymptomatic men with culture proven gonococcal
infections (Handsfield et at., 1974).
7. 7. 2 Gram-stained smear results from women
For women gram-staining of smears of cervical and urethral secretions
has been reported to be less reliable, detecting only 55 to 65% of patients
who subsequently gave positive cultures (Chipperfield and Catterall,
1976; Barlow eta!., 1976; Evans, 1976). The presence of intracellular
GNDC in cervical smears from women was associated with a 97.3% probability
that they had gonorrhoea. Whereas the absence of intracellular GNDC in
cervical smears was associated with a 51.2% probability that these women
did not have gonorrhoea (Goodhart et a!., 1982).
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Lossick, Smeltzer and Curran ( 1982) reported that the cervical
gram-stain detected 70% (1,179 of 1,675) of women who subsequently
had positive cultures. It was also reported in a recent survey of clinics
in England and Wales that overall 71% of women were diagnosed initially
by the gram-stain (Belsey, 1983). However, in some clinics, particularly
in London, this figure was much lower. With the addition of epidemi¬
ological data, 91% (Lossick et al., 1982) and 96% (Belsey, 1983) of women
with culture proven gonococcal infections were treated on their initial
visit to the clinic or after the first set of microbiological tests. Lossick
et at. (1982) reported that the addition of gram-staining increased
by 42% the number of women treated for gonorrhoea at their first visit
compared with diagnosis based solely on epidemiological and clinical
data.
However, initiation of treatment in patients with negative smear
results and diagnosed solely on epidemiological grounds without awaiting
culture results must lead to unnecessary treatment with antibiotics.
Belsey ( 1983), in a study of 2,903 women diagnosed or treated
as having gonorrhoea, showed that the initial diagnosis of gonorrhoea
was confirmed by gram-stain or culture in 2,420 (83%) of cases prior to
administering treatment, 35 women were treated on clinical grounds
alone and 448 were treated on epidemiological grounds alone. Only 161
(36%) oTthe 448 women treated on epidemiological grounds alone sub¬
sequently had positive culture results. This gives overtreatment rates
of 10% for all treated women and 64% for women treated solely on epidemi¬
ological grounds alone. However, Lossick et al. ( 1982) observed that
treating a greater number of women at their initial clinic visit brought
about a decrease in the number who subsequently developed PID.
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Others have reported that the sensitivity of cervical gram-stained
smears based on the presence of intracellular GNDC is very low (32%)
(Oxtoby eta!., 1982).
1. 2 Limitations of gram-staining
Gram-staining has no place in the diagnosis of pharyngeal infections
in either sex and rectal smears are seldom carried out routinely (Young,
1981). Non-gonococcal neisseriae are common in the naso-pharynx
and may also grow on selective media. In one study 74.2% and 3.7% of
GNDC found in throat cultures yielded N. meningitidis and N. lactamica
respectively. Only 20.3% of the cultures yielding GNDC were shown to
contain gonococci (Young and Bain, 1983).
McMillan and Young (1979) found that the routine examination
of gram-stained rectal material obtained by protoscopy from homosexual
men was of limited diagnostic value.
The performance of the gram-stained smear is also affected by
the experience of the technical staff involved in screening. Goodhart
et al. (1982) found that the efficiency of the gram-stain fell drastically
when smears were interpreted by an inexperienced technician.
1. 3 Simplification of staining methods
There has been some move to evaluate the use of single stain
procedures. Stains such as methylene blue (Danielsson, 1965; Danielsson
and Johannisson, 1973), methylgreen-pyronin (Hanna etal., 1980) and
safranin (Oxtoby et at., 1982) have been used. However, Oxtoby et al.
( 1982) reported no obvious advantage in these procedures. The time
saved in staining with a single stain was lost by making the screening
of smears much more difficult.
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1.4 Immediate immunofluorescence
Unfortunately fluorescent antibody (FA) staining of secretions
direct from the patient has not provided a more sensitive and reliable
routine diagnostic technique than gram-staining.
Danielsson and Forsum ( 1975) in a detailed review on the method¬
ology and application of immunofluorescence for the diagnosis of neisserial
infections, state that direct FA staining of uro-genital smears can provide
diagnostic results which equal culture results for gonorrhoea within
one hour. However, this is dependent on well-trained and experienced
technicians. They did not recommend the use of this technique on
a routine basis because it was laborious and requires a highly skilled
technologist at the clinic. However they found it useful under certain
circumstances, for example in patients who have received antibiotics
and whose cultures might be anticipated to be negative. Use of FA in
the diagnosis of gonococci in skin lesions of patients with DGI has been
successfully used by Bayer (1980, cited by O'Brien et a!., 1983).
2.0 Culture
The importance of selective media is now established beyond
doubt; over 70% of laboratories in England and Wales now use some
form of selective media (Adler, 1978). There are three criteria which
should be met by selective media: they should prevent overgrowth of
gonococcal colonies by commensal flora; they should prevent the growth
of any other microbial species which may inhibit gonococcal growth; and
they should also promote luxuriant gonococcal growth within 24-48 h.
Most selective media contain a rich nutrient base supplemented with
blood, partially lysed by heat (chocolate agar) or completely lysed by the
chemical saponin. There are two main selective media used: Thayer-
Martin and New York City medium, and modifications of these two.
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2.1 Thayer-Martin and modified Thayer-Martin medium
The first selective medium formulated to grow only gonococci and
meningococci was developed by Thayer and Martin ( 1964, 1966). This
medium contains the antibiotics vancomycin, colistin and nystatin.
However, it did not prevent cultures being overgrown with Proteus
species, nystatin at the concentrations used was not an effective inhibitor
of Candida albicans, and the growth of gonococci was slow and the
colonies were small.
2. 1. 1 Modified Thayer-Martin medium
Superior culture results were obtained with modified Thayer-
Martin (MTM) medium (Martin, Armstrong and Smith, 1974). MTM
differed from TM medium in containing an increased agar concentration
(2%), additional glucose (0.25%) and trimethoprim (5 pg/ml). When
cervical specimens were cultured in both media, 122/328 (37%) were
positive on MTM compared with only 110/328 (33.5%) on TM medium.
Trimethoprin has been shown to inhibit the growth of Proteus
species (Seth, 1970). MTM completely eliminated spreading growth by
Proteus, whereas 23 (9.5%) of the TM cultures (four male urethral and
19 female cervical cultures) were overgrown with spreading Proteus
(Martin et a!., 1974). In another modification of TM medium nystatin
was substituted by anisomycin.in an effort to control the growth of yeasts
on the culture plates (Martin and Lewis, 1977). The enhanced inhibition
of yeasts on Martin-Lewis medium has been reported to make screening
of plates for presence or absence of gonococcal colonies much easier
(Smeltzer, Curran and Lossick, 1979).
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2. 2 New York City and modified New York City medium
In 1973 a new medium, New York City (NYC) medium, which
provided luxuriant growth of pathogenic neisseriae after incubation for
24 hours was described (Faur et al., 1973a; 1973b). NYC medium
consists essentially of a proteose peptone-corn starch, buffered agar
base to which a haemoglobin solution prepared from fresh horse erythro¬
cytes, horse plasma, yeast dialysate, glucose and the antibiotics vanco¬
mycin, colistin, amphotericin B and trimethoprim lactate are added.
2. 2. 1 Modified New York City medium
The NYC medium as described by Faur et a!. ( 1973a,b) is incon¬
venient for many service laboratories to prepare routinely and it was
modified by Young ( 1978a). The MNYC medium is prepared from com¬
mercially available gonococcal base and contains lysed whole blood in
the place of plasma and haemoglobin made from fresh horse erythrocytes
and is therefore much simpler to prepare. Vancomycin was replaced
by lincomycin (1.0 ag/ml) (Young, 1978a), and amphotericin B is used
in both NYC and MNYC since it has a much greater inhibitory effect
on Candida. MNYC was not compared directly with NYC but in a trial
with routinely used TM medium it was shown to considerably increase
both the number of culture positive specimens and the rapidity of growth
of gonococcal isolates (Young, 1978a). Faur and Wilson ( 1982) reported
that the use of lincomycin resulted in gross contamination of 22-34%
anorectal cultures with the subsequent loss of 3.8% of gonococcal isolates.
They recommended that the use of vancomycin should be continued.
Most of these media are available commercially for laboratories
who do not wish to prepare their own. In a survey to compare commercially
available NYC and Martin-Lewis media, it was found that the NYC was
much superior (Lawton and Koch, 1982).
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2. 3 Combination of selective and non-selective medium
Recently, gonococcal strains with increased susceptibility (hyper¬
sensitive) to a variety of antibiotics have been discovered (Eistenstein
and Sparling, 1977). Gonococcal strains which are also sensitive to
vancomycin at the levels used in selective media (2-4 ng/ml) have been
reported to account for approximately 1% to 30% of clinical isolates
(Windall ef al., 1980; Goodhart etal., 1982; Mirret, Reller and Knapp,
1981). Mirret et al. (1981) have associated sensitivity to vancomycin
and to other antibiotics including lincomycin and penicillin with strains
of the auxotype AHU-. They found that 28/31 strains which failed
to grow on TM and ML media containing 4 ug/ml of vancomycin had
this auxotype compared with 9/31 control strains. These discoveries
lend credence to the suggestions that both selective and non-selective
media should be routinely used for isolation of N. gonorrhoeae (Reyn and
Bentzon, 1972).
Such a procedure is too time consuming, technically demanding
and not cost effective for routine use, and in practice less than 10% of
clinics in England and Wales employ such a routine (Adler, 1978). How¬
ever, in those areas where there is a high proprotion of antibiotic sensi¬
tive gonococcal strains such a procedure may well be required.
In Britain vancomycin sensitivity does not appear to pose a problem.
However, a cautionary note was sounded by Talbot, Spencer and Kinghorn
( 1983). They found that in Sheffield three (3.9%) of 79 isolates were
sensitive to vancomycin; one of these isolates was a penicillinase-
producing strain (Talbot et al. , 1983).
It was shown in a study using split plates that there was no
advantage in using both non-selective and selective media (vancomycin
free selective medium [VFSM] and MTM medium) for the isolation of
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N. gonorrhoeae (Bonin, Tanino and Handsfield, 1984). Because of
the reduced rate of culture contamination it was found that MTM and
VFSM actually increased the gonococcal isolation rate by 1.6% and 1.9%
respectively, when compared with the non-selective 'chocolate' agar
plates. Therefore they concluded that the routine use of non-selective
plates was not cost effective or more efficient as it did not give better
culture results and considerably more time was required for screening
plates after incubation. However, they previously reported that the
number of vancomycin sensitive strains in the Seattle area was low
(Totten et al., 1983), and while the routine use of non-selective media
was not required in their situation, they recognised the need for each
individual laboratory to assess their own isolation and cultural procedures.
2.4 Assessment of cultural systems
This may be done by checking smear results with culture results.
If the culture negative/smear positive ratio becomes large, the cultural
procedures being used should be reevaluated. Occasionally, studies
should be undertaken to assess the proportion of antibiotic sensitive
gonococcal strains within the population.
If laboratories prepare their own media the quality of the medium
should also be under constant surveillance.
2. 5 Other factors which may affect cultural results
Other factors such as sampling error due to insufficient inoculum
or poor plating technique, failure to pre-warm plates, a long delay
before plates are placed in a C02 incubator, and taking samples from
only one site per patient have all been suggested or implicated in reduc¬




Poor sampling can occasionally be checked by instigating a periodic
double-sampling procedure whereby two swabs per site are inoculated
onto one culture plate or by inoculating one swab onto the two halves
of one plate. Bonin ef aI. (1984) increased their gonococcal isolation
rate by 1.7% by inoculating male urethral specimens (one swab per
patient) onto the two halves of split plates and by inoculating two cervical
specimens per female patient onto one culture plate. As this was a cost
effective way of increasing culture sensitivity they instigated it as a
routine procedure.
Gartner and Edwards (1984) used a triplate in an effort to reduce
the cost of taking samples from genital, pharyngeal and rectal sites.
Their results showed that there was no significant difference in isolation
rate when all three sites were cultured on a triplate compared with
conventional isolation on three separate plates. This may be a useful
way of sampling all three sites for clinics and laboratories which have
a small budget and limited incubator space. Sampling at all sites may
be more important in particular groups of patients. It has been reported
that of homosexual men with gonorrhoea, the gonococcus is isolated in
the rectum alone in 60.5% of cases and in the pharynx alone in 18.4%
of cases (Owen and Hill, 1972). Therefore if urethral specimens were
taken alone a total of 78.4% of gonococcal infections in homosexual men
would be missed.
2. 5. 2 Culture plate temperature
It is thought that refrigerated plates for the isolation of clinical
specimens should be brought to room temperature by removing from
the refrigerator 30 min to 1 hour prior to inoculation. However, there
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are logistical problems associated in having a source of high quality
plates readily available at room temperature and clinics require to have
a refrigerator. One study examined this problem and showed that
there was no significant difference in the isolation rates of N. gonorrhoeae
on plates inoculated straight from the refrigerator and on those warmed
to room temperature (Ratner et al., 1985). However, the gonococcal
colonies tended to be larger and more numerous on the room temperature
plates after 24 h growth than on the refrigerated plates. Growth was
essentially the same on both plates after 48 h incubation.
3.0 Transport and culture systems
When direct plating and immediate incubation is impracticable,
several transport and culture systems are available in addition to the
conventional non-nutrient transport media such as Stuart's ( 1946), or
Amies' modification of Stuart's medium (Amies, 1967).
The transport and culture systems utilise a selective medium
usually present in a small chamber containing C02.
3.1 Transgrow
Transgrow was the first combined transport and culture system
to be described (Martin and Lester, 1971). It consists of a flat-faced
bottle containing MTM medium and a carbon dioxide enriched atmosphere.
However, incubation results in the production of condensation on the
glass making it difficult or impossible to examine the cultures. Therefore
blind sampling is required for the identification of growth of gonococci
for all identification techniques including the delayed FA method (Jephcott,
Morton and Turner, 1974).
114.
3. 2 Jembec/Neigon system
The problems associated with Transgrow are overcome in the
Jembec/Neigon system which is based on the biological environment
chamber described by Martin and Jackson ( 1975). It consists of a
rectangular culture plate containing a selective medium (usually MTM
medium). The plates incorporate a small recess into which a C02-
generating tablet is placed at the time of inoculation. The moisture of
the plate ensures that C02 is generated owing to the reaction between
the citric acid and sodium bicarbonate in the tablet. The closed plate
is placed into a plastic bag which is sealed to make it gas tight. This
system offers easy, direct access to the surface of the culture medium
so that suspect colonies can be further identified.
These systems are available commercially in one form or another.
In addition dehydrated media (MTM) have also been incorporated into
a kit (Microcult GC). These kits offer the advantage of a long shelf life
and may be particularly useful in areas or countries which lack laboratory
facilities (Willcox and John, 1976; Unsworth, Talsania and Philips,
1979).
3.3 Factors affecting isolation rates following transport of specimens
A number of factors affect the efficiency of cultures which have
been transported to the laboratory. The longer the delay in transport,
including holding at the clinic and transit time, the greater the decrease
in viability. The conditions in which the specimens are held prior
to transport to the laboratory are also important. Spence, Guzick and
Katta (1983) compared the isolation of N. gonorrhoeae in three culture
transport systems; inoculation directly on to MTM medium, the place¬
ment of specimens into modified Stuart's transport medium (Culturette)
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and inoculation into Transgrow bottles. The specimens inoculated onto
the MTM plates (in candle extinction-jars) and in Stuart's media were
held at room temperature and transported to the hospital laboratory with¬
in 3 hours .(h). The specimens inoculated into Transgrow bottles were
first incubated in the hospital and were then sent to the Maryland State
Health Department Laboratory, usually the following morning or within
72 hours if the specimen was collected on a Friday. The sensitivities
for Transgrow, Culturette and MTM medium were 63.9%, 83.6% and 87.0%
respectively (Spence et al., 1983). They estimated that ~20% of patients
with gonorrhoea would not have been diagnosed using Transgrow and
sending the specimens 'off-site' for processing. Although they expressed
reservations about using the Transgrow system, the role of Transgrow
medium and delay in transport were not evaluated separately. Spence
et at. (1983) also examined the efficacy of 'on-site' processing compared
to that of sending specimens to the State laboratory for processing.
They recommended that where feasible, an on-site laboratory should be
used for the evaluation of clinical specimens in an effort to increase
both the sensitivity of culture and the speed by which results were made
available to the clinicians.
In another study in Singapore it was stated that the preferred
method of isolation of N. gonorrhoeae was direct inoculation of the
specimen onto selective medium when it is collected (Sng et al., 198 2).
They found that specimens inoculated into Amies transport medium
lost viability after holding for more than 3 h. This loss of viability
was particularly pronounced when the specimens in Amies were held at
room temperature: in areas such as Singapore the ambient air temperature
is greater than 26°C . However, specimens inoculated directly onto
MTM medium and held in a C02-enriched environment could be held at
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room temperature for 18-24 h prior to incubation without significant
loss of viability. The loss of viability was more pronounced in isolates
from women and in the case of PPNG. This study highlighted the
fact that isolation rates are dependent on inoculum size and that the
inoculum can be further reduced by using a non-cultural transport
medium such as Stuart's or Amies (Sng et al ., 1982).
The loss of viability in modified Stuart's medium was confirmed by
other workers (Ebright et al1982). They showed that modified Stuart's
medium (Culturette, Marion Scientific Corporation) was acceptable when
the transport time was ^3 h. However the rates of isolation were found
to be only 60% and 27% for 24 h and 48 h of transport respectively.
Overall, 49.1% of STD clinics in England and Wales send specimens
to the laboratory in transport media - 87% used Stuart's and 13% used
Amies (Adler et al. , 1978).
It is concluded that in areas or countries where there are few
laboratory facilities and in other countries where laboratory services
tend to be centralised some form of transport and culture system is
required. Culture of N. gonorrhoeae remains very important particularly
for determining antibiotic sensitivities. Some of the transport and
culture systems mentioned here may be of value. However, each area
must determine the best policy for transport of specimens, taking into
account clinic and laboratory facilities, ambient temperature, transport
time and cost effectiveness.
4.0 Identification of isolates
After 24 h of incubation the culture plates are examined and
identity of colonies suspected of containing gonococci are confirmed by
a variety of methods. Tests which are easy to carry out (reducing
operator error)., and are sensitive and specific are the obvious goal.
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4.1 The cytochromeoxidase test
The oxidase test is the first test used to screen primary plates.
All neisseriae are oxidase positive whereas many other organisms, such
as coliforms, staphylococci and lactobacilli, are negative. The test can
be easily carried out by touching a part of the suspect colony with
a swab soaked in a 1% (w/v) solution of tetramethyl-p-phenylenediamine
dihydrochloride, or alternatively by flooding the plate with the oxidase
reagent. A positive reaction is indicated by the colony turning purple
within five to 15 seconds.
4.2 Gram-stained smear from colony
Because other species such as Kingella, Moraxella and Haemophilus
are also oxidase-positive, oxidase-positive colonies must be gram-stained
and smears examined for gram-negative diplococci (GNDC). A presump¬
tive diagnosis of gonorrhoea made on the basis of oxidase-positive GNDC
growing on selective medium is approximately 98% accurate for specimens
taken from a genito-urinary site (Young, 1981). However, because
the various Neisseria spp. are indistinguishable by microscopy, further
identification is necessary to provide a precise diagnosis for infection
at all sites but particularly in determining infection of the pharynx
and rectum.
4. 3 Biochemical tests
A number of new tests have recently been developed for the
identification of Neisseria. However the most common biochemical
tests in use are carbohydrate utilisation tests.
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4. 3. 1 Carbohydrate utilisation tests
These tests are based on the differences in the ability of Neisseria
spp. to utilise various sugars. Gonococci produce acid from glucose
only, meningococci produce acid from glucose and maltose, whereas
N. lactamica utilises lactose in addition to glucose and maltose. Carbo¬
hydrate utilisation tests are basically of two types, conventional and
rapid.
4. 3. 2 Conventional sugar tests
In conventional tests a solid or semi-solid medium containing
the appropriate carbohydrate and pH indicator is inoculated with the
test organism. Although widely used these tests are unsuitable since
a positive reaction is dependent on adequate growth of the test organism
which may require incubation for up to 72 h (Pollock, 1976). The
main problem with these tests is finding a suitable medium to support
good growth of all strains of gonococci while at the same time giving
reproducible and clear-cut indicator changes. Faur et at. ( 1975),
in a comparison of a plate carbohydrate utilisation system (based on
NYC medium) with the widely used semi-solid cystic-trypticase agar base
(CTA) containing carbohydrates, noted that the CTA system often
gave equivocal results because of inadequate growth of fastidious strains
of pathogenic Neisseria. Commercially available MNYC carbohydrate
medium was recently shown to be much more accurate and reliable than
CTA medium or the Minitek system (impregnated discs: with biochemicals
to which Mueller Hinton broth is added) (Simms and Lue, 1982).
Recently Knapp and Holmes ( 1983) developed a semi-solid medium
which they termed modified oxidation-fermentation (MOF) medium. This
contains a low percentage of proteose peptone (low protein level), buffer,
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carbohydrates and phenol red indicator. It proved much more reliable
than any of CTA media in determining carbohydrate utilisation by
Neisseria spp. However inoculated tubes require a minimum of 4 h
and up to a maximum of 24 h incubation to obtain results.
4. 3. 3 Rapid carbohydrate utilisation tests
Rapid carbohydrate utilisation tests (RCUT) were pioneered
by Kellogg andTurner ( 1973). These tests are based upon the measure¬
ment of preformed enzyme by adding growth from an overnight culture
of suspect organism to a buffered (non-nutrient) solution containing
the sugar to be tested and a pH indicator. Since preformed enzyme
is being measured the system does not require growth of the organism
and the problems of supporting the growth of fastidious isolates is
overcome. These organisms can be grown in a suitable medium first.
Brown ( 1974) reported that a number of laboratories were unable to
obtain comparable results to those of Kellogg andTurner ( 1973). However,
this system was modified by altering the buffer composition (Young,
Paterson and McDonald, 1976). Results obtained with this modified
RCUT system were reproducible and easy to read. Positive tests are
yellow or sometimes orange/yellow, whereas negative tests remain red.
The test itself is simple to perform and very rapid, results usually
being available within one hour. When MNYC medium is used the RCUT
can be carried out directly from the primary isolation plate enabling
the vast majority of isolates to be identified within 24 h of seeing the
patient (Young, 1978b).
For those laboratories which may have problems with the buffered
solution for RCUT and for those laboratories which do not routinely
isolate gonococci, the RCUT system as described by Young et at. ( 1976)
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is available commercially (Oxoid, Basingstoke). This test consists
of discs impregnated with the buffer, pH indicator and the sugar to
be tested. The discs are placed in tubes and are reconstituted with
distilled water and RCUTs are carried out as per normal.
4. 3. 4 Measurement of preformed enzymes and enzymes produced
during growth
Yong and Prytula ( 1978) described a modified RCUT which
utilised both preformed enzymes and enzymes formed by the gonococci
as a result of growth in a super enriched medium. The combined action
of two sources of enzyme probably make this RCUT system suitable
for very small inocula. However, as it requires growth of the test
organism it is unlikely that it could be used to characterise isolates
directly from primary isolation cultures because of possible contamination
by other bacteria.
4.4 Other biochemical tests
A number of neisserial identification systems are now available
commercially. These are based on a variety of biochemical tests with
or without sugar utilisation being incorporated. Two such systems
are RapID NH (Innovative Diagnostics Systems Inc) and GonocheK
(E-Y Laboratories).
4. 4. 7 RapID NH
The RapID NH is a 4 h test designed to differentiate Neisseria
spp. , Branhamella, Moraxeila and Haemophilus. spp. and is based on
a variety of conventional rapid sugar tests and single-substrate chromo-
genic biochemical tests. It consists of a plastic tray with 10 wells con¬
taining dehydrated reagents. These are rehydrated and a suspension
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of the test organism is added to each well. In addition to sugar utilisa¬
tion, tests such as g-D-galactosidase, aminopeptidase, indole production,
urea hydrolysis and phosphate and nitrate degradation are included.
In one study (Robinson and Oberhofer, 1983) it was found that there
were considerable problems associated with the use of this system. B.
catarrhalis could not be distinguished from species of the gram-negative
cocco-bacilli Moraxella and Kingella; 44% of gonococcal isolates tested
did not utilise glucose and the other tests had to be relied upon to
give definitive identification (Robinson and Oberhofer, 1983). Similar
problems were found with isolates of N. meningitidis. For non-pathogenic
Neisseria the level of accurate identification varied. One strain of N.
subflava was mis-identified as a pathogenic Neisseria.
4. 4. 2 Gonochefc
Gonochek is designed to differentiate N. gonorrhoeae, N. mening¬
itidis, N. lactamica and B. catarrhalis. It is based upon the degradation
of three substrates contained in one tube. The enzymes produced
by N. gonorrhoeae, N. meningitidis and N. lactamica are proline amino-
peptidase, Y~glutamylamino peptidase and 8-galactosidase respectively.
B. catarrhalis does not produce any of these enzymes.
Oxidase positive GNDC are added to the reconstituted tubes
which are then incubated at 35°C for 30 min. The colour of the tubes
are then read. A blue colour designates a N. lactamica, a yellow colour
designates N. meningitidis. If there is no colour development a solution
(EY 20) is added. If the tube subsequently turns red the isolate is
a gonococcus. If no colour develops after the addition of EY20 then
the isolate is B. catarrhalis.
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In a comparison of Gonochek with RapID NH and the RCUT system
of Young et al. ( 1976), it was found that GonocheK compared well
with RCUT provided that the tubes were read carefully for colour produc¬
tion prior to the addition of the EY20 reagent (Welburn, Uyeda, Ellison -
Birang, 1984). The addition of EY20 to tubes which had developed
a slight blue colour would result in a false positive red colour and the
organism being falsely identified as a gonococcus. The RapID NH was
not recommended.
Wood and Young ( 1985) in a small study compared Gonochek
with RCUT and the Phadebact Gonococcus (coagglutination) test..
The overall correlation between Gonachek and RCUT (97.5%) and the
Phadebact coagglutination test and RCUT (96.9%) was virtually identical.
However, these authors found that some meningococci produced very
low levels of y-glutamyl aminopeptidase and very little or no yellow
colour developed. This resulted in the misidentification of three strains,
two as N. gonorrhoeae and one as B. catarrhalis, on first testing from
primary culture plates. After 24 h subculture these strains were
correctly identified. Gonochek persistently misidentified one gonococcal
strain as B. catarrhalis.
Gonochek correctly identified the five N. lactamica tested whereas
the Phadebact test gave positive results with three of these strains
(Wood and Young, 1985).
Prior to the use of commercially available and new biochemical
tests for identification of N. gonorrhoeae, these should be rigorously
evaluated for specificity and sensitivity in relation to conventional
methods of identification. In some instances such tests may be useful
but the cost may prove prohibitive and reliability prove unacceptable.
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5.0 Immunological identification
The requirement of smaller amounts of growth and the possibility
of shortening the period required for identifying N. gonorrhoeae coupled
with early difficulties with culture and carbohydrate utilisation tests
made the development of immunological identification tests very attractive.
5.1 Delayed immunofluorescence
Delayed immunofluorcscent antibody (FA) tests can be used to
test colonies direct from the primary isolation plate. Danielsson and
Forsum (1975) stated that FA was a useful test for this purpose. However,
they stressed that because of the risk of cross-reactions with other
Neisseria spp. it should always be used in conjunction with conventional
diagnostic tests. However cross-reactions with meningococci can be
reduced or eliminated by absorption of the conjugate with strains of
N. meningitidis. Lind ( 1975) recommended that this technique should
not be used for the identification of throat cultures in which there
is an increased risk of cross-reactions with other neisseriae such as
N. lactamica.
A suitable fluorescence microscope and technical expertise are
also required for the FA tests to be carried out.
5. 2 Identification by coagglutination
The basis of coagglutination (CoA) has already been described
(page 73 ) elsewhere.
Coagglutination was first used as a method for typing pneumococci
(Kronvall, 1973) and was adapted for confirmatory diagnosis of gonococci
by Danielsson and Kronvall (1974). They used specific antigonococcal
sera attached to whole protein A containing staphylococcal cells. The
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antiserum was absorbed with meningococci and Moraxella strains to
remove unwanted cross-reactions. The CoA test gave concordant results
with carbohydrate utilisation and FA tests in routine identification of
N. gonorrhoeae (Danielsson and Kronvall, 1974).
5. 2. 7 The Phadebact gonococcus test
CoA test kits are available commercially as Phadebact gonococcus
test (Pharmacia Diagnostics AB, Uppsala, Sweden). Tests are carried
out by making a suspension of test GNDC in distilled water and boiling
for 10 min. A drop of this suspension is added to one drop of the
Phadebact test suspension and to one drop of the control reagent (normal
rabbit serum attached to protein A containing whole staphylococci). The
suspensions are mixed and slides rocked for two minutes and examined
for agglutination visible to the eye: the addition of 1% methylene blue
makes viewing easier.
Young and McMillan (1982) compared the rapidity and reliability
of coagglutination (CoA) and FA staining for the identification of gonococci
cultured on MNYC medium. Sensitivity of CoA was 96.7% compared
with 97.9% for FA tests, whereas specificity of both methods was 96.8%.
Fewer (86.9%) isolates could be identified by CoA after 24 h culture
compared with 93.9% using the FA method (Young and McMillan, 1982).
Seven gonococcal isolates gave false negative results on first testing
but were positive on repeat testing and four meningococci gave false
positive results but were subsequently negative on repeat testing.
However similar problems are associated with the FA method. It was
concluded that the specificity and sensitivity of the test was acceptable
for the immunological identification of gonococcal strains from urogenital
specimens from men and women. However because of the risk of
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misidentifying N. meningitidis as a gonococcus all ano-rectal isolates
from homosexual men and pharyngeal isolates in general should always
be confirmed by carbohydrate tests. Similar conclusions have been
made by other workers. Carlson et al. ( 1982) found that the Phadebact
CoA test had an overall sensitive of ~92.6%: 13 gonococci gave initial
negative results but upon retesting nine were positive and four (1.7%
overall) remained negative. They found no cross-reactions with non¬
gonococcal neisscriae and concluded that the high sensitivity and specifity
of the test made it useful for the rapid identification of N. gonorrhoeae
(Carlson et al., 1982). Lim and Wall (1980) found that the Phadebact
CoA test correctly identified 97.8% (269/275) of gonococcal isolates
while 93.9% (31/33) of other bacteria including non-gonococcal neisseriae,
gave negative tests. The two strains which gave false positive results
were gram-positive cocci and it was concluded that if the CoA test had
been used in conjunction with the Gram stain no false positives would
have occurred (Lim and Wall, 1980). They concluded that the Phadebact
gonococcus test was able to provide rapid and accurate confirmatory
identification of N. gonorrhoeae.
Shanker, Daley and Sorrell (1981) found that the Phadebact
test performed better than Difco flourescent antibody test. They
found that 287/298 gonococcal isolates were correctly identified by
CoA, a sensitivity of 96%. False positive results due to cross-reactions
with non-gonococcal neisseriae were rare (1/18) and the test had a
specificity of 94% (Shanker et al. , 1981). However they found that
interpretation of the test to be difficult initially and had to repeat 32
(10%) of the tests. Whereas Anand and Kadis ( 1980) found that nine
of 19 N. lactamica were positive with the Phadebact test. Johnston (1981)
who prepared her own CoA reagents (polyvalent antigonococcal serum
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absorbed with N. meningitidis and Moraxella) found that her CoA identified
98.6% of the gonococcal isolates correctly. Two strains of N. meningitidis
gave cross-reactions.
5. 2. 2 Gonococcal autoagglutination
The CoA tests are best carried out using fresh cultures of N.
gonorrhoeae in boiled suspensions to prevent autoagglutination (Lewis
and Martin, 1980; Izakson and Morse, 1981). Autoagglutinating strains
results in agglutination with both the test and control reagents. A
number of workers have attempted to modify the test to prevent auto¬
agglutination. Johnston (1981) found that heating gonococcal suspension
allowed reading to be obtained with some autoagglutinable strains but
not others. A number of enzymes were tested including trypsin, pronase
and Streptomyces enzyme. It was found that Streptomyces enzyme allowed
most stains to give clear results (Johnston, 1981). Other workers have
reported that the use of Mg2+ and Ca2+ (which are responsible for the
integrity of the outer membranes) chelators such as EDTA enhanced the
Phadebact gonococcus test (Izakson and Morse, 1981). Doyle et al.
(1984) appeared to be able to prevent gonococcal autoagglutination by
treating gonococci with DNase.
5. 2. 3 Availability of gonococcal monoclonal antibodies
The problems associated with the occasional cross-reaction observed
between CoA reagents and non-gonococcal neisseriae may be alleviated
with the advent of monoclonal antibodies to N. gonorrhoeae (Tarn et a I. ,
1982). CoA reagents for the identification of N. gonorrhoeae prepared
with monoclonal antibodies are now commercially available and await wide-
scale evaluation.
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However despite some of the problems associated with CoA, a
large number of laboratories are using this technique for the confirmatory
identification of N. gonorrhoeae because it is quick, easily handled,
lends itself to screening of a large number of isolates, and on the whole
gives results which are easily interpreted.
6.0 Identification of gonococcal isolates with lectins
Lectins, proteins which react with carbohydrates, have been used
in a rapid slide agglutination test for the confirmatory identification
of N. gonorrhoeae (Schaeffer, Keller and Doyle, 1979; Curtis and Slack,
1981; Doyle et at., 1984; Yajko, Chu and Hadley, 1984). It was found
that all gonococci tested could be agglutinated by peanut, soyabean,
ricin and wheatgerm lectin in low concentrations (2.5- 0.5 pg/ml of lectin)
(Allen, Connelly and Apicella, 1980).
6.1 Gonococcal components which react with lectins
Allen et at. (1980) used lectins to obtain structural information
about the polysaccharide components in the cell envelope of gonococci.
They found that lectins reacted with gonococcal LPS and Gc acidic poly¬
saccharides. However, the specificities of the lectins were different.
The lectins generally reacted with B-D-acetylglucosamine or galactose
residues on the gonococcal LPS.
6.2 Evaluation of gonococcal identification by lectins
Schaeffer et at. ( 1979) and Curtis and Slack (1981) evaluated
the use of wheatgerm (WG) lectin.
Suspensions of neisserial isolates were mixed with various dilutions
of WG lectin (500 |ig/ml to 2 pg/ml) on glass slides. Slides were agitated
for 10 min and then examined for visible agglutination.
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Schaeffer et al. ( 1979) found that WG lectin at a concentration
of 62 Mg/ml agglutinated 99% of 165 gonococcal strains tested. Only
one out of 24 meningococcal strains gave a positive reaction with the
lectin. However, Curtis and Slack (1981) found that only 94.6% (159/
168) gonococcal strains agglutinated with WG lectin at this concentration.
Of the nine strains which failed to agglutinate five gave positive results
on repeat testing. Positive reactions with this concentration of lectin
were observed with 21 (21.9%) of 96 meningococcal and one of two N.
lactamica strains. They found that non-groupable meningococcal strains
were responsible for the majority of these positive reactions (Curtis
and Slack, 1981). WG lectin was previously reported to agglutinate
many strains of non-groupable meningococci (Frasch, 1980). Curtis
and Slack (1981) postulated that the composition of the culture medium
and the age of the cultures might affect the composition of the polysac¬
charide capsule of these strains and hence their agglutination by WG
lectin. Frasch ( 1980) found that meningococcal capsular material blocked
the N-acetyl glucosamine receptors for WG lectin and prevented agglutina¬
tion of all N. meningitidis and N. gonorrhoeae tested.
Hence lectin agglutination is not a suitable technique for the
identification of pharyngeal gonococcal isolates.
6.3. Use of lectin agglutination in conjunction with other tests
Recently lectin agglutination tests have been used in conjunction
with chromogenic peptidase assays for the identification of N. gonorrhoeae
(Doyle et al., 1984; Yajko et al., 1984).
However both groups observed similar problems of meningococcal
agglutination with lectins and definitive identification had to be made
with the chromogenic tests. As simple chromogenic tests for peptidase
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and carbohydrate degradation are available (EY Laboratories) it would
appear that there is no advantage to be gained by using lectins.
7.0 Non-cultural identification of N. gonorrhoeae
The non-cultural detection of N. gonorrhoeae is based upon detec¬
tion of gonococcal components in secretions. The need for such a system
is apparent because of the number of clinics which have to rely on
culture results from specimens which have been transported. The
major problem inherent in transportation of specimens is the loss of
gonococcal viability. A number of assay systems have been developed
for the detection of gonococcal components. Because of the lack of
sensitivity of gram staining in female patients any new non-cultural
diagnostic method is of greater potential value in the diagnosis of gonor¬
rhoea in women than in men.
7.1 Limulus amoebocyte assay
The Limulus amoebocyte assay detects endotoxin. It is based
on the initial finding that endotoxin from gram-negative bacteria reacted
to form a gel with a lysate of washed amoebocytes from the horseshoe
crab, Limulus polyphemus (Levin and Bang, 1964). Following the demon¬
stration by Rice and Rasper ( 1977) of the sensitivity of the limulus
endotoxin assay for components of N. gonorrhoeae, the system has
been shown to be of value in the rapid presumptive diagnosis of gonococcal
urethritis in men (Spagna, Prior and Perkins, 1979). Endotoxin was
detected in urethral exudates from 73 patients with culture-positive
gonococcal urethritis while negative results were obtained from 26 out of
27 patients with negative urethral cultures. Consequently, the authors
suggested that the method may also be of value in identifying cases of
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non-gonococcal urethritis (Spagna et al. , 1979). However the test
is not specific and depends on the absence of other bacteria producing
endotoxin in amounts that might produce a positive result. Selection
of an appropriate specimen dilution is also vitally important.
To simplify and standardise the dilution process, Prior and Spagna
(1981) described a closed system by which specimens could be collected
and diluted using a syringe combined with a dilution reservoir contain¬
ing the required amount of pyrogen-free water. Using this method
to test specimens from men with exudative urethritis, it was shown
that the test had a sensitivity of 99.2% and a specificity of 96.7%. The
overall ability of the test to predict culture results was 98.4%. This
compared well with the sensitivity and predictive value of gram-staining.
They concluded that the Limulus amoeboycte tests was an accurate
presumptive diagnostic test for gonococcal and non-gonococcal urethritis
in men presenting with symptoms of urethritis, and that it would enable
the private practitioner to make a diagnosis within 30 min without the
need of gram-staining, thus enabling the correct treatment to be given
at the patient's initial visit (Prior and Spagna, 1981).
7. 7. 7 The use of the Limulus test for gonococcal infections in women
In a study of 66 women attending a STD clinic it was found that
the Limulus amoebocyte test detected 15 (62.5%) of 24 women with gonor¬
rhoea confirmed by gram-stained smear and/or culture (Young, Sarafian
and McMillan, 1981). Secretions were used at a 1/100 dilution. A dilution
of 1/50 was used to retest the nine patients with confirmed gonorrhoea
and of these two gave positive results, increasing the positivity rate
of the test to 17 (70.8%) of 24 patients. Only four (9.5%) of the 42
patients without any microbiological evidence of gonorrhoea gave positive
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results with the Limulus lysate test. However, the positivity rate of
the Limulus lysate test (62.5%) was less sensitive than gram-staining
which detected 75% of infected women. The usual level of sensitivity
for the gram-stain is 55-65% and thus the Limulus lysate assay fell
within this range (Young et aI., 1981). It was suggested that poor
sampling and the effect of endotoxin-producing commensal flora in the
female genital tract may affect the results obtained with cervical speci¬
mens in the Limulus lysate assay. In another study the Limulus lysate
assay detected 16 (84.2%) of 19 patients with cervical gonorrhoea and in
three patients (17.6%) with no microbiological evidence of gonorrhoea
(Young ef o/., 1983).
Spagna, Prior and Perkins ( 1980) evaluated the Limulus lysate
assay for diagnosis of gonococcal cervicitis in 40 women presenting
with vaginal discharge and/or abdominal pain. They found with a 1/800
dilution of cervical specimens that 17/18 (94%) of women with culture
proven cervical gonorrhoea gave positive Limulus results. The Limulus
lysate assay was negative for the 22 women with non-gonoccal cervicitis..
The Limulus lysate assay was considered to be much better than gram-
staining which detected 11/18 (61%) culture positive women and quick
and easy to perform.
7. 2 Detection of gonococcal components by enzyme-linked, immunosorbent
assays (ELISA)
Enzyme-linked immunosorbent assays (ELISA) are being used
widely not only for research but also for routine detection of microbial
antigens and antibodies.
ELISA tests are based upon the attachment of antigen to a solid
phase either to polystyrene balls or to the wells of microtitre plates
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(Figure 8). The antigen is detected by the addition of specific
antisera, or patients serum, which are in turn detected by specific
enzyme conjugated immunoglobulins. The addition of an enzyme sub¬
strate results in colour development which is measured spectrophoto-
metrically: the absorbance reading obtained allows quantitation of
the assay and the calculation of appropriate cut-off points.
A number of laboratories have attempted to develop their own
ELISA system although a commercial system (Gonozyme, Abbot Diagnostics)
is now available for the detection of gonococcal antigens in genito¬
urinary specimens.
Sarafian and Young ( 1982) used polystyrene beads armed with
mouse antiserum raised against whole untreated cells of N. gonorrhoeae
strain 9 to capture antigen; rabbit antiserum raised to the same strain
was used to detect the captured antigen. In a small study the use
of this ELISA assay was assessed for detection of gonococcal components
in the cervical and vaginal washes from 37 women (Young ef al 1983).
Positive results were obtained from 12 (60%) of the 20 patients with
gonorrhoea. Two false positives (11.7%) were detected from the 17
patients with no microbiological evidence of gonorrhoea.
A number of groups have evaluated the Gonozyme ELISA system
(Abbot Diagnostic Laboratories) (Aardoom et al., 1982; Papasian,
Bartholomew and Amsterdam, 1984; Stamm ef a I. , 1984). The Gonozyme
assay consists of beads 'pretreated' to aid antigen capture, rabbit
antibody to N. gonorrhoeae (obtained by injecting different strains
into rabbits) and an anti-rabbit I gG-peroxidase conjugate.
Recent studies have shown overall sensitivities and specificities
of 94-100% and 95.8-100% respectively for urethral samples from men.
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FIGURE 8: Schematic representation of the indirect sandwich EUSA.
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and specificities of 78-91.7% and 87.2-98% (Aardoom et al. , 1982;
Papasian et al., 1984; Stamm et al., 1984).
7. 3 Detection of N. gonorrhoeae in clinical specimens by means of
genetic transformation and DNA hybridisation
Transformation of gonococci as a means of detecting gonococcal
DNA in clinical specimens was investigated by Janik, Juni and Heym
( 1976). The detection of gonococcal DNA was based upon the transforma¬
tion of auxotrophic mutants (indicator strains) of N. gonorrhoeae to
prototrophy by crude DNA preparations obtained from clinical specimens.
The recipient auxotrophic mutant (Strain 488) which gave greatest
specificity required uracil and arginine for growth. Proteus and C.
albicans and other clinical isolates of gram-positive and gram-negative
organisms gave negative results when used as a source of donor DNA.
The assay is extremely sensitive, requiring a minimum of approximately
50 colony forming units (cfu) of donor gonococci to give a positive trans¬
formation assay.
Positive transformation assay results were obtained with 90 speci¬
mens confirmed as containing N. gonorrhoeae by conventional methods
(Janik et al. , 1976). However, 39 clinical specimens in which there
was no microbiological evidence of N. gonorrhoeae gave positive trans¬
formation results. According to Janik et at. ( 1976), examination of
clinical and epidemiological data for these specimens correlated with
the positive transformation assay findings.
However, the main problem associated with this technique is that
clinical isolates of N. gonorrhoeae may be auxotrophic. The proportion
of these auxotrophic strains, particularly those requiring AHU , in various
areas varies from 8^57% (Knapp et al. , 1978). In addition, AHU- auxo-
trophs are associated with asymptomatic gonococcal infections in men
(Crawford et al. , 1977).
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In a comparison of a number of non-cultural detection methods
for gonococcal components in cervical and urethral aspirates it was
found that 15 (75%) of 20 patients with gonorrhoea gave positive trans¬
formation results. Of the 17 patients with no microbiological evidence
of gonorrhoea, two (11.7%) gave a positive transformation result (Young
et al. , 1983). One of these patients was a contact of gonorrhoea. How¬
ever, this method was not considered to be simple, rapid or sensitive.
7. 3. 7 DNA hybridisation
The detection of gonococcal DNA in urethral exudates by DNA-
hybridisation using the gonococcal cryptic plasmid as a radiolabeled
probe was evaluated by Totten et al. (1983).
Clinical specimens hybridised to the radiolabeled DNA probe
were bound to nitrocellulose, resulting in a dark spot being produced
on X-ray film. The test was extremely sensitive requiring only 100 cfu
of N. gonorrhoeae and 0.1 pg of gonococcal cryptic plasmid DNA to
give a positive result. The test was also very specific, only two non¬
gonococcal neisseria species N. mucosa and N. cinerea gave positive
results.
Tests with clinical specimens from men with urethritis indicated
that 63 (89%) of 71 patients who had positive cultures were also positive
by the DNA hybridisation technique. All 42 patients with negative
culture results were also negative by the hybridisation assay. To
obtain the above sensitivity, nitrocellulose filters required to be auto-
radiographed for three days. However, in the majority of cases a positive
result could be detected after 24 h (Totten et al. , 1983). As DNA
hybridisation techniques are improved by replacing radioactive probes
with enzyme conjugated probes this technique may prove of greater
value in diagnosis.
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The major problem associated with non-cultural detection of
N. gonorrhoeae is lack of information concerning antibiotic sensitivities
of strains and whether or not they produce penicillinase. DNA hybridisa¬
tion techniques could possibly be adapted to incorporate detection of
B-lactamase plasmids. Despite this problem some form of non-cultural
detection is important given the problems of loss of viability of the
gonococcus in transport systems.
8.0 Antibiotic sensitivity testing
Antibiotic sensitivity testing requires the culture of gonococcal
isolates. Tests have to be carried out on pure cultures and therefore
results may not be available for several days. Hence antibiotic sensitivity
tests are generally retrospective since most patients will have been
treated on the basis of gram-stained smear results. However, they
are required for epidemiological purposes and for rational therapy regimens
for use in the geographical area concerned (Jackson and Jephcott, 1976).
The World Health Organisation recommended in 1978 that standardisation
of gonococcal penicillin sensitivity testing should be instigated around
the world. It was considered that standard reference strains, standardis¬
ation of media used and a specific methodology were required. Three
standard reference strains WHO III, V and VII for penicillin sensitivity
testing are available (WHO, 1978). However, most laboratories use
disc or agar dilution procedures with media and inocula to suit their
individual needs and preferences. Therefore the desired standardisation
of antibiotic sensitivity tests required for accurate comparative assess¬
ment of sensitivities in different geographical areas has not been achieved.
Only laboratories throughout Australia have standardized penicillin
sensitivity testing with the result that trends in penicillin resistance
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can be assessed accurately from area to area and nationally (Members
of the Australian Gonococcal Surveillance Programme, 1984).
Since the discovery of PPNG in 1976 (Phillips, 1976; Ashford
et al., 1976) which have now established themselves among the endemic
gonococcal population (McCutchan et al. , 1982) it is vital that rapid
routine sensitivity testing to penicillin is carried out.
8.1 Detection of penicillinase-producing gonococci
Gonococci which are less sensitive or relatively resistant to peni¬
cillin are generally considered to have an MIC of SO. 06 gg/ml (Sparling,
1977). Such strains must be tested for penicillinase production. A
simple disc technique can be used to screen for such isolates which
can then be tested for penicillinase production by one of the several
tests available (WHO, 1978).
One of these tests depends upon the hydrolysis by penicillinase
of the lactam bond of a chromogenic cephalosporin substrate giving
rise to a coloured product (O'Callaghan et al. , 1972). Other tests
depend upon the bacterial breakdown of penicillin to penicilloic acid
which is detected by the ability of penicilloic acid to dissociate a starch-
iodine complex (Odugbemi, Hafiz and McEntegart, 1977) or by a pH
indicator system (Phillips, Aller and Cohen, 1976). The later system
has been adapted so that it can be carried out alongside the RCUT
(Young, 1978b). Hence all strains can be tested during routine identifica¬
tion of isolates, many of them directly from the primary plate. However,
for this to be effective a number of colonies must be used for the inoculum
to prevent misidentification of small numbers of PPNG which may be
present in a mixed infection.
Bae, Ledesma and Kortis ( 1983) suggested using a reagent-impreg¬
nated, either starch-iodine or chromogenic cephalosporin (nitrocefin)
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filter paper replica method to test all colonies on the primary isolation
plate. They simulated a variety of mixtures of PPNG : non-PPNG on
culture plates ranging from 1:1, 1 : 10 and 1 : 100, and found that
either methods detected the PPNG colonies. However they found that
filter papers impregnated with nitrocefin, giving development of a yellow
colour, gave clearer results. They examined 186 clinical isolates on
primary cultures with the replica method. They detected cultures
which consisted of mixtures of PPNG and non-PPNG in 2 (1%) out of
186 of primary plates. In the first case, 83% of the colonies were g-
lactamase producers. However, in the second case only 2 (4%) of 46
colonies were g-lactamase producers. They concluded that in the second
case the PPNG may well have gone undetected by selection of only a
few colonies from the primary plate for conventional testing (Bae etal.,
1983). Colonies could be picked from the remains of colonies on the
primary plate or from the filter papers for subsequent purification
and culture.
9.0 Serological diagnosis
As discussed previously (page 97) antibody responses of patients
infected with N. gonorrhoeae are extremely variable or non-detectable.
Those patients who do produce an antibody response do so to a number
of different gonococcal components. In addition most people without
a history of gonococcal infection have 'natural' antibody to the gonococcus.
These factors make selection of test antigens and determination of cut¬
off points to differentiate between infected and non-infected patients
very difficult. Persistence of antibody following a recent successfully
treated infection is a further complication in interpreting serological
tests. Although a number of assays have been studied including radio-
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immunoassay (Usategiu et al. , 1982), ELISA, gonococcal complement
fixation tests and an indirect haemagglutination reaction (Oranje et at.,
1983) none have proved suitable for routine use.
9.1 Detection of local antibody responses
The production of localised IgA antibody can be detected in cervical
secretions by an indirect immunoflourescent-antibody method (McMillan
et al., 1980b). Antigonococcal IgA was detected in the cervical secre¬
tions of 56/78 (72%) of 78 women with untreated gonorrhoea but in only
25/490 (5%) of non-infected women. The sensitivity of this test was
no better than that of cervical gram-stained smears (74%) and it was
concluded that the low sensitivity, the expense and the laboriousness
of the indirect immunoflourescent test made it unsuitable for routine
diagnostic work (McMillan et a!., 1980b).
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AIMS OF STUDY
It is clear that the diagnosis and hence control of gonococcal
infection is dependent on properties of the bacterium as well as the
behaviour of the host. The surface structures of the gonococcus are
important in pathogenesis and genetic mechanisms have already been
discussed which can alter the surface properties of the gonococcus.
The surface antigens are of importance in the non-cultural detection
of N. gonorrhoeae.
This study was carried out to (i) examine the temporal distribu¬
tion of CoA serogroups (based on protein I) within the local gonococcal
population; (ii) to examine protein I and cell envelope phenotype in
relation to factors such as anatomical site of isolation which may select
gonococci with different surface properties and permeability; and
(iii) to use the information generated on CoA serogroups as a rational





Gonococcal major outer membrane protein (MOMP) reference strains
A-l, B-2, C-3, D-4, E-5, F-6, G-7, H-8, N-10, R-ll, S-12, T-13,
U-14, V-15 and W-16 were kindly supplied by Dr D. Danielsson,
Department of Clinical Bacteriology and Immunology, Central County
Hospital, Orebro, Sweden.
Gonococcal cell envelope phenotype reference strains FA140 (penA 2,
mtr-2, penB 2); FA102 (penA 2), FA19 (wild type), BR87 (env-2, str-7,
penA 2, mtr-2, penB2) and FA136 (penA 2, mtr-2) were kindly supplied
by Dr P.F. Sparling, University of North Carolina, Chapel Hill, USA.
Bacteroides spp. Bacteroides bivius, B. intermedius WPH 20, B. ureolyt-
icus NCTC 10941, B. asaccharolyticus GNAB 57 were obtained from Mr
R. Brown, MPRL Laboratory, Department of Bacteriology, The Medical
School, University of Edinburgh.
Cultures obtained from the National Collection of Typed Cultures, Colindale
London. The following were obtained from the National Collection of
Typed Cultures.
Staphylococcus aureus NCTC 8530
Neisseria flavescens NCTC 8263
N. cavaiae NCTC 10293
N. cuniculi NCTC 10297
N. can is NCTC 10296
N. cinerea NCTC 10294
N. elongata NCTC 10660
N. anamalis NCTC 10212
N. mucosa var. heidelbergensis NCTC 10777
Branhamella spp. NCTC 11015 & 11017




N. elongata subsp. glycolytica
N. ovis





N. meningitidis strains of groups A, B, C, L, X, W135, Z, Z1, Y and
RAS10 and a non-groupable strain were kindly supplied by Dr R.J.
Fallon, Director, Meningococcus Reference Laboratory (Scotland),
Ruchill Hospital, Glasgow.
1. 2 Clinical isolates
Fresh clinical isolates of N. gonorrhoeae, N. lactamica, N. perflava,
Gardnerella vaganalis, Candida albicans, Group B Streptococci and
lactobacilli were obtained from the Sexually Transmitted Diseases Diagnostic
Laboratory, Department of Bacteriology, The Medical School, University
of Edinburgh.
1.3 Culture media
Modified New York City Medium. MNYC medium (Young, 1978a) comprised
of Difco gonococcal base enriched with 10% human blood lysed with
0.5% Saponin, 2.5% yeast dialysate prepared as described by Faur et al.
( 1973b), 0.1% glucose, lincomycin (1.0 ng/ml), colistin (6 ug/ml),
amphotericin B (1.0 gg/ml) and trimethoprim lactate (6.5 ug/ml).
SMNYC. As for MNYC except that SMNYC lacks antibiotics.
CC + medium . Difco gonococcal base supplemented with L-glutamine,
thiamine pyrophosphate, ferric nitrate and glucose as described by
Kellogg et al. ( 1963).
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Blood agar. Columbia agar base (Oxoid) containing 5% human blood.
PPY medium. PPY is composed of 2% proteose peptone (Oxoid), 1%
yeast extract (Difco), 0.5% sodium chloride (NaCl), Haemin 5 tig/ml
final concentration, vitamin K (Menadione) 1 pg/ml final concentration,
L-cysteine 0.075% final concentration, sodium carbonate 0.04% final
concentration, pH 7.4 before autoclaving.
1.4 Viable counts
Viable counts were carried out by making serially ten-fold dilutions
of the appropriate suspensions and placing six 20 pi drops of each
dilution on culture plates.
1.5 Incubation
Standard incubation conditions, unless otherwise stated, were
overnight at 37°C in an aerobic C02-enriched (10%) humidified atmosphere.
1. 6 Confirmatory identification of N. gonorrhoeae
Gonococcal cultures were checked for purity by Gram-staining
and by the oxidase test. The oxidase test was carried out by touching
a few colonies with a cotton-tipped swab soaked in a solution of 1%
(w/v) tetramethyl-p-phenylenediamine dihydrochloride. This was followed
by the rapid carbohydrate utilisation test (Young et al. , 1976) and
testing isolates with the Phadebact gonococcus test (Pharmacia Diagnostics,
Uppsala, Sweden).
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1.7 Chemicals and biochemicals
Unless stated otherwise, all chemicals and biochemicals were
obtained from Sigma Chemical Company, Poole, England, or from BDH
Chemicals Ltd, Poole, England.
1.8 Buffers
Phosphate-buffered saline (PBS) pH 7.2: 10 mM phosphate buffer
pH 7.2 containing 0.15M NaCl.
1. 9 Protein determination - modified Lowry
1.6 ml of a 12. 5% solution of Na2C03 and 0.2 ml of 0.1% CuSOi*.
5HzO solution were added to 400 pi of test protein solution and incubated
for 1 h at room temperature. 0.2 ml of a one-third dilution of Folin
reagent was then added to the solution and incubated for a further
25 min at room temperature. Absorbance was read at 750 nm. Each
test was carried out in triplicate and compared with standard bovine
serum albumin standards.
1.10 Statistical analysis
Chi squared tests were used for all statistical analysis.
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SPECIFIC METHODOLOGY
SECTION I: CHARACTERISATION OF GONOCOCCAL ISOLATES BY
COAGGLUTINATION (CoA) SEROGROUPING AND CELL ENVELOPE
PHENOTYPING
1.0 Characterisation by CoA serogrouping
Preparation of antisera against the gonococcal MOMP reference strains
Antisera against MOMP E-5, D-4, V-15, N-10, S-12, U-14 and
F-6 were raised in New Zealand white rabbits. Antigen was prepared
and rabbits immunised according to the procedure of Sandstrom and
Danielsson (1980b).
Determination of antisera titres
The titres of the antisera were determined by an indirect immuno¬
fluorescence antibody (FA) method.
Suspensions of gonococcal strains to be used as antigen were
prepared by emulsifying a few colonies in 1 ml of distilled H20. 10 |H
of the antigen suspensions were applied to each well on 16 well microtitre
FA slides. The antigen was allowed to dry onto the slides.
Four-fold serial dilutions of each antiserum to be tested were
prepared in PBS from 1/4 to 1/64000. 10 pi of each dilution was placed
on an antigen coated well of the FA slides. Slides were placed in a
humidified chamber and incubated at 37°C for 30 min. Slides were
then washed in PBS for 10 min, rinsed in distilled H20, given a second
wash in fresh PBS and dried. 10 gl of a 1/10 dilution of fluorescein
conjugated anti-rabbit IgG conjugate was placed on each well. Initially
the conjugate was obtained from Wellcome Reagents Ltd (Wellcome Research
Laboratories, Beckenham, England), but latterly was obtained from
Sigma.
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Slides were then placed in the humidified chamber and incubated
at 37°C for 20,min. The slides were removed from the incubator, washed
thoroughly in PBS, dried and coverslips were mounted on the slides
in PBS buffered glycerol (Difco). The slides were examined immediately
by UV microscopy. The end point titre was determined as the last
antiserum dilution which gave a bright halo of flourescence round the
gonococcal cells.
Preparation of CoA serogrouping reagents
Antisera raised against the MOMP reference strains were selectively
absorbed and used to prepare CoA reagents.
A bsorp tion of an tisera
MOMP reference strains used for absorption of the antisera (Table
1) were grown on GC+ agar for 18 hours, harvested and washed once
in 0.01M PBS pH 7.2: ten plates gave approximately 0.3-0.5 g wet
weight of gonococcal cells. The cells were resuspended in 5 ml of PBS,
boiled for 30 min and centrifuged at 4000 x g for 20 min. The pellet
was used for absorption. Equal volumes of antisera and pellet were
incubated at 37°C for 4 h and then held overnight at 4°C. The absorbed
antiserum was collected by centrifugation and CoA reagents were prepared
to test the specificity of the antiserum. Absorption was repeated if
cross-reactions persisted.
Preparation of CoA reagents
This was essentially as described by Jephcott (1981). Staphylococcus
aureus NCTC 8530 was grown onGC+agar for 18 h, harvested and washed
thoroughly in 0.01M PBS pH 7.2, resuspended in PBS containing 0.5%
(v/v) formalin and incubated at room temperature for 3 h. The cells
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TABLE 1: Absorption scheme for producing antisera for CoA reagents.
Serogroup defined by
corresponding CoA
Antisera against Absorption strain reagent
MOMP E-5 MOMP N-10 WI
" D-4 " C-3 WI
V-15 " C-3 WI
MOMP N-10 MOMP D-4 WII
" S-12 " A-l WII
" U-14 " R-11 WII
MOMP F-6 MOMP B-2 & U-14 Will
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were then washed twice, resuspended in PBS, and heated at 80°C for
5 min. The stabilised cells were then washed twice, resuspended to
10% (w/v) in PBS and stored at -20°C in 1 ml aliquots.
Preparation of sensitised test suspension
Absorbed anti-gonococcal serum (0.1 ml) was mixed with 1 ml
of washed stabilised staphylococcal cell suspension and held at room
temperature for 15 min. The cells were then harvested by centrifuga-
tion at 2500 x g for 15 min and the deposit washed twice in PBS. The
sensitised cells were finally resuspended in 10 ml of sterile PBS.
The control reagent was prepared in exactly the same way with
normal rabbit serum substituted for anti-gonococcal serum.
Test procedure
Test suspensions of N. gonorrhoeae were prepared by harvesting
organisms from half a culture plate into 400 pi of distilled water and
boiling for 10 min. Tests were done with 20 pi of test gonococcal sus¬
pension and 20 pi of CoA reagent thoroughly mixed on a glass slide
and rocked for 2 min.
Slides were examined under oblique light, against a dark back¬
ground and the amount of agglutination with the test reagent compared
with that obtained in a similar test with the control reagent. The reactions
were graded negative (-), and positive: weak (+), moderate (2+) and
strong or very strong (3+).
Serogrouping protocol
In a pilot study, 58 strains were tested with each CoA reagent.
When it was shown that the CoA reagents anti-E-5 and N-10, defining
serogroups WI and WII respectively, reacted with the majority of the
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gonococcal strains within these serogroups, each test gonococcal
strain was thereafter screened against the three reagents anti-E, N-10
and F-6, defining serogroups WI, WII and Will. When the serogroup
of the strain was known, the reaction pattern of the strain with the
remaining reagents within its serogroup was determined.
1.1 Distribution of CoA serogroups over four consecutive time periods
and correlation of the reaction patterns obtained with the CoA
reagents
A total of 745 gonococcal strains isolated from patients who had
acquired their infections in the Edinburgh area were serogrouped over





1. Nov 1982 - June 1983 195
2. July - Dec 1983 204
3. Feb - Jun 1984 131
4. Aug - Dec 1984 215
Total Nov 1982 - Dec 1984 745
The distribution of CoA serogroups and the reaction patterns
of the CoA reagents with 713 of the 745 gonococcal strains were correlated
and examined.
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1. 2 Distribution of CoA serogroups among isolates from homosexual
men and heterosexual men and women
The serogroups of the gonococcal isolates were correlated in relation
to three patient groups: homosexual men, heterosexual men and women.
Differences in distribution of serogroups between the three patient
groups were compared.
1. 3 Correlation of CoA serogroups in relation to anatomical site of
isolation
The CoA serogroups of strains isolated from the rectum, urethra
and throat of homosexual men, the urethra and throat of heterosexual
men and the genitalia (cervix, urethra and Bartholins glands), rectum
and throat of heterosexual women were collated and compared.
1. 4 Correlation of CoA serogroup with presence of symptoms and oral
contraception in women
A retrospective study of the case notes of 64 women patients in
whom gonorrhoea was diagnosed and other genital infections excluded
was carried out in order to correlate the CoA serogroup of the infecting
strain with presence or lack of symptoms. Only one isolate per patient,
generally a cervical isolate, was used for analysis of clinical data.
Statistical analysis was carried out using Chi squared test with
Yate's correction.
1. 5 Comparison of CoA serogroup of strains isolated from 22 women
and their respective partners
The serogroup of gonococcal isolates from 20 women and their
respective partners, one woman and her two partners and one woman,
her husband and child were compared.
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1. 7 CoA serogroups of cloned gonococcal colonies
Single colonies (10) were picked from the primary culture plates
of seven WI strains and three WII strains and subcultured. The cloned
gonococci were serogrouped according to the previously described
protocol.
1.8 Distribution of serogroups among gonococcal strains isolated from
infections acquired outwith Edinburgh
The CoA serogroups of 50 gonococcal strains isolated from infections
acquired either elsewhere in the United Kingdom or abroad were correl¬
ated and compared with serogroups of strains isolated from infections
acquired in the Edinburgh area.
2.0 Characterisation of gonococcal isolates by cell envelope phenotyping
Determination of cell envelope phenotype
Each isolate was tested for sensitivity to the following hydrophobic
compounds: erythromycin (Abbott Laboratories Ltd, Queenborough,
England ME11 5EL), fusidic acid (Leo Laboratories Ltd, Princes Risborough,
England), Triton X-100 (Fisons Scientific Apparatus, Loughborough,
England) and crystal violet (Koch-Light Laboratories, Colnbrook, England).
A 19-point hand-held replicator (Mast Laboratories Ltd, Mast House,
Serby Road, Bootle, England) was used to seed separate plates of SMNYC
medium containing: erythromycin (doubling concentrations from 0.015-
2.0(ig/ml); crystal violet (doubling concentrations from 0.5-4.0 ug/ml);
fusidic acid (0.03, 0.25 and 0.5(ig/ml); and Triton X-100 (0.06, 1.0
and 2.0mg/ml). The inoculum was approximately 105 cfu of an overnight
culture of each isolate to be tested.
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Each batch of plates was set up in duplicate and included the
reference strains FA 140, BR87, FA 19 and FA 136. After incubation
for 48 h at 37°C in air with 10% C02 , plates were examined and the
MIC determined as the lowest concentration of each agent that prevented
visible growth.
Strains exhibiting the following MICs, which were given by the
Mtr reference strains FA 140 and FA 136, were designated the Mtr pheno-
type: erythromycin 20.5 pg/ml, fusidic acid 20.5 pg/ml, crystal violet
22.0 |ig/ml and Triton X-100 22.0 mg/ml. Strains exhibiting the follow¬
ing MICs, which were given by the Env reference strain BR87, were
designated the Env phenotype: erythromycin 20.06 pg/ml, fusidic
acid 20.03 pg/ml, crystal violet 20.5 pg/ml and Triton X-100 20.06 mg/ml.
The wild type reference strain FA 19 exhibited the following MICs:
erythromycin 0.12 pg/ml, fusidic acid 0.25 fig/ml, crystal violet 1.0
pg/ml and Triton X-100 1.0 mg/ml. Test strains with erythromycin
MICs of 0.12-0.25 pg/rnl were designated wild type.
2.1 Overall distribution of cell envelope phenotypes and correlation
of phenotype of infecting strain with patient group
The cell envelope phenotypes were determined for 482 gonococcal
strains isolated from patients who acquired their infections in the
Edinburgh area. Cell envelope phenotypes were correlated and compared
for gonococcal strains isolated from three patient groups: homosexual
men, heterosexual men and women.
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2. 2 Correlation of cell envelope phenotype with patient group and
anatomical site of isolation
The cell envelope phenotype of the gonococcal strain was correl¬
ated with patient group and with anatomical site of isolation. Differences
in distribution were compared by site of isolation.
2. 3 Relationship of cell envelope phenotype with CoA serogroup
The cell envelope phenotype was correlated with CoA serogroup
for 475 of the gonococcal strains and compared by patient group.
2.4 Cell envelope phenotype and CoA serogroup of gonococcal strains
isolated from infections acquired outwith the Edinburgh area
The phenotypes of 24 strains isolated from patients who acquired
their infections outwith Edinburgh were determined and correlated
with CoA serogroup. The results were compared with those obtained
for gonococci acquired within Edinburgh.
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SECTION II: NON-CULTURAL DETECTION AND
IDENTIFICATION OF N. GONORRHOEAE
1.0 Preparation of antisera against MOMP E-5 and N-10 protein I antigen
Purification of protein I antigen
Protein I was purified from MOMP E-5 and N-10 essentially by
the method of Heckels (1981) and James and Heckels (1981).
Culture of gonococcal strains
MOMP E-5: MOMP E-5 was inoculated onto GC+ medium in large trays
(nine 27 x 38 cm; eight 40 x 35 cm) and incubated at 37°C in 10% C02
for 20 h. The growth was scraped off the surface of the medium with
sterile glass slides and harvested into ice cold 0.1M PBS (pH 7.2).
If the trays contained more than 1% surface contamination they were
discarded. The bacteria were pelleted by centrifugation at 12,000 g
for 20 min (Sorvall).
The yield of MOMP E-5 cells was approximately 22 g wet weight.
MOMP N-10: Because of gross contamination of the trays, MOMP N-10
was cultured on GC+ medium in large round petri plates (diameter 13.5
cm) for 20 h at 37°C in 10% COz. The growth was harvested as for
MOMP E-5 and the pellet stored in 0.1M PBS (pH 7.2) at -20°C. This
procedure was repeated until approximately 27 g (wet weight) of MOMP
N-10 cells had been produced.
Preparation of purified outer membranes
The bacterial pellets were suspended in 0.2M lithium acetate buffer
(pH 6.0) at approximately 10 g wet-weight/100 ml of buffer and incubated
at 45°C for 2.5 h with occasional vigorous shaking. After incubation
the suspensions were placed in a tissue homogeniser (Waring Commercial
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Blender, Waring Products Division, Connecticut) and homogenised
at maximum speed for 1 min. The homogenised suspensions were centri-
fuged three times at 15,000 g for 20 min (Sorval) to remove bacterial
fragments. The supernatants were centrifuged at 100,000 g for 2 h
(Beckman, Super Speed 40) to sediment crude outer membranes.
The membrane pellets were suspended in 6M urea-0.2M sodium
acetate buffer (pH 6.0) at an approximate protein concentration of
10 mg/ml and incubated at room temperature for 30 min. After incubation
the suspensions were diluted with an equal volume of 6M urea - sodium
acetate buffer to give a final volume of approximately 15 ml. The sus¬
pensions were then centrifuged at 100,000 g for 3 h (Beckman, Super
Speed 40). The pellets containing pure outer membrane complex were
resuspended and washed three times in distilled water.
Purification of outer membrane proteins
The pelleted outer membranes were suspended in 15 ml of 1% (w/v)
sodium cholate in 0.1M glycine -NaOH buffer (pH 9.5) and incubated
at 37°C for 1 h. After incubation the suspensions were centrifuged
at 100,000 g for 2 h. The pelleted sodium cholate insoluble material
was suspended in 2 ml of 1% (v/v) Empigen-BB detergent (a gift from
Albright and Wilson, Whitehaven, England) in 0.1M glycine-NaOH
buffer (pH 9.5) and incubated at 37°C for 1 h. The suspensions were
centrifuged at 100,000 g for 2 h and the supernatant containing Empigen-
BB soluble material (ESM) rich in protein I was collected. The samples
were diluted 1 : 2 to give 2.5 ml of ESM from each of MOMP E-5 and
N-10 at a protein concentration of approximately 1.5 mg/ml. Protein
concentration was estimated by measuring absorbance at 280 nm (Pye
Unicam SP6-550 UV/VIS spectrophotometer) and comparing with a bovine
serum albumin protein standard.
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Protein I was separated from the ESM by column chromatography.
Column chromatography
1 ml volumes (2 ml total) of the ESM material from each of MOMP
E-5 and N-10 were applied to a 320 mm x 15 mm column containing
Sephacryl 200 (S-200) (Pharmacia Fine Chemicals, Pharmacia Ltd, Milton
Keynes, England). The ESM was eluted down the column in 1% (v/v)
Empigen-BB in 0.1M glycine-NaOH buffer (pH 9.5) at a flow rate of
37.5 ml/h and 1 ml fractions were collected at 1.5 min intervals in an
automatic fraction collector (2070 Utrorac® II, LKB, Sweden).
The absorbance at 280 nm was determined for each fraction collected
and the absorbance v fraction number was plotted on a graph. The
graphs obtained with MOMP E-5 and MOMP N-10 eluted ESM are shown
in Figures 9 and 10 respectively. The fractions comprising each peak
were pooled to give a total of four pooled samples: two samples A and
B and two samples C and D from MOMP E-5 and N-10 respectively.
The pooled samples were dialysed against 0.5M sodium carbonate-
bicarbonate buffer (pH 9.0) four times and against distilled H20 two
times and concentrated to approximately 1 ml in a micro-volume stirred
ultrafiltration cell (Amicon Ltd, Woking, England) containing an Amicon
PM10 ultrafilter membrane with an exclusion of >10,000 MWt.
The protein concentrations of the samples were 1 mg/ml, 0.977
mg/ml and 1.032 mg/ml for samples A and B, C and D respectively.
The samples and the remainder of the ESM from MOMP E-5 and
N-10 were stored at -20°C until required for analysis by polyacrylamide
gel electrophoresis and for production of antisera against protein I.
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FIGURE 10: Fractionation of empigen soluble material from MOMP N-10 by column chromatography.
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Sodium dodecyl sulphate - polyacrylamide gel electrophoresis (SDS-PAGE)
The procedure was essentially as described by Poxton and Brown
( 1979). Slab gels ( 170 x 140 mm) of 10% (w/v) acrylamide with a 10 mm
4% (w/v) acrylamide stacking gel were used in a gel electrophoresis
apparatus (Raven, Haverhill, Suffolk).
The buffers used were as described by Laemmlf (1970). Samples of
the material to be examined were solubilised by heating in a boiling
water bath for 3 min in SDS-sample buffer containing 2% (w/v) SDS
and 5% mercaptoethanol (Poxton and Brown, 1979). Samples of 50 pg
of protein were applied to the wells of one gel and samples of 5 pg
of protein were applied to the wells of a second gel. Molecular weight
standards were included in the first gel. Electrophoresis was carried
out at a constant voltage of 50V until the samples entered the separating
gel (approximately 1 h) and was then maintained at 150V until the bromo-
phenol blue tracking dye was near the bottom of the gel (approximately
3 h). The first gel and half of the second gel were stained for protein
with Coomassie Brilliant Blue (Poxton and Sutherland, 1976). The
other half of the second gel was stained for lipopolysaccharide by silver
after periodic acid treatment by the method of Tsai and Frasch (1982).
Immunisation procedure for production of antisera against protein I
Antisera against MOMP E-5 and MOMP N-10 protein I were raised
in New Zealand white rabbits. The rabbits were test bled prior to
immunisation.
Aliquots of MOMP E-5 and N-10 protein I antigen were thawed
and diluted with an equal volume of Freund's complete adjuvant to give
a final vaccine volume of 0.5 ml containing 100 pg of protein I antigen.
The rabbits were immunised intramuscularly according to the following
procedure: Day 1, two 0.5 ml injections,one in each hind leg; Day 14,
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two 0.5 ml injections in the back; Day 28, one 0.5 ml injections in
each hind leg; 14 days later the rabbits were test bled and then received
a 0.5 ml booster injection. Two weeks later the rabbits were exsanguin¬
ated by cardiac puncture.
Determination of antibody titres
The antibody titres were determined by an indirect FA assay as
previously described.
1.1 Preparation of antisera to MOMP E-5 and N-10 whole cell antigen
Antisera to MOMP E-5 and N-10 whole antigen were those used
in Section I.
2.0 Preliminary studies on gonococcal antigen detection by an indirect
enzyme linked immunosorbent assay (ELISA) using wheat germ
lectin for antigen capture
2.1 Agglutination of MOMP E-5 and N-10 by wheat germ lectin
This was carried out essentially as described by Curtis and Slack
(1981). An aliquot of wheat germ_(WGt) lectin (lmg/ml) was serially diluted
in two-fold steps down to a dilution of 1/512 corresponding to a final
concentration of 2 pg/ml of lectin. N. gonorrhoeae MOMP E-5 and N-10
were harvested from overnight MNYC plates in 0.01M PBS (pH 7.2)
and the suspensions were adjusted to McFarland's standard 0.5 with
PBS. 40 pi of each lectin dilution and 40 pi of the gonococcal suspensions
were placed on glass slides, mixed together and slides were rotated
for 10 min. Controls consisted of 40 pi of PBS mixed with 40 pi of
gonococcal suspension.
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The amount of agglutination was read by eye and scoring attempted
by the protocol of Curtis and Slack (1981): 4+ very few clumps in
clear supernatant; 3+ medium sized clumps in clear supernatant; 2 +
small easily seen agglutinates; + agglutination just visible to the naked
eye; +/- no visible agglutination. The end point was taken as the
highest WG lectin dilution giving 2+agglutination.
2.2 Effect of boiling on lectin agglutination of thick gonococcal sus¬
pensions
Thick suspensions, two of MOMP E-5 and two of MOMP N-10, were
prepared by harvesting approximately half the growth from overnight
culture plates into 400 pi of PBS. The first suspension of each strain
was untreated and the second suspension was boiled for 10 min prior
to testing with WG lectin as above.
2.3 Indirect enzyme-linked immunosorbent assay using polystyrene
beads coated with wheat germ lectin
Preparation of lectin dilutions
A duplicate set of seven WG lectin dilutions were made in 0.01M
PBS (pH 7.2) and in 0.05M carbonate buffer (pH 9.6) to give WG lectin
concentrations ranging from 200 pg/ml to 3.0 pg/ml.
Procedure for coating polystyrene beads with lectin
24 universal bottles each containing 24 polystyrene beads, 0.25 in;
c. 0.6 cm RIA grade with frosted finish (Euro-matic Ltd, Brentford,
England) were set up and divided into three sets of eight. 5 ml volumes
of each of the seven lectin/PBS dilutions were added to universals
of sets one and two, 5 ml volumes of each of the seven lectin/carbonate
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dilutions were added to universals of set three and to the eighth universal
of sets one, two and three 5 ml of the respective diluent buffer was
added to give uncoated control beads.
Universal set one was incubated at 37°C for 2 h and sets two and
three at 37°C for 4 h and 5 h respectively. All three sets were then
incubated overnight at 4°C.
After incubation the supernatants were removed from all universals
using a pasteur pipette and the polystyrene beads turned out into
labelled petri dishes containing paper towels and allowed to air dry.
Once completely dry the beads were placed in labelled sterile universals
and stored at 4°C until required.
EL ISA procedure
The following procedure was used throughout this study. Details
of the relevant lectin coated beads and MOMP E-5 antigen preparations
used will be described later for each experiment.
The lectin coated and uncoated control polystyrene beads were
placed in clean glass Wasserman tubes (1 bead/tube) and 400 |il of
antigen was added to appropriate tube. Tubes containing beads and
400 pi of buffer acted as controls. The tubes were incubated in a 37°C
water bath for 30 min. The supernatant from each tube was then aspirated
and the beads were washed three times with PBS/Tween 20 (0.01M
PBS (pH 7.2) containing 0.05% (v/v) Tween-20). 400 al of anti-MOMP
E-5 whole cell unabsorbed antiserum at a dilution of 1/100 in PBS/Tween
20 was added to each tube and the tubes were then incubated for a
further 30 min at 37°C . The supernatants were removed and the beads
were washed as before. 400 yl of a 1/1000 dilution of anti-rabbit IgG-
horseradish peroxidase conjugate (Miles Scientific Division, Slough,
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England) in PBS/Tween-20 was then added to each tube and the tubes
were incubated as before. After incubation supernatants were aspirated
and the beads were washed as before. The beads were then carefully
transferred to clean glass tubes. O-phenylenediamine (OPD) substrate
[0.04% (w/v) OPD, 0.012% (v/v) H202 in phosphate-citrate buffer
(0.05M diabasic sodium phosphate; 0.025M citric acid) (pH 5.0)]
was added to each tube and the tubes were incubated at 37°C for 30
min. The supernatant was quickly transferred to the wells of a 96-well
microtitre plate and extinction read at 490 nm in a multiskan plate reader
(Titrek®, Dynatech Laboratories, Billingshurst, England).
2. 3. 7 Determination of minimum amount of whole cell antigen detected
by polystyrene beads armed with lectin in PBS
The ELISA was carried out according to the previously described
procedure. Rabbit anti-E-5 serum and anti-rabbit IgG peroxidase
conjugate were used at dilutions of 1/100 and 1/1000 respectively. Poly¬
styrene bead sets 1 and 2, prearmed with lectin/PBS dilutions at 37°C
for 2 h and 4 h respectively, were used. Lectin concentrations ranged
from 200 gg/ml to 3 ug/ml as shown in Figure 11.
MOMP E-5 whole cell antigen was used: antigen ranged from
undiluted (3 x 107cfu) to a 1/1,050,000 dilution (29 cfu).
The whole cell antigen was prepared by harvesting the growth
from an overnight MNYC plate into 0.01M PBS (pH 7.2) and adjusting
the suspension to McFarland's standard 1.0. A viable count was immed¬
iately carried out and ten four-fold serial dilutions were carried out
in PBS.








































2. 3. 2 Determination of the minimum amount of sonicated antigen detected
by polystyrene beads armed with lectin in carbonate buffer
(pH 9. 6)
The ELISA procedure was as previously described. Rabbit anti-
E-5 serum and anti-rabbit IgG peroxidase conjugate were used at dilu¬
tions of 1/100 and *71000 respectively. Polystyrene bead set 3, prearmed
with lectin in carbonate buffer (pH 9.6), was used. Lectin concentrations
ranged from 200 pg/ml to 3 |ig/ml as shown in Figure 11. MOMP E-5
sonicated antigen was used: antigen concentration ranged from undiluted
(400 Mg of protein e 9.4 x 107 cfu) to a dilution of 1/1,050,000 (0.0004
jjg = 90 cfu).
The sonicated MOMP E-5 antigen was prepared by harvesting
the growth from 15 overnight MNYC plates into 4 ml of 0.01M PBS (pH
7.2). A viable count was rapidly carried out and the bacterial suspen¬
sion was centrifuged for 15 min at 3000 rpm in a bench centrifuge.
The bacterial pellet was resuspended in the original volume of PBS.
The bijou containing the MOMP E-5 suspension was placed on ice and
the probe of an MSE ultrasonicator was placed just under the meniscus
of the suspension. The gonococcal cells were disrupted by sonication
for 2 min at setting 8: if the suspension did not become opalescent,
sonication was repeated for a further two minutes. The sonicate was
examined by Gram staining to ensure that disruption of the gonococci
had occurred.
The protein concentration of the sonicate was determined to be
4.77 mg/ml by the modified Lowry protein assay. A portion of the
sonicate was diluted in PBS to 1 mg/ml of protein and 10 four-fold serial
dilutions in PBS were carried out on this portion. The dilutions of
sonicate were used in the ELISA as shown in Figure 11.
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3.0 Gonococcal antigen detection on nitrocellulose by an indirect enzyme
linked immunosorbent assay (dot-blot immunoassay)
Dot-blot immunoassay procedure
The following procedure was used throughout this study. Details
of the relevant antigen and anti-gonococcal antiserum used will be des¬
cribed later for each experiment.
Strips of nitrocellulose (Bio-Rad Laboratories Ltd, Watford, England)
were cut to the required size and placed in Tris buffered saline (TBS)
(20 mM Tris, 500 mM NaCl, pH 7.5) at a 45° angle and allowed to wet
by capillary action. Strips were removed from the TBS, air dried and
antigen either 1 gl or successive 1 nl amounts were applied to separate
sites on the nitrocellulose strips. The strips were air dried and placed
in a blocking solution of 3% (w/v) gelatin in TBS and incubated at room
temperature with constant shaking for 45 min. The strips were then
transferred to antigonococcal antiserum in antibody buffer (1% (w/v)
gelatin in TBS containing 0.05% Tween 20) and incubated at room tem¬
perature with constant shaking for 1 h. The strips were washed two
times in TBS containing 0.05% Tween 20 and transferred to the conjugate
solution containing a 1/3000 dilution of anti-rabbit IgG horseradish
peroxidase conjugate (Bio-Rad) in antibody buffer containing 0.05%
Tween 20.
The strips were incubated with the conjugate solution at room
temperature with constant shaking for 1 h. Strips were washed as
before, rinsed in distilled H20 and transferred to the substrate solution.
The substrate solution was prepared by adding 60 mg of 4-chloro-l-
napthol (Bio-Rad) in 20 ml of methanol to 100 ml of TBS containing
0.015% ice cold H202.
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The strips were incubated at room temperature for 20 min unless
stated otherwise with constant shaking. Colour reactions were stopped
by placing the strips in distilled H20 for 10 min. Positive reactions
resulted in a purple colour appearing on the dots. A control containing
only TBS was included on each strip.
3.1 Detection of (A) untreated whole cell, (B) boiled, and (C) sonicated
MOMP E-5 antigen by anti-E-5 antiserum
The dot-blot immunoassay was carried out as previously described
except that the nitrocellulose strips were incubated with the substrate
solution for 15 min instead of 20 min.
Unabsorbed MOMP E-5 whole cell antiserum at a 1/50 dilution was
used for antigen detection. This antiserum was previously used for
preparing CoA reagents.
MOMP E-5 antigen was used. This comprised of (A) untreated
whole cell, (B) boiled whole cell, and (C) sonicated antigen.
The antigen suspensions were prepared as follows. MOMP E-5
was harvested from five overnight MNYC plates into 5 ml of TBS, the
cells were washed twice in TBS and resuspended in TBS. The suspen¬
sion was adjusted to an OD of 1.0 at 540 nm equivalent to approximately
109 cfu/ml. A viable count was performed and 1 ml aliquots were placed
into three bijoux labelled A, B and C, the remainder of the original
suspension was stored at -20°C for future use. Suspension A was
untreated, B was boiled for 10 min and C was sonicated at setting 8
for 2 min in an MSE ultrasonicator. Each suspension was then serially
diluted from 1/2 to 1/1024. Antigen 1 ul from each dilution (undiluted
to 1/1024) was applied to separate spots on three nitrocellulose strips
labelled A, B and C corresponding to the three antigen suspensions
used.
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Colour development on the spots was graded subjectively, by
eye, according to the following protocol: 3+, strong positive reaction
(very deep purple); 2+, medium positive reaction (purple); +, positive
reaction (light purple); +/-, very slight colour development; -, no
colour development.
3.2 Detection of MOMP E-5 and N-10 boiled whole cell antigen by anti-
N-10 antiserum
The dot-blot immunoassay was carried out according to the previously
described protocol.
Unabsorbed MOMP N-10 whole cell antiserum was used for antigen
detection at a 1/50 dilution. This antiserum had previously been used
to prepare CoA reagents.
MOMP E-5 and N-10 boiled whole cell suspensions (OD 1.0) from
undiluted to 1/1024 dilution were used as antigens.
MOMP N-10 antigen was prepared by harvesting the growth from
five overnight MNYC plates into 5 ml of TBS. The cells were washed
twice in TBS, resuspended in TBS and the suspension was adjusted
to an OD of 1.0 at 540 nm. A 400 pi aliquot was removed and the
remainder of the suspension was frozen at -20°C.
The aliquot of MOMP N-10 suspension and a 400 pi thawed aliquot
of MOMP E-5 suspension OD 1.0 (used in 3.1 ) were boiled for 10 min
and serial two-fold dilutions from 1/2 to 1/1024 were carried out. 1 pi
of each dilution (undiluted to 1/1024) were applied to separate spots
on two nitrocellulose strips labelled E-5 and N-10.
Colour development was scored subjectively according to the proto¬
col described in 3.1.
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3.3 Detection of MQMP E-5 and N-10 boiled whole cell antigen by a
mixture of anti-E-5 and anti N-10 antiserum
The dot-blot immunoassay was carried out as previously described.
A mixture of anti-E-5 and anti-N-10 unabsorbed whole cell antiserum
at a ratio of 1 : 1 to give a total antiserum dilution of 1/50, with each
individual antiserum at 1/100, was used for antigen detection.
Aliquots of MOMP E-5 and N-10 whole cell antigen described in
3.1 an 3.2 were thawed and boiled for 10 min. Serial two-fold dilutions
were carried out from 1/2 to 1/1024 and 1 pi of each antigen dilution
(undiluted to 1/1024) were applied to separate spots on nitrocellulose
strips labelled E-5 and N-10. Colour development was scored subjec¬
tively as previously described.
3.4 Detection of MQMP E-5 and N-10 boiled whole cell antigen by un¬
absorbed anti-E-5 and absorbed anti-E-5 and absorbed anti-N-10
antisera
The dot-blot immunoassay procedure was carried out as previously
described. The MOMP E-5 and N-10 boiled whole cell antigen was as
previously described and 1 pi amounts of undiluted to 1/1024 dilution
of these antigens were applied to separate spots on nitrocellulose strips.
Unabsorbed anti-E-5 whole cell antiserum and absorbed anti-E-5 and
absorbed anti-N-10 whole cell antisera at dilutions of 1/50 were used
for antigen detection. The absorbed antisera were those used for
preparation of CoA reagents and the absorption procedure is described
in Section I 1.0.
Colour development was read subjectively by eye and scored accord¬
ing to the previously described protocol.
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3. 5 Detection of MOMP E-5 and N-10 boiled whole cell antigen with
a mixture of anti-E-5 protein I and anti-N-10 protein I antisera
The dot-blot immunoassay was carried out as previously described.
MOMP E-5 and N-10 boiled whole cell antigen used were as previously
described. 5 nl amounts (1 pi volumes applied successively) of un¬
diluted and dilutions from 1/32 to 1/1024 were applied to separate spots
on nitrocellulose strips.
Unabsorbed antisera raised against protein I purified from MOMP
E-5 and N-10 respectively were mixed in a ratio of 1 : 1 and dilutions
of 1/50, 1/100 and 1/200 of this mixture were used for antigen detection.
Colour development was read and scored as in previous experi¬
ments .
3.6 Determination of the minimal amount of purified MOMP E-5 and
N-10 protein I antigen detected by a mixture of unabsorbed whole
cell antisera and by a mixture of anti-protein I antisera
The dot-blot immunoassay was carried out as previously described.
Purified protein I antigen (50, 10, 5 and 1 ng) from MOMP E-5 and
N-10 respectively, was applied to separate spots on nitrocellulose strips.
Antigen was detected by a 1/100 dilution of a 1 : 1 mixture of anti-E-5
and anti-N-10 whole cell antisera and by a 1/100 dilution of a 1 : 1 mixture
of anti-E-5 protein I and anti-N-10 protein I antisera.
Colour development was read and scored as previously described.
3. 7 Detection of gonococcal antigen in male urethral specimens by
anti-gonococcal antisera in the dot-blot immunoassay
The dot-blot immunoassay was carried out as previously described.
Clinical urethral specimens were obtained from 95 male patients with
urethritis attending the Department of Genitourinary Medicine, The
167.
Royal Infirmary, Edinburgh. The urethral specimens were taken using
small cotton tipped chlyamidial swabs (Medical Wire & Equipment Ltd,
Corsham, England) after material had been taken from the patients
for routine diagnostic smear and culture tests. On receiving the urethral
specimens, the swabs were broken off into 200 pi of TBS in clean glass
tubes, mixed with a vortex mixer for 60 sec, boiled for 10 min and
prior to being discarded the swabs were rotated against the sides of
the tubes to express all material. The specimens were then labelled
and stored at -20°C until required.
Prior to testing for gonococcal antigen in the dot-blot immuno¬
assay, the specimens were allowed to thaw and were boiled for a further
10 min. Each specimen was applied to separate spots on nitrocellulose
strips by placing successive 1 pi amounts to give a total of 10 pi of
antigen/spot.
Control antigen was included on each test strip. Initially this
consisted of 10 pi of undiluted (107 cfu) MOMP E-5 and 10 pi of undiluted
(107 cfu) MOMP N-10 boiled whole cell antigen used in previous experi¬
ments. Latterly control antigens consisted of MOMP E-5 boiled whole
cell antigen at concentrations of 10 7, 1.6 x 105 and 8 x 104 cfu which
gave 3+ (strong positive), 1+ (positive) and +/- (very little colour)
reactions respectively.
Antigen was detected by a 1 : 1 mixture of anti-E-5 and anti-N-10
whole cell antiserum. Initially a 1/50 dilution of this antisera mixture
was used but this was later changed to a 1/100 dilution. In the second
half of the study 45 specimens were also tested with a 1/100 dilution
of a 1 : 1 mixture of anti-E-5 protein I and anti-N-10 protein I antisera.
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Scoring of clinical specimens: Colour development on the spots was
read by eye and scored subjectively according to the previously des¬
cribed protocol (Section 3.1). The results were compared with those
of the control antigen and clinical specimens were scored positive if
they gave ^1+ reaction and negative if very little (+/- reaction) or
no colour (- reaction) developed.
Correlation with culture results: The dot-blot immunoassay results
for the clinical specimens were read without prior knowledge of the
respective culture results. Once the immunoassay results for each
clinical specimen had been determined comparisons were then made
with the respective urethral culture results.
3.8 Determination of the minimum amount of antigen detected in the
dot-blot immunoassay and the corresponding CoA serogroups for
9 clinical isolates of A/, gonorrhoeae
Nine gonococcal strains were isolated from male patients from whom
urethral specimens had been taken for testing in the dot-blot immuno¬
assay.
Determination of the minimum amount of antigen detectable: The dot-
blot immunoassay was carried out as previously described. Suspensions
of the gonococcal isolates were made in TBS, adjusted to an OD of approxi¬
mately 1.0 (range 0.8 to 1.1) at 540 nm (approximately 109 cfu). An
aliquot of each suspension was boiled for 10 min and doubling dilutions
were prepared in TBS from 1/2 to 1/1024. 1 pi amounts of each antigen
dilution from undiluted to 1/1024 were applied to separate spots on
nitrocellulose strips.
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Antigen was detected by a 1 : 1 mixture of anti-E-5 and anti-N-10
whole cell antisera and by a 1 : 1 mixture of anti-E-5 protein I and
anti-N-10 protein I antisera. A dilution of 1/100 was used for both
antisera mixtures.
Colour development was read by eye and scored subjectively as
previously described.
CoA serogrouping: The nine gonococcal isolates were serogrouped
by CoA reagents as previously described (Section I).
3. 9 Specificity of the dot-blot immunoassay
The dot-blot immunoassay was carried out as previously described.
The bacterial species used to test the specificity of the dot-blot immuno¬
assay were:
Commensal Neisseria: N. flavescens NCTC 8263, N. caviae NCTC
10293, N. cuniculi NCTC 10297, N. canis NCTC 10296, N. cinerea
NCTC 10294 N. elongata NCTC 10660, N. anamalis NCTC 10212,
N. mucosa var. heidelbergensis NCTC 10777, N. sp. NCTC 11049,
N. denitrificans NCTC 10295, N. pharyngis NCTC 4590, N. elongata
subsp. glycolytica NCTC 11050, N. ovis NCTC 11018, N. mucosa
var. mucosa NCTC 11017 and 2 clinical specimens of N. perflava.
Pathogenic/commensal Neisseria: N. meningitidis groups Y, RAS 10,
Z1, L, Ref Z, X, W135, A, B, C and a non-groupable strain;
N. lactamica PHLS 696 and three clinical isolates of N. lactamica.
Branhamella: Two Branhamella spp. NCTC 11015 and NCTC 11017.
Bacteria common to the urogenital tract: C. vaganalis, B. bivius,
C. albicans, group B Streptococcus, Lactobacillus, B. ureolyticus,
B. intermedius, and B. asaccharolyticus.
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Suspensions of the 31 non-gonococcal Neisseria, the 2 Branhamella
spp. and the 8 other bacterial species commonly isolated from the uro¬
genital tract were prepared in TBS. The suspensions were adjusted
to an OD of approximately 1.0 at 540 nm and an aliquot of each suspen¬
sion was boiled for 10 min. Doubling dilutions of each boiled suspension
from 1/2 to 1/1024 were prepared in TBS and 1 gl amounts of each
dilution from undiluted to 1/1024 were applied to separate spots on
nitrocellulose strips.
Antigen was detected by a 1 : 1 mixture of anti-E-5 and anti-N-10
whole cell antisera and by a 1 : 1 mixture of anti-E-5 protein I and
anti-N-10 protein I antisera: both antisera mixtures were used at a
dilution of 1/100.
Colour development was read by eye and scored subjectively as
previously described.
3.10 Antigen detection using antisera absorbed with B. bivius
The dot-blot immunoassay was carried out as previously described.
Aliquots of whole cell antigen from MOMP E-5, MOMP N-10, four
Bactericides spp. and two meningococcal strains, prepared for previous
experiments, were thawed, boiled for 10 min and dilutions of each sus¬
pension from 1/2 to 1/1024 were prepared in TBS. 1 gl amounts of
each antigen dilution were applied to separate spots on nitrocellulose
strips. In addition four male urethral specimens were included (10 gl:
successive 1 gl amounts) . These specimens gave false positive results
when tested previously in the dot-blot immunoassay.
Antigen was detected by a 1 : 1 mixture of anti-E-5 and anti-N-10
whole cell antisera and by a 1 : 1 mixture of anti-E-5 protein I and
anti-N-10 protein I antisera: both antisera mixtures had been absorbed
by B. bivius and were used at a dilution of 1/100.
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A b sorp tion of an tisera
B. bivius was inoculated into two 20 ml starter cultures of pre-
reduced PPY medium and incubated anaerobically at 37°C for 48 h.
The starter cultures containing B. bivius were used to inoculate 2 1
of prereduced PPY medium which was then incubated anaerobically
at 37°C for 72 h.
The bacteria were harvested from the PPY medium by centrifuga-
tion, washed two times in distilled water, resuspended in PBS and
boiled for 30 min. The bacteria were recovered by centrifugation and
washed twice in PBS. The bacterial pellet was weighed and 1 g (wet
weight) was added to 1 ml of the anti-gonococcal whole cell antisera
mixture and 1 g was added to 1 ml of the anti-gonococcal protein I
antisera mixture. The antisera were absorbed with the B. bivius for
4 h at 37°C and overnight at 4°C. The absorbed antisera were recovered
by centrifugation.
3.11 Reduction of non-specific colour development by blocking with
bovine serum albumin
The dot-blot immunoassay was carried out essentially as previously
described, except that one nitrocellulose strip was blocked in 3% gelatin/
TBS as per normal and the other was blocked in a solution of 3% bovine
serum albumin in TBS.
Control antigen consisted of MOMP E-5 antigen at undiluted 1/32,
1/64 and 1/128 dilutions and undiluted MOMP N-10 antigen. 1 pi amounts
of each control antigen dilution were applied successively to separate
spots on two nitrocellulose strips to give a total of 10 pi of antigen/spot.
Five male urethral clinical specimens (10 ul/specimen) were also applied
to spots on the nitrocellulose strips. The preparation of the clinical
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specimen has been described previously (Section 3.7). Antigen was
detected using a 1/50 dilution of a 1 : 1 mixture of anti-E-5 and anti-N-
10 whole cell antisera.
The results for the strip blocked in the BSA were compared with
those on the strip blocked with gelatin.
3.12 Testing of the anti-rabbit IgG conjugate for non-specific binding
to antigen and for endogenous peroxidase activity in urethral
clinical specimens
Control antigen consisted of undiluted (1 x 106 cfu), 1/64 and
1/256 dilutions of the MOMP E-5 boiled whole cell antigen and undiluted
(1 x 106 cfu) of the MOMP N-10 boiled whole cell antigen. 1 pi amounts
of each antigen dilution were applied successively to separate spots
on two nitrocellulose strips to give a total of 10 pi of antigen/spot.
Three male urethral clinical specimens were also applied to each strip.
These were treated as previously described and successive 1 pi amounts
were applied to separate spots on the nitrocellulose strips to give a
total of 10 pi of antigen/spot.
Both strips were placed in the 3% gelatin/TBS blocking solution
for 45 min.
Testing for non-specific binding of the conjugate
One strip was then placed in the conjugate solution ( 1/3000
dilution of anti-rabbit IgG peroxidase conjugate in antibody buffer)
for 1 h, washed and placed in the substrate solution for 20 min.
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Testing for endogenous peroxidase activity
The second strip was removed from the blocking solution, washed
in distilled H20 and placed directly into the substrate solution and
incubated for 20 min.
After incubation in the substrate solution both strips were removed,
washed in distilled H20 for 10 min and examined for colour development.
4.0 Immunological identification of N. gonorrhoeae with monoclonal
and polyclonal antibody coagglutination reagents
Clinical isolates of neisseriae were obtained from patients attending
the Department of Genitourinary Medicine of the Royal Infirmary of
Edinburgh. Anogenital and pharyngeal material was inoculated directly
on to Modified New York City (MNYC) medium and transported to the
laboratory within 4 h. After overnight incubation at 36°C in air enriched
with carbon dioxide (5-10%), cultures were screened for oxidase positive
Gram negative diplococci (GNDC). Suspected neisserial colonies (oxidase
positive GNDC) were subcultured on to MNYC medium and incubated
overnight before carrying out the rapid carbohydrate utilisation and
coagglutination tests. If more than one anogenital site from a female
patient yielded Gram negative diplococci, cultures from one site only,
usually the cervix, were tested by coagglutination.
In the first part of the study all Gram negative diplococci were
tested in parallel with polyclonal and monoclonal coagglutination reagents.
Thirteen stock cultures of N. lactamica and five of g-lactamase producing
Branhamella catarrhalis were also tested with both types of reagent.
During the second half of the study only monoclonal reagents were
used, and test performance was compared with bacterial suspensions
prepared by boiling and by treatment with antigen releasing agent.
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Coagglutination
Coagglutination with polyclonal antibody reagents (Phadebact
Gonococus test, Pharmacia Diagnostics AB, Sweden) was performed
with a boiled suspension of organism as described by Young and McMillan
( 1982), except that a 20 al unit volume was used.
Coagglutination with monoclonal reagents (GONO GEN, New
Horizons Diagnostic Company, Columbia, MD) was carried out with
boiled suspensions of organisms and with suspensions treated with
an antigen releasing agent available from the same source.
4.1 CoA using boiled gonococcal suspensions and an antigen releasing
agent
Boiled suspension method
A heavy suspension of each culture to be tested was made by
removing the growth from the culture plate with a cotton tipped swab
and emulsifying it in 0.2 ml of distilled water in a tube. The tube
was covered and the suspension heated in a boiling water bath for
5 min. After cooling to room temperature, 20 pi aliquots of suspension
were mixed with an equal volume of test reagent (murine monoclonal
anti-protein I antibody bound to dead staphylococci) and control reagent
(non-immune rabbit IgG bound to dead staphylococci) on a clear glass
slide. Three tests were carried out on a single slide (7.6 cm x 5.0 cm)
with six clearly defined areas. The slide was rocked gently in a rotary
fashion for 1 min and the results read against a dark background using
indirect light.
Antigen releasing agent
Suspensions of each test organism were made on a glass slide
by mixing several colonies with 20 ul volumes of antigen releasing agent
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(diluted 1/5 with distilled water). Test reagent (20 |il) and control
reagent (20 pi) were mixed with the suspensions and the slides rocked
and read as above.





clumping or agglutination with test reagent
significantly stronger than with control reagent.
clumping or agglutination slightly stronger with
test reagent than with control reagent.
reaction of equal strength with test and control
reagents.
no reaction with the test reagent irrespective
of any reaction with the control reagent.
Calculation of sensitivity and specificity were as follows:
Sensitivity
Specificity
percentage of gonococcal isolates by carbo¬
hydrate utilisation that were coagglutination
positive.
the percentage of non-gonococcal isolates by
carbohydrate utilisation that were coagglutination
negative.
4. 2 Calculation of predictive values
Predictive values were calculated according to the formula given
by Veehio ( 1960) .
The predictive value of a positive test (PV+) is the probability
that the Gram negative diplococci giving a positive coagglutination test
are gonococci and is calculated according to the formula:
PV
pa
pa + (l-p)( 1-b)
x 100
176.
The predictive value of a negative test (PV~) is the probability
that the Gram negative diplococci giving a negative coagglutination
test are non-gonococcal neisseriae (or Branhamella) and the formula is:
PV~ d~P)b x 100
(l-p)b + p(l-a)
where p = prevalence of gonococcal Gram negative diplococci within
the total population of Gram negative diplococci isolated from a given
site, a = test sensitivity, and b = test specificity.
The significance of differences in the results was determined
by the x2 test with Yates' correction.
RESULTS
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SECTION I: CHARACTERISATION OF GONOCOCCAL STRAINS
BY CoA SEROGROUPING AND CELL ENVELOPE PHENOTYPING
1.0 Characterisation by CoA serogrouping
Table 3 shows the titres of the rabbit antisera raised against
the seven MOMP reference strains E-5, D-4, V-15, N-10, S-12, U-14
and F-6. All except anti F-6 had titres in the range of 1/256 to 1/4096.
Anti F-6 had a titre of 1/64.
TABLE 3: Titres of antisera raised against gonococcal MOMP reference
strains.
Antiserum 1IF titre against









1.1 Distribution of CoA serogroups over four consecutive time periods
and correlation of the reaction patterns obtained with the CoA
reagents
Table 4 shows the overall distribution of CoA serogroups for
gonococcal strains isolated over the four separate time periods spanning
two years. Overall 311 (41.8%), 372 (49.9%), 61 (8. 2%) and 1(0.1%)
of strains belonged to CoA serogroups WI, WII, WII/WIII and Will respec¬
tively .
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TABLE 4: Overall distribution of CoA serogroups for strains isolated
from infections acquired in Edinburgh for the four time
periods.
Number (percentage) of strains
belonging to serogroup
period WI WII WII/WIII Will Total
1 85 (44) 110 (56) 0 0 195
2 89 (44) 108 (53) 7 (3) 0 204
3 60 (46) 53 (40) 18 (14) 0 131
4 77 (35.8) 101 (47) 36 (16.7) 1 (0.5) 215
Total 311 (41.8) 372 (49.9) 61 (8.2) 1 (0.1) 745
The number of WI strains isolated dropped by approximately
10% in the fourth study period: 35.8% compared with 44% in periods
1 and 2 and 46% in period 3. This change in proportion of WI strains
in period 4 is significant when compared with periods 1-3 inclusive
(xf = 4.035; p <0.05). In period 1 none of the strains reacted with
both the WII reagents and Will reagent whereas in periods 2, 3 and
4 there were 7, 18 and 36 serogroup WII/WIII strains respectively
(Table 4).
Only one gonococcal strain isolated from infections acquired
in the Edinburgh area belonged to serogroup Will. The increase in
the number of WII/WIII strains over the four periods represented a
significant change in the distribution of CoA serogroups (x§ = 55.62;
p <0.001). There was no significant change in the distribution of the
other serogroups over the four time periods (x^ = 9.85; 0.5 > p > 0.1).
Reaction patterns obtained
Table 5 shows the CoA reaction patterns obtained with the
gonococcal strains isolated from infections acquired in the Edinburgh
area. Thirty-one of the 311 WI strains were not tested fully because
of a shortage of the CoA WI reagents.
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TABLE 5: Reaction patterns of gonococcal strains with CoA reagents
defining CoA serogroups WI and WII/WIII.
CoA
reagents Reaction patterns
Serogroup WI 1 2 3 4 5
Anti E-5 + + + + -
Anti D-4 + - - + +
Anti V-15 + + - - +
No. of isolates 168 52 48 11 1
(total 280)
Serogroup
WII/WIII 6 7 8 9 10 11 12 13 14 15 16 17 18
Anti N-10 + + - + + - + - + + + -
Anti S-12 + - + - + + + + + - - -
Anti U-14 + + + - + - - + + - - + -
Anti F-6 + + + + + +
No. of isolates 279 29 7 22 4 29 2 34 5 7 4 11 1
(total 131)
+ positive; - negative.
A total of 18 CoA reaction patterns were observed during the
course of this study: 5 WI patterns, 7 WII patterns and 5 WII/WIII
patterns. One strain reacted only with the Will reagent anti F-6 to
give the eighteenth pattern.
Overall, 168/280 (60%) of the WI strains gave pattern 1 with CoA
WI reagents, 279/372 (75%) of the WII strains gave pattern 6 with CoA
WII reagents and 34/61 (56%) of the WII/WIII strains gave pattern 13
with CoA WII/WIII reagents.
The WI reagent anti E-5 alone detected 99.6% (279/280) of the
WI strains and the WII reagent anti N-10 detected 95.8% (415/433) of
the WII and WII/WIII strains.
In the last two periods difficulty was encountered in serogrouping
eight strains. These strains did not react with the WI reagents but
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gave very weak reactions with one or more of the WII reagents and
were subsequently placed in serogroup WII.
1.2 Distribution of CoA serogroups among homosexual men and hetero¬
sexual men and women
The overall distribution of CoA serogroup among the three patient
groups is shown in Table 6. The majority of gonococcal strains isolated
from homosexual men belonged to CoA serogroup WII and WII/WIII,
102 (94%) compared with 151 (53%) and 180 (51%) isolates from hetero¬
sexual men and women respectively. Only 6% of isolates from homosexual
men belonged to serogroup WI compared with 47% and 48.9% of isolates
from heterosexual men and women respectively. The difference in
distribution of serogroups between homosexual men and heterosexual
men is highly significant (xi = 55.99; p <0.001) as is the difference
between homosexual men and heterosexual women (xf = 63.60; p <0.001).
There were no statistically significance differences in the overall
distribution of serogroups for strains isolated from heterosexual men
and women (xa =0.23; p >0.5).
Table 7 shows the distribution of the CoA serogroups among
these three patient groups for each of the four time periods.
Homosexual men
WI strains were isolated from homosexual men only in period 1
and accounted for 10% of the strains isolated. No WII/WIII strains were
isolated in period 1 compared with 4 (33%), 2 (18%) and 7 (27%) in periods
2, 3 and 4 respectively. No Will strains were isolated from this group
of patients. The difference in the distribution of serogroups for strains
isolated over the four periods is significant (x'£ = 22.78; p <0.001):
when the WII/WIII isolates are excluded the difference is not significant
(X 3 = 6.00; 0.5 > p > 0.1) .
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TABLE 6: Overall distribution of CoA serogroups among homosexual
men and heterosexual men and women.
Number (and percentage) of
strains within serogroup
Patient group WI WII WII/WIII Will Total
Homosexual men 6 (6) 89 (82) 13 (12) 0 108
Heterosexual men 132 (47) 130 (46) 21 (7) 0 283
Women 173 (48. 9) 153 (43. 2) 27 (7.6) 1 (0. 3) 354
Total 311 (41. 8) 372 (49. 9) 61 (8.2) 1 (0. 1) 745
TABLE 7: Distribution of CoA serogroups among homosexual men
and heterosexual men and women for each of the four
time periods.
Number (and percentage) of
Patient Time strains within CoA serogroup
group period WI WII WII/WIII Will Total
Homo¬ 1 6 (10) 53 (90) 0 0 59
sexual 2 0 8 (67) 4 (33) 0 12
men 3 0 9 (82) 2 (18) 0 11
4 0 19 (73) 7 (27) 0 26
Hetero¬ 1 37 (66) 19 (34) 0 0 56
sexual 2 38 (41) 52 (57) 2 (2) 0 92
men 3 20 (44) 20 (44) 5 (11) 0 45
4 37 (41) 39 (43) 14 (16) 0 90
Women 1 42 (53) 38 (47) 0 0 80
2 51 (51) 48 (48) 1 (1) 0 100
3 40 (53) 24 (32) 11 (15) 0 75
4 40 (40.4) 43 (43.4) 15 (15.2) 1 (0.3) 99
Total 311 (41.8) 372 (49.9) 61 (8.2) 1 (0.1) 745
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Heterosexual men
In the first period 66% (Table 7) of gonococcal strains isolated
from heterosexual men belonged to CoA serogroup WI whereas in periods
2, 3 and 4 this number dropped by approximately 20-25% to 41%, 44%
and 41% respectively. Concurrently the number of WII strains increased.
A similar increase in the number of gonococcal strains grouped as WII/
Will was observed in heterosexual men as was observed for strains
isolated from homosexual men. No Will strains were isolated from hetero¬
sexual men who had acquired their infections in Edinburgh. The reduction
in the number of WI and increase in WII and WII/Will strains isolated
from this group of patients resulted in a significant difference in the
distribution of serogroups over the four periods (xl =26.32; p <0.001).
When WII/Will strains are excluded from the analysis the proportion
of WI and WII strains over these periods remains significantly different
(xl = 9.88; 0.05 > p > 0.02).
Women
In periods 1 and 2 the distribution of CoA serogroups WI and
WII was very similar (Table 7). In period 3 the number of WI strains
was similar to the number isolated in periods 1 and 2 but the number
of WII strains decreased and 11 (15%) WII/WIII strains were isolated.
In period 4 only 40.4% of strains belonged to serogroup WI compared
with 51% in period 2 and 53% in periods 1 and 3. When the proportion
of WI strains in period 4 is compared with the proportion of WI strains
in periods 1 to 3 the difference just fails to reach significance (xi = 3.48;
0.1 > p > 0.05). In period 4, 15.2% of the isolates belonged to serogroup
WII/WIII and one isolate was a Will strain.
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The difference in distribution of the serogroups over the four
periods was significant (x I = 31.76; p <0.001). However when the
WII/WIII strains are excluded the difference is not significant (xl = 7.68;
0.5 > p > 0.1).
1.3 Serogroup in relation to anatomical site of isolation
Table 8 shows the distribution of serogroups in relation to anatomical
site of isolation for each patient group over periods 1-4 inclusive.
TABLE 8: Distribution of serogroups in relation to anatomical site of
isolation.
Number (and percentage) of
Patient Anatomical strains within
group site WI WII WII/WIII Will Total
Women Throat 25 (52) 21 (44) 2 (4) 0 48
Rectum 38 (48) 33 (42) 8 (10) 0 79
Genital 109 (48.2) 99 (43.8) 17 (7.5) 1 (0.5) 226
Others X1 0 0 0 1
Hetero¬ Throat 9 (35) 16 (62) 1 (4) 0 26
sexual Urethra 123 (48) 114 (44) 20 (8) 0 257
men
Homo¬ Throat 3 (12) 19 (72) 3 (12) 0 25
sexual Rectum 2 (4) 45 (83) 7 (13) 0 54
men Urethra 1 (4) 25 (86) 3 (10) 0 29
Total 311 372 61 1 745
1 right hip aspirate
In homosexual men serogroups WII and WII/WIII predominate
regardless of the anatomical site of isolation.
In women gonococcal strains isolated from the rectum and genitalia
(urethra, cervix and Bartholins glands) are distributed among the
CoA serogroups in similar proportions (Table 8). However a higher
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proportion of throat isolates belonged to serogroup WI compared with
rectal or genital isolates: 52% compared with 48% and 48.2% respectively.
Slightly fewer WII/WIII strains were isolated from the throat than either
the rectum or genitalia: 4% compared with 10%and 7.5% respectively.
However these differences in distribution of serogroups among strains
isolated from different anatomical sites in women are not significant
(xi_. = 2.16; p >0.5). The majority of women had strains of the same
serogroup infecting each anatomical site. However both WI and WII
strains were isolated from the rectum of one woman and in a second
woman a WI strain was isolated from her rectum whereas a WII strain
was isolated from her cervix.
In heterosexual men there is no significant difference in the
distribution of serogroups among strains isolated from the throat compared
with those isolated from the urethra (xl. = 2.91; 0.5 >p > 0.1). However
fewer WI strains were isolated from the throat.
The distribution of CoA serogroups of genital strains isolated
from women is very similar to that for male heterosexual urethral isolates
(Table 8).
1.4 Correlation of CoA serogroup with presence of symptoms and oral
contraception in women
7. 4. 7 Serogroup in relation to symptoms
Table 9 shows the correlation of symptoms with serogroup of
infecting gonococcal strain for 64 women. Overall 38/64 (59%) of the
women had asymptomatic gonococcal infections. Of the 26 women present¬
ing with symptoms, 19 had vaginal discharge not associated with other
vaginal pathogens such as Candida or Trichomonas, three had dysuria,
three had pelvic inflammatory disease and one had a disseminated gonococcal
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infection. Fifteen (58%) of the symptomatic women had infections with
gonococcal strains of serogroup WI compared with 18 (47%) of asympto¬
matic women: this difference is not statistically significant (xi = 0.31;
p > 0.5).




Number (percentage) of infecting
strains within serogroups
WI WII Total
Yes 15 (58) 11 (42) 26
No 18 (47) 20 (53) 38
Total 33 (52) 31 (48) 64
Serogroup in relation to women taking oral contraceptives
Table 10 shows the correlation of serogroup of infecting strain
in women taking oral contraceptives. Overall 41/64 (64%) of the women
were taking oral contraceptives. Of these women 25 (61%) had infections
with strains of CoA serogroup WI compared with 8/23 (35%) of women
not taking oral contraceptives. However this difference fails to reach
significance (xi = 3.06; 0.1>p> 0.05).
TABLE 10: Correlation of serogroup of infecting strain with oral
contraception in women.
Oral
Number (percentage) of infecting
strains within serogroups
contraception WI WII Total
Yes 25 (61) 16 (39) 41
No 8 (35) 15 (65) 23
Total 33 31 64
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1. 5 Comparison of CoA serogroup of strains isolated from 22 women
and their respective partners
The serogroup of gonococcal isolates from 20 women and their
respective partners, one woman and her two partners and one woman,
her husband and child were compared. The serogroup of isolates from
each respective set of contacts were found to match (Table 11).
With regards to the reaction patterns obtained with the CoA reagents
all strains isolated matched in 12/22, at least one female isolate matched
with the respective male isolate in 4/22 and none of the female isolates
matched the respective male isolate in 6/22 sets of contacts.
1.6 CoA serogroups of cloned gonococcal colonies
All clones were found to have the same serogroup as the parent
culture.
1. 7 Distribution of CoA serogroups among gonococcal strains acquired
outwith Edinburgh
A total of 45 patients acquired their infections outwith the Edinburgh
area: 12 in other areas in the United Kingdom, 12 in Europe and 21
in non-European countries.
Table 12 shows the area the infection was acquired, patient group
and CoA serogroup of gonococcal isolates. Of the 12 strains isolated
from infections acquired in other areas of the United Kingdom, 2 (17%),
9 (75%) and 1 (8%) belonged to serogroups WI, WII and WII/WIII respec¬
tively. Five of the WII strains were isolated from patients who had
acquired their infections in London; two of these patients were homosexual
men.
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TABLE 11: CoA serogroup and reaction pattern of gonococcal strain
isolated from 22 women and their respective partners.
Key: W - women, M - male, B - baby; Cx - cervix,
R - rectum, U - urethra, F - throat.
Contact Sex of Site of CoA Reaction
pairs patient isolation serogroup pattern
1 W Cx WII 13
F WII 17
R WII 13
M U WII 7
2 W Cx WI 3
U WI 1
M u WI 3
3 W R WII 7
M U WII 6
4 W Cx WII 6
M U WII 6
5 W U WI 1
M U WI 1
6 W Cx WII 6
M U WII 6
7 W Cx WI 3
F WI 2
M F WI 1




M U WI 3
9 W Cx WII 6
Ml U WII 6
M2 u WII 6
10 W Cx WI 2
R WI 1
M u WI 3
11 W R WII 6
M U WII 6
F WII 6
12 W Cx WI 1
M U WI 1
13 W Cx WII 11
M u WII 6
14 W Cx WII 6
M U WII 6
B right eye WII 6
left eye WII 6
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TABLE 11 (cont.)
Contact Sex of Site of CoA Reaction
pairs patient isolation serogroup pattern
15 W Cx WII 7
M R WII 7
16 W Cx WI 1
R WI 4
M U WI 1
17 W Cx WI 4
M R WI 3
18 W U WI 3
Cx WI 1
M U WI 1
19 W Cx WI 1
M U WI 1
20 W F WII 6
Cx WII 6
U WII 6
M u WII 6
21 W u WII 6
Cx WII 6
M u WII 6
22 W Cx WII 9
M Cx WII 9
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TABLE 12: Gonococcal infections acquired outwith Edinburgh.
CoA serogroup
Area infection Patient Number
of isolates
acquired group of patients WI WII WII/WIII WII
Other areas in:
Perthshire Male 1 0 1 0 0
Inverness Male 2 1 1 0 0
Wales Female 1 1 0 0 0
Northern Ireland Male 1 0 0 1 0
England Male 1 0 1 0 0
Torquay Male 1 0 1 0 0
London Female 2 0 2 0 0
Homosexual
Male 2 0 2 0 0
Male 1 0 1 0 0
Total 72 2 9 7 0
Europe:
Spain Female 2 2 0 0 0
Homosexual
Male 1 1 0 0 0
Male 4 0 3 0 1
Italy Male 1 1 0 0 0
Holland Male 1 0 1 0 0
Greece Male 1 0 1 0 0
Germany Homosexual
Male 1 0 1 0 0
Male 1 0 0 1 0
Total 72 4 6 7 7
Non-Europe:
Thailand Male 9 0 6 2 1
Homosexual
Male 1 0 1 0 0
Singapore Male 1 0 1 0 0
Hong Kong Male 0 3 0 0
Sri Lanka Male 1 0 1 0 0
Nigeria Male 1 0 0 0 1
Kenya Male1 1 0 2 0 0
Morocco Male 1 0 1 0 0
Trinidad Female 1 0 1 0 0
Antigua Male 2 0 2 0 0
Total 27 0 18 2 2
■"■Two strains isolated: one PPNG, one non-PPNG.
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Of the 12 strains isolated from infections acquired in Europe, 4
(34%), 6 (50%), 1 (8%) and 1 (8%) belonged to serogroups WI, WII, WII/WIII
and Will respectively. Strains isolated from infections acquired in
Spain appear to cover the full range of serogroups.
None of the strains isolated from infections acquired in non-
European countries belonged to CoA serogroups WI: 18/22 (82%), 2/22
(9%) and 2/22 (9%) belonged to serogroups WII, WII/WIII and Will respec¬
tively. Only one of these strains was isolated from a homosexual male,
the rest being isolated from heterosexual patients.
2.0 Characterisation of gonococcal isolates by cell envelope phenotyping
2.1 Overall distribution of cell envelope phenotypes and correlation
of phenotype of infecting strain with patient group
A total of 482 gonococcal strains isolated from infections acquired
in the Edinburgh area were phenotyped. Table 13 shows the distribution
of cell envelope phenotypes among homosexual men and heterosexual
men and women. Overall 24 (5%), 417 (87%) and 41 (8%) were of the
Env, wild type, and Mtr cell envelope phenotypes respectively. Of
the strains isolated from homosexual men 17/47 (36%) had an Mtr pheno¬
type compared with 5% and 6% from heterosexual men and women. No
gonococcal strains with an Env phenotype were isolated from homosexual
men. There is a highly significant difference in the proportion of Env/
wild type and Mtr phenotypes when isolates from homosexual men are
compared with those from heterosexual men (x2i = 36.56, p <0.001) and
with those from women (xf = 38.19; p <0.001). There is no such difference
when isolates from heterosexual men are compared with those from women
(x? = 0.33; p >0.5).
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TABLE 13: Distribution of cell envelope phenotypes among isolates
from homosexual men and heterosexual men and women.
Patient
Number (percentage) of isolates
with the cell envelope phenotype:
group Env Wild type Mtr Total
Homosexual 0 30 (64) 17 (36) 47
men
Heterosexual 12 (6) 176 (89) 9 (5) 197
men
women 12 (5) 211 (89) 15 (6) 238
Total 24 (5) 417 (87) 41 (8) 482
2.2 Correlation of cell envelope phenotype with patient group and
anatomical site of isolation
Table 14 shows the distribution of cell envelope phenotypes of
strains in relation to anatomical site of isolation and patient group.
TABLE 14: Cell envelope phenotype in relation to patient group and
site of isolation.
Patient Site of
Number (percentage) of strains
with cell envelope phenotype:
group isolation Env Wild type Mtr Total
Homosexual U 0 9 (53) 8 (47) 17
men R 0 17 (81) 4 (19) 21
F 0 4 (44) 5 (55) 9
Heterosexual U 12 (7) 159 (88) 9 (5) 180
men F 0 17 (100) 0 17
women G 7 (4) 145 (92) 6 (4) 158
R 2 (4) 47 (87) 5 (9) 54
F 3 (12) 19 (73) 4 (15) 26
Total 24 (5) 417 (87) 41 (8) 482
Key: U - urethra; R - rectum; F - throat; G - genital.
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A significantly higher proportion of urethral isolates from homo¬
sexual men had an Mtr phenotype compared with urethral isolates from
heterosexual men (xi = 29.71; p <0.001) and with female genital isolates
(xi = 33.37; p <0.001). There is no significant difference in the
proportion of Mtr phenotypes isolated from the rectum of homosexual
men compared with the number of Mtr phenotypes isolated from the
rectum of women ( xi = 0.60; 0. 5 > p > 0.1).
A higher proportion of Mtr phenotypes were isolated from the
urethra and the throat than from the rectum of homosexual men, however
this failed to reach significance (xi = 3.57; 0.1>p> 0.05).
A significantly higher proportion of homosexual male throat
isolates had an Mtr phenotype compared with throat isolates from hetero¬
sexual men and women (xi = 8.13; p <0.01).
2. 3 Relationship of cell envelope phenotype with CoA serogroups
Table 15 shows the distribution of envelope phenotype in relation
to CoA serogroup and patient group.
Serogroup WII (including WII/WIII) accounted for 100% of isolates
from homosexual men, 58% from heterosexual men and 52% from women.
With regards cell envelope phenotype, serogroup WII accounted for
34/40 (85%) of Mtr isolates compared with 245/435 (56%) of the non-Mtr
strains. This is a significant difference (xi = 17.33; p <0.001). One
Mtr strain belonged to serogroup Will.
The Mtr phenotype occurred significantly more often among WII
isolates from homosexual men than among WII isolates from heterosexual
men (xi = 17.47; p <0.001) and women (xi = 15.67; p <0.001).
A significantly higher proportion of Mtr strains compared with
wild type strains isolated from heterosexual patients belonged to CoA
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serogroup WII or WII/WIII ( x 1 = 4.25; 0. 05 > p > 0.02). However, there
was no significant difference in the distribution of CoA serogroups
among Env and wild type strains isolated from heterosexual patients
(Xi = 1-36; 0. 5 > p >0.1).
TABLE 15: Relationship of cell envelope phenotype with CoA sero-
group and patient group.
Patient CoA
Number (percentage) of strains
with cell envelope phenotype:
group serogroup Env Wild type Mtr Total
Homosexual WI 0 0 0 0
men WII or
WII/WIII
0 30 (65) 16 (35) 46
Heterosexual WI 7 (8.4) 75 (90.4) 1 (1.2) 83
men WII or
WII/WIII
5 (4) 100 (89) 8 (7) 113
women WI 7 (6) 101 (90) 4 (4) 112
WII or
WII/WIII
4 (3) 106 (89) 10 (8) 120
Will 0 0 1 1
Total 23 (5) 412 (87) 40 (8) 475
2. 4 Cell envelope phenotypes and serogroups of gonococci isolated
from infections acquired outwith the Edinburgh area
A total of 24 strains were acquired outwith the Edinburgh area
either elsewhere in the United Kingdom or abroad (Table 16). Strains
with an Mtr phenotype accounted for 13/24 (54%) compared with 41/482
(8%) of Edinburgh isolates. Of these, six were acquired in Thailand,
three in Hong Kong, one in Antigua, one in Spain and two in London.
Only three of the 13 (23%) Mtr phenotype strains were isolated from
homosexual men, the remaining 10 (77%) being isolated from heterosexual
men.
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TABLE 16: Envelope phenotype and serogroup of gonococcal isolates
from male infections acquired outwith the Edinburgh area.
Area infection Envelope CoA Patient
acquired phenotype serogroup group
Europe:
Spain Mtr Will Heterosexual
London Wild type WII TT
England Wild type WII Tf
Northern Ireland Wild type WII TT
Inverness Wild type WII ft
Spain Wild type WII Homosexual
Wild type WI TT
London Wild type WII TT
Mtr WII TT
Mtr WII TT
Germany Wild type WII TT
on-Europe:





Hong Kong Mtr WII TT
Mtr WII TT
Mtr WII TT
Antigua Mtr WII TT
Wild type WII TT
Morocco Wild type WII TT
Kenya Wild type WII TT
Thailand Mtr WII Homosexual
All isolates except one belonged to CoA serogroups WII, WII/WIII
or Will. The WI isolate (wild type phenotype) was isolated from a homo¬
sexual man who had acquired his infection in Spain. The difference
in distribution of Env/wild type and Mtr phenotypes when isolates
acquired outwith Edinburgh are compared with those acquired in Edinburgh
is significant (y? = 45.32; p <0.001).
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Three of the 13 Mtr strains were isolated from infections acquired
in Europe, two of the three being isolated from homosexual men. Nine
of the 10 Mtr strains isolated from infections acquired in non-European
countries were isolated from heterosexual men and one was isolated
from a homosexual male. All of these strains belonged to CoA serogroup
WII or WII/WIII.
A total of 12 gonococcal strains were isolated from heterosexual
men who acquired their infections in non-European countries (Table 16).
Nine of the 12 strains (75%) had an Mtr phenotype compared with 9/197
(5%) of strains isolated from heterosexual men who had acquired their
infections in Edinburgh (Table 13). This is a significant difference
(xi = 52.62; p <0.001). The number of Mtr strains isolated from hetero¬
sexual men who acquired their infections in non-European countries
is also significantly higher than the number of Mtr strains isolated
from homosexual men who acquired their infections in Edinburgh: 9/12
(75%) compared with 17/47 (36%) (Table 13) (Xi = 4.37; 0.05 >p > 0.02).
A much higher proportion of serogroup WII strains was isolated
from heterosexual men who acquired their infections in non-European
countries compared with heterosexual men who acquired their infections
in Edinburgh: 11/12 (92%) (Table 16) compared with 113/196 (58%)
(Table 15) ( xi = 4.1; 0.05 > p > 0.02). The proportion of WII strains
isolated from these heterosexual men was similar to that for homosexual
men who had acquired their infections in Edinburgh: 11/12 (92%) (Table
16) compared with 46/46 ( 100%) (Table 15).
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SECTION II: NON-CULTURAL DETECTION AND
IDENTIFICATION OF N. GONORRHOEAE
1.0 Preparation of antisera against MOMP E-5 and N-10 protein I
antigen
SDS-PAGE results
Figure 12 shows the results of the SDS-PAGE for sample A (Lane
4) from MOMP E-5 and sample C from MOMP N-10 (Lane 1). These
samples were used for immunising rabbits against protein I antigen
and correspond to peaks A and C after column chromatography of
Empigen soluble material (ESM) purified from MOMP E-5 and N-10 respec¬
tively (Figures 9 and 10). These samples should, according to the
method of James and Heckels (1981) contain purified protein I. Samples
B and D corresponding to peaks B and D (Figures 9 and 10) and samples
of the ESM purified from MOMP E-5 and N-10 prior to column chromato¬
graphy were run for comparison (Figure 12, Lanes 5, 2, 6 and 3).
According to the method of James and Heckels (1981), peaks B and D
should correspond to protein II.
Lane 7 contained molecular weight standards comprising six poly¬
peptide bands corresponding to molecular weights of 77,000, 66,200,
45,000, 25,000, 17,200 and 12,300. The relative mobility of each poly¬
peptide band was calculated according to the following formula:
distance moved
percentage relative _ by the band front ^
mobility distance moved by
bromophenol blue
A standard graph was drawn of molecular weight of standards v. per¬
centage relative mobility. This was used to determine the molecular
weights of the protein bands in the samples tested. All samples were





FIGURE 12: SDS-PAGE of proteins extracted from MOMP N-10 and
E-5 and purified by column chromatography.
Gel was stained with Coomassie blue for protein. All
samples were applied at 50 (ig of protein/track.
MOMP N-10: profile 1, sample C; profile 2, sample D; profile 3, ESM.
MOMP E-5: profile 4, sample A; profile 5, sample B; profile 6, ESM
Molecular weight standards: profile 7.
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The protein I purified from MOMP N-10 and E-5 had molecular
weights of 34,500 and 37,000 (Lanes 1 and 4) and these corresponded
to the most heavily staining bands. However, both of these samples
C and A have minor staining bands of approximate molecular weights
of 30,000 and 28,000. These are thought to correspond to species
of protein II. Very faintly staining bands corresponding to these molecular
weights can be seen in samples D and B (Lanes 2 and 5) which correspond
to the peaks which should contain protein II after column chromatography
of the ESM. Obviously column chromatography did not separate protein
I and II completely. This was partially observed in the graphs obtained
from the OD V fraction number which gave two illdefined peaks from
the fractionated ESM from both MOMP E-5 and N-10 (Figures 9 and 10).
However the amount of material in samples C and A from MOMP E-5 and
N-10 (Lanes 4 and 1) corresponding to these minor proteins is much
reduced when compared to the corresponding staining protein bands
observed in the ESM from these strains prior to column chromatography
(Lanes 6 and 3) (Figure 12).
Column chromatography removed the high molecular weight bands
(range 100,000 - 41,000) found in the ESM prior to chromatography.
Figure 13 shows the same samples run in SDS-PAGE at 5 ug of
protein perwell. Lanes 1 and 4 correspond to samples A and C from
MOMP E-5 and N-10. The major bands stained in these lanes correspond
to protein I. Very few or none of the minor lower molecular weight
proteins are visible in these lanes. However, protein I from MOMP E-5
(Lane 1) stained very faintly (Figure 13).
The second half of this gel containing samples A and C was stained
for lipopolysaccharide (LPS) with silver (results not shown). A few
bands were observed in each sample, one which corresponded to the
FIGURE 13: SDS-PAGE of proteins extracted from MOMP N-10 and
E-5 and purified by column chromatography.
The gel was stained with Coomassie blue for protein.
All samples were applied at 5 gg of protein/track.
MOMP E-5: profile 1, sample A; profile 2, sample B; profile 3, ESM.
MOMP N-10: profile 4, sample C; profile 5, sample D; profile 6, ESM.
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protein I of MOMP E-5 and N-10 respectively, and a few minor bands
of lower molecular weight which appeared to correspond to the low
molecular weight bands stained with Coomassie blue. Therefore some
LPS appeared to be present in samples A and C, possibly aggregated
with the proteins.
Titre of antisera raised against protein I from MOMP E-5 and N-10
(samples A and C)
Table 17 shows the titre of the antisera raised against protein
I from MOMP E-5 and N-10. Anti-E-5 protein I antiserum had a titre
of 1/1024 and the anti-N-10 protein I antiserum had a four-fold lower
titre of 1/256.
TABLE 17: Titres of antisera raised against protein I purified from
gonococcal MOMP reference strains E-5 and N-10.
Antiserum 1IF titre against
against homologous strain
E-5 protein I 1 : 1024
N-10 protein I 1 : 256
1IF - immunofluorescence
2.0 Preliminary studies on gonococcal antigen detection by an indirect
enzyme linked immunosorbent assay (ELISA) using wheat germ
lectin for antigen capture
2.1 Agglutination of MOMP E-5 and N-10 by wheat germ lectin
The results of the wheat germ (WG) lectin agglutination of MOMPs
E-5 and N-10 are shown in Table 18. The end point titration for agglutina¬
tion was taken as the highest dilution of lectin which gave a 2+ reaction.
This was found to be 2 ug/ml and 16 pg/ml of lectin for MOMPs E-5
and N-10 respectively. Reaction of the gonococcal suspensions with
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TABLE 18: Reaction of MOMP E-5 and N-10 (McFarland's standard









63 3 + 2+
31 3 + 2 +
16 3 + 2 +
8 3 + +
4 3 + -
2 2 + —
PBS control
3+ - Many small agglutinates with little or
no clearing of supernatant.
2+ - Small easily seen agglutinates.
+ - Agglutination just visible to the eye.
- - No agglutination.
TABLE 19: Reaction of thick boiled MOMP E-5 and N-10 suspensions





MOMP E-5 MOMP N-10
500 3 + 3 +
250 3 + 3 +
125 3 + 2/3+
63 2/3 + 2 +
31 2 + 2+1 +
16 + +
8 2 + -
4 + -
2 - -
PBS control - -
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the lectin dilutions gave very fine particles of agglutination with little
or no clearing of the supernatant. No agglutination was observed
in the PBS controls.
2.2 Effect of boiling on lectin agglutination of thick gonococcal
suspensions
The results of the reactions of the thick boiled MOMP E-5 and
N-10 suspensions with lectin dilutions are shown in Table 19. The
end point of agglutination was found to be 8 ug/ml and 31 pg/ml of
lectin for MOMP E-5 and N-10 respectively. These end points were
four- and two-fold higher than with the respective McFarland's standard
0.5 suspensions of E-5 and N-10. However the agglutination produced
by reaction of lectin with the thick boiled gonococcal suspensions was
easier to read than in the previous experiment.
The thick untreated suspensions of MOMP E-5 and N-10 auto-
agglutinated.
The wheat germ lectin reacted best with MOMP E-5, therefore
MOMP E-5 was chosen as antigen for use in the ELISA experiments.
2. 2. 7 Determination of the minimum amount of whole cell antigen
detected by polystyrene beads armed with lectin in PBS
MOMP E-5 whole cell antigen ranged from 3 x 107 to 29 cfu.
Polystyrene beads of sets one and two armed with lectin (3-200 pg/ml)
for 2 h at 37°C and 4 h at 37°C respectively and overnight at 4°C were
used.
The corrected absorbance (absorbance obtained in wells containing
antigen minus the absorbance obtained in control wells with no antigen)
was plotted on semilog graph paper against antigen concentration for
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each dilution of lectin used. The minimum amount of antigen detected
by beads coated with each lectin dilution was determined at two arbitrary
cut off points of OD 1.0 and 0.5 (490 nm). The minimum number of
gonococci detected with beads of set one and two are shown in Table 20
and results obtained with beads of sets one and two coated with 200
Mg/ml of lectin and no lectin (PBS) are shown in Figures 14 and 15
respectively.
At the cut off points chosen the lowest number of gonococci were
consistently detected by the control beads (no lectin) of both bead
sets one and two (Table 20). Beads coated with less than 50 pg/ml
of lectin detected fewer gonococci than beads coated with 100 and 200
Mg/ml of lectin.
The curves obtained by plotting absorbance (490 nm) against
antigen concentration for untreated beads and beads coated with 200
Mg/ml of lectin rapidly fell to an OD of less than 0.1 at 105 cfu of gono¬
cocci (Figures 14 and 15). Similar observations were made for each
of the other lectin dilutions observed. Although the minimum numbers
of gonococci detected by the lectin dilutions varied between the two
sets of beads (set one coated with lectin for 2 h at 37°C and set two
for 4 h at 37°C) a similar trend in the detection was observed for both
sets of beads.
2. 2. 2 Determination of the minimum amount of sonicated antigen
detected by polystyrene beads armed with lectin in carbonate
buffer pH 9. 6
The concentration of E-5 sonicated antigen used ranged from
400 Mg of protein (equivalent to 9.4 x 107 cfu) down to 0.00038 Mg of
protein (equivalent to 90 cfu).
FIGURE
14:
Numberofrganismsdetectedwi huntreat db adandsm200(j /ml
oflectinf r2hat37°Cndvern ght4°(sone).
FIGURE15:Numberofrganismsdetectedwi hntreateb adandr edwith200|ig/ml oflectinf r4hat37°Cndovernight4°C(stw ).
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TABLE 20: Minimum amount of antigen detected by lectin armed
polystyrene beads of sets one and two at arbitrary cut
off points OD 1.0 and 0.5.
Minimum amount of antigen
(cfu) detected with
Concentration polystyrene beads of sets:
of lectin one two
Ug/ml 1.0 0.5 1.0 0.5
200 1.0 X 107 1.5 X 106 7 X 106 1.6 X 10
100 1.0 X 107 6 X 10s 8 X 106 1.7 X 10
50 3.5 X 106 8 X 10s 6.5 X 106 1.5 X 10
25 2.8 X 106 7 X 105 4.5 X 10e 1.2 X 10'
12.5 1.5 X 106 3.2 X 105 3 X 106 1.0 X 10
6.0 1.5 X 106 3.5 X 105 3.5 X 106 8.5 X 10
3.0 1.0 X 106 2 X 10s 3 X 106 5 X 10
no lectin 7.5 X 105 1.4 X 105 1.7 X 106 5 X 10
TABLE 21: The minimum amount of sonicated E-5 antigen detected
with beads coated with lectin in carbonate buffer
(pH 9.6) at two arbitrary cut off values.
Minimum amount of sonicated
Concentration anti^n < MS of protein)






12. 5 0.7 0.18
6.0 0.55 0.4
3.0 0.52 0.22
no lectin 0.28 0.12
The corrected absorbance (absorbance obtained in wells contain¬
ing antigen minus the absorbance obtained in control wells containing
no antigen) were plotted against protein concentration of the sonicated
antigen for each lectin dilution used for coating the beads and for un¬
treated beads. OD 1.0 and 0.5 were chosen as arbitrary cut off points.
The minimum amounts of antigen detected at these cut off points by
beads coated with lectin are shown in Table 21. Figure 16 shows the
results for beads coated with 200 pg/ml of lectin and for untreated
control beads.
The amount of antigen detected at OD 1.0 ranged from 0,8 (ig
to 0.28 pg of protein corresponding to 1.4 x 10s to 1.2 x 10s cfu. The
amount detected at OD 0.5 ranged from 0.35 pg to 0.12 pg of protein,
corresponding to 7 x 101* to 4 x ltf cfu. As in the previous experiment,
beads coated with lower concentrations of lectin detected the lower
amounts of antigen. However overall uncoated control beads detected
the lowest amount of antigen.
The range of antigen detected with beads coated with lectin in
carbonate buffer (pH 9.6) and using a sonicated antigen was better
than in the previous experiments using beads coated with lectin in
PBS and a whole cell antigen.
The plot of the results for beads coated with 200 pg/ml of lectin
and for untreated control beads (Figure 16) gave sigmoidal curves
with plateaus at an OD of 2.0, corresponding to approximately Si. 56
pg of protein. However between 0.1 pg and 1.0 pg of protein (101* to
105 cfu) the absorbance values rapidly fell to approximately an OD of
0.1. Similar observations were made for each of the other lectin dilutions.
The straight part of the curve for the uncoated control beads was less
steep than that of the curve obtained with beads coated with 200 pg/ml
of lectin.
FIGURE16:Concentrationofso ic edMOMPE-5ant gendetectedbyuntreatedeadsd beadscoatedwi h200pg/mlfle t nincarbonateuffer.
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3.0 Gonococcal antigen detection on nitrocellulose by an indirect
enzyme linked immunosorbent assay (Dot-Blot immunoassay)
3.1 Detection of (A) untreated whole cell, (B) boiled and (C) soni¬
cated MOMP E-5 antigen by anti-E-5 antiserum
Table 22 shows the results of the dot-blot immunoassay with
dilutions of MOMP E-5 antigen suspensions A, B and C, using a 1/50
dilution of anti-E-5 for antigen detection.
The viable count for the MOMP E-5 antigen suspension (1.75 x
10s cfu/ml) was much lower than the expected 1 x 109 cfu/ml for a
suspension of OD 1.0 (A540 nm). The loss of viability may have been
due to suspension of the gonococci in TSB. Therefore antigen concen¬
trations (Table 22) are given as the expected cfu for a suspension
of OD 1.0. These ranged from 106 cfu for undiluted antigen to 1 x 102
cfu for antigen of 1/1024 dilution.
The last dilution of antigen to give a 1+ reaction was chosen as
the end point.
The minimum amount of MOMP E-5 antigen preparations A (un¬
treated), B (boiled) and C (sonicated) detected in the assay were 3.2 x
10**, 1.6 x 104 and 6.5 x 104 cfu respectively. Therefore dot-blot immuno¬
assay results proved to be better with the whole cell boiled antigen
preparation.
3. 2 Detection of MOMP E-5 and N-10 boiled whole cell antigen by
anti-N-10 antiserum
The detection of MOMP E-5 and MOMP N-10 boiled whole cell antigen
by anti-N-10 antiserum (1/50 dilution) is shown in Table 23. Antigen
concentrations shown in Table 23 are those expected for dilutions of
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TABLE 22: Detection of MOMP E-5 antigen preparations A, B and C
by anti-E-5 whole cell antiserum.
Reaction of anti-E-5 antiserum
Antigen (1/50 dilution) with E-5
concentration antI®en Prorations
(cfu) A° Bb Cc
1 X 106 3+ 3 + 3 +
5 X 105 3+ 3+ 2/3+
2.5 X 105 3 + 3 + 2 +
1.3 X 105 2+ 2/3+ 2+
6.5 X 10" 2+ 2+ +
3.2 X 10" 1+ 1 + +/-
1.6 X 10" + /- 1+ -
8 X 103 +/- +/- -
4 X 103 +/- +/- -
2 X 103 - - -
1 X 103 - - -
a untreated whole cell antigen; ^boiled whole cell
antigen; c sonicated suspension.
3+ - strong positive reaction;
2+ - medium positive reaction;
1+ - positive reaction;
+/- - very slight colour development;
- - no colour development.
TABLE 23: Detection of MOMP E-5 and N-10 boiled whole cell anti¬
gens by anti-N-10 antiserum.
Reaction of anti-N-10 antiserum
... (1/50 dilution) with MOMP













3 + 3 +
3 + 3 +
3 + 3 +
2+ 2 +
2+ 2 +





suspensions of OD 1.0 at 540 nm. A cut off value was chosen as
the last dilution of antigen to give a 1+ reaction.
The unabsorbed anti-N-10 antiserum detected its homologous
strain MOMP N-10 and the heterologous strain MOMP E-5 to a similar
degree. The lowest amount of MOMP N-10 and E-5 antigen detectable
was 3.2 x 10u cfu. The lowest amount of MOMP E-5 antigen detectable
by its homologous antiserum anti-E-5 was 1.6 x ltf* cfu (Table 22).
3.3 Detection of MOMP E-5 and N-10 boiled whole cell antigen by a
mixture of anti-E-5 and anti-N-10 antiserum
The detection of MOMP E-5 and N-10 boiled whole cell antigen
by the antiserum mixture is shown in Table 24. The antiserum mixture,
at a total dilution of 1/50, was composed of anti-E-5 and anti-N-10
in a 1 : 1 ratio. The minimum amount of MOMP E-5 and N-10 antigen
detectable was 1.6 x 101* cfu (Table 24). The antiserum mixture detected
the same amount of E-5 antigen as anti-E-5 on its own (Table 22) and
a two-fold lower amount of N-10 antigen than anti-N-10 on its own (Table
23).
3.4 Detection of MOMP E-5 and N-10 boiled whole cell antigen by un¬
absorbed anti-E-5 and absorbed anti-E-5 and absorbed anti-N-10
antisera
The results for the detection of MOMP E-5 and N-10 antigen by
unabsorbed anti-E-5, absorbed anti-E-5 and absorbed anti-N-10 antisera
are shown in Tables 25 and 26 respectively.
Unabsorbed anti-E-5 antiserum detected its homologous antigen
MOMP E-5 at 1.6 x 101* cfu (Table 25). This was the same level
of detection as previously observed (Table 22). The absorbed anti-E-5
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TABLE 24: Detection of MOMP E-5 and N-10 boiled whole cell antigens
by a mixture of anti-E-5 and anti-N-10 antisera.
Reaction of anti-E-5 and
~ . .. anti-N-10 antiserum mixtureConcentration ...
- .. with MOMPs
of antigen
Ccfu) E-5 N-10
1 X 106 3 + 3+
5 x 10s 3+ 3 +
2. 5 x 10s 3 + 3+
1.3 x 10s 2/3+ 2+
6.5 x lO* 2+ 2+
3.2 x 10** 2+ +
1.6 x 10* + +
8 x 103 +/- +/-
4 x 103 +/- +/-
2 x 103 - +/-




+/- very slight colour development
no colour
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TABLE 25: Detection of MOMP E-5 boiled whole cell antigen by
unabsorbed anti-E-5, absorbed anti-E-5 and absorbed
anti-N-10 antisera.
Concentration
Detection of MOMP E-5 antigen by:
of antigen Unabsorbed Absorbed Absorbed
<• (cfu) Anti-E-5 Anti-E-5 Anti-N-10
1 X 106 3+ 3 + 2+
5 x 105 3+ 3 + 2+
2.5 x 105 3+ 2 + +
1.3 x 105 2/3 + + +/-
6.5 x 10" 2/3+ + +/-
3.2 x 10" 2+ + +/-
1.6 x 10" + +/- -
8 x 103 +/- - -






+/- very slight colour development;
- no colour.
TABLE 26: Detection of MOMP N-10 boiled whole cell antigen
by unabsorbed anti-E-5, absorbed anti-E-5 and absorbed
anti-N-10 antisera.
~ . .. Detection of MOMP N-10 antigen by:Concentration 6 J
of antigen Absorbed Unabsorbed Absorbed
(cfu) Anti-N-10 Anti-E-5 Anti-E-5
1 X 106 3 + 3 + 2+
5 x 105 3 + 3 + +
2. 5 x 105 2 + 3 + +
1.3 x 105 2+ 2+ +/-
6.5 x 10" + 2 + +/-
3. 2 x 10" + /- + -
1.6 x 10" + /- +/- -
8 x 103 - +/- -
4 x 103 - - -
2 x 103 - - -
1 X 103 - - -
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detected MOMP E-5 at a level of 3.2 x 10u cfu, two-fold higher than
with the unabsorbed antiserum. MOMP E-5 antigen was detectable
at a level of 2.5 x 105 cfu with absorbed anti-N-10. Unabsorbed anti-
N-10 antiserum was not used, therefore direct comparisons with absorbed
anti-N-10 antiserum were not possible. However Table 23 shows results
of detection of MOMP E-5 and N-10 antigen with unabsorbed anti-N-10
antiserum: MOMP E-5 and N-10 antigen were both detected at 3.2 x
101* cfu. Absorbed anti-N-10 antiserum detected MOMP E-5 antigen
at 2.5 x 105 cfu (Table 25) and its homologous antigen MOMP N-10 at
6.5 x 10^ cfu (Table 26).
MOMP N-10 antigen was detected at levels of 3.2 x 101* and 2.5 x
105 cfu by unabsorbed and absorbed anti-E-5 antisera respectively
(Table 26). Absorbed antisera anti-E-5 and anti-N-10 detected their
respective homologous antigens at similar levels which were approximately
two-fold higher than with the unabsorbed sera. However it was interest¬
ing to note that the absorbed anti-E-5 and anti-N-10 antisera cross-
reacted with their heterologous strains detecting antigen at 2.5 x 105
cfu. CoA reagents prepared with the absorbed anti-E-5 and anti-N-10,
defining CoA serogroups WI and WII respectively, do not react with
the heterologous strains MOMP N-10 and E-5.
3. 5 Detection of MOMP E-5 and N-10 boiled whole cell antigen with
a mixture of anti-E-5 protein I and anti-N-10 protein I antisera
The results of the detection of MOMP E-5 and N-10 boiled whole
cell antigen by 1/50, 1/100 and 1/200 dilutions of a mixture of anti-E-5
protein I and anti-N-10 protein I antisera are shown in Tables 27 and
28.
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TABLE 27: Detection of MOMP E-5 boiled whole cell antigen by a
1 : 1 mixture of anti-E-5 protein I and anti-N-10
protein I antisera.
Detection of MOMP E-5 antigen by
0 . ,. a mixture of anti-protein I antiseraConcentration . ,.. ,. .
e .■ at dilutions of:of antigen
(cfu) 1/50 1/100 1/200
5 x 106 3+ 3 + 3+
1.6 x 10s 2+ 2+ 2+
8 x 104 + + +
4 x 104 + +/- -
2 x 104 - - -
1 X 104 - - -




+/- slight colour development;
- no colour.
TABLE 28: Detection of MOMP N-10 boiled whole cell antigen
by a 1 : 1 mixture of anti-E-5 protein I and anti-
N-10 protein I antisera.
Detection of MOMP N-10 antigen
Concentration a mixtufe1 °f Protein, 1 an«sera
of antigen at dilutions of:
























The anti-protein I antisera mixture at dilutions of 1/50, 1/100
and 1/200 detected a minimum of MOMP E-5 antigen of 4 x 10\ 8 x 101*
and 8 x 101* cfu respectively (Table 27). The same antiserum dilutions
detected MOMP N-10 antigen at 1.6 x 105cfu (Table 28).
A similar mixture of anti-E-5 and anti-N-10 whole cell antisera
detected MOMP E-5 and N-10 antigen at a level of 1.6 x lO^cfu (Table
24). Therefore the anti-protein I antisera mixture appeared to be
slightly less sensitive, requiring more concentrated antigen suspensions
for detection of both MOMP E-5 and N-10.
3.6 Determination of the minimal amount of purified MOMP E-5 and
N-10 protein I antigen detected by a mixture of unabsorbed whole
cell antisera and by a mixture of anti-protein antisera
The mixture of anti-E-5 and anti-N-10 whole cell antisera detected
E-5 and N-10 protein I antigen at a concentration of 1 ng (1+ reaction).
The mixture of anti-E-5 protein I and anti-N-10 protein I antisera
detected MOMP E-5 and N-10 protein I at a concentration of 5 ng (2+
reaction): a little colour developed (+/- reaction) on the MOMP E-5
protein I spot containing 1 ng of protein but no colour developed with
MOMP N-10 protein I at a similar concentration.
3.7 Detection of gonococcal antigen in 95 male urethral specimens
by anti-gonococcal antisera in the dot-blot immunoassay
Detection of antigen with a mixture of anti-E-5 and anti-N-10 whole
cell antisera
Table 29 shows the correlation of the dot-blot immunoassay results
with culture results for 95 male urethral specimens. Antigen was detected
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in the immunoassay with a 1 : 1 mixture of anti-E-5 and anti-N-10 whole
cell antisera. Overall 48/95 (51%) and 47/95 (49%) of the urethral speci¬
mens were scored positive and negative respectively.
TABLE 29: Correlation of gonococcal culture results with dot-blot
immunoassay results using a mixture of anti-E-5 and anti-




Number of clinical isolates
result Positive Negative Total
Positive 43 4 47
Negative 5 43 48
Total 48 47 95
Correlation with culture results showed that the dot-blot immuno¬
assay had a sensitivity of 91.5% (dot-blot positive/culture positive
specimens) and a specificity of 89.6% (dot-blot negative specimens/culture
negative specimens). There were four false negative and five false
positive clinical specimens.
Insufficient gonococcal antigen in the clinical specimens was thought
to be a likely cause of the false negative results obtained in the dot-
blot immunoassay. It was observed that there was very little material
on the swabs obtained for two of the specimens which gave false negative
results. In addition, all false negative results occurred when the antisera
mixture was changed from a ^/50 to a 1/100 dilution. The dilution
was changed to 1/100 to obtain more economical use of the antisera and
to reduce non-specific colour development.
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False positive immunoassay results may represent non-specific
reactions of the reagents used with material in the urethral exudates,
cross reactions of the antisera with some other genital pathogen or
commensal organism or true gonococcal infections where no viable
organisms are isolated.
Figure 17 shows the dot-blot immunoassay results and demon¬
strates the colour intensity obtained with clinical specimens 1-19. In
order to obtain the photograph, clinical specimens 1-19 were retested
in the dot-blot immunoassay as one batch. All except two of the results
corresponded to those when the specimens were first tested. The two
aberrant results were for clinical specimens 4 (Row A8) and 7 (Row B3):
when first tested clinical specimen 4 was clearly positive and clinical
specimen 7 gave a +/- reaction and was scored negative.
Detection of antigen with a mixture of anti-E-5 protein I and anti-N-W
antisera
Table 30 shows the correlation of culture results with the dot-
blot immunoassay results for 45 clinical specimens tested with a 1/100
dilution of a 1 : 1 mixture of anti-E-5 protein I and anti-N-10 protein I
antisera.
The sensitivity and specificity of the immunoassay with the anti-
protein I antisera was 84% and 85% respectively. Four false negative
and three false positive results were obtained.
FIGURE 17: Dot-blot immunoassay results for 19 male urethral clinical
specimens.
Row A: Al, strong positive control; A2, strong positive control;
A3, positive control; A4 negative control; A5, CS1 negative;
A6, CS2 negative; A7, CS3 positive; A8, CS4 positive.
Row B: Bl, CS5 negative; B2, CS6 negative; B3, CS7 negative;
B4, CS8 positive; B5, CS9 positive; B6 CS10 negative;
B7, CS11 negative; B8, CS12 negative.
Row C: CI, CS 13 positive; C2, CS 14 negative; C3, CS 15 negative;
C4, CS16 negative; C5, CS17 positive; C6, CS 18 negative;
C7, CS19 negative; C8, buffer control.
214.
TABLE 30: Correlation of culture results with dot-blot immunoassay
results using a mixture of anti-E-5 protein I and anti-







results Positive Negative Total
Positive 21 4 25
Negative 3 17 20
Total 24 21 45
3.8 Determination of the minimum amount of antigen detected in the
dot-blot immunoassay and the corresponding CoA serogroups for
9 clinical isolates of N. gonorrhoeae
As shown in Table 31 the amount of gonococcal antigen detected
ranged from 4 x 103 to 3 x lO4 (8-fold range) cfu. The mixture of
anti-E-5 and anti-N-10 whole cell antisera generally detected approxi¬
mately a two-fold lower number of gonococci than the mixture of anti-
E-5 protein I and anti-N-10 protein I antisera. However, the minimum
amount of antigen detected by the two antisera mixtures was identical
for gonococcal strains 3 and 5: coincidently both of these strains were
detected at 8 x 103 cfu. Antigen from gonococcal isolates belonging
to different CoA serogroups was detected at similar levels with the
exception of strain 9.
Antigen from gonococcal strain 9, a CoA serogroup WII/WIII strain,
was detected at the highest concentrations of 1.6 x 104 and 3 x 101* cfu
with the anti-whole cell and anti-protein I antisera mixtures












































































































respectively. This strain was isolated from a patient whose urethral
specimen was negative in the dot-blot immunoassay (Table 31). It
was observed that there was very little material on the urethral swab
obtained from this patient for testing in the dot-blot immunoassay.
One other gonococcal strain (strain 4) was isolated from a patient
whose urethral specimen was negative in the dot-blot immunoassay.
However antigen from this strain was detected at levels comparable
to that for the other gonococcal isolates.
3. 9 Specificity of the dot-blot immunoassay
Table 32 shows the range in the minimum amount of antigen
detected in the dot-blot immunoassay for N. gonorrhoeae MOMP E-5
and N-10, other pathogenic Neisseria, commensal Neisseria, Branhamella
spp. and a variety of other species found in the urogenital tract either
as pathogens or commensals.
MOMP E-5 antigen was detected at 8 x 103 and 1.6 x 101* cfu by
the anti-E-5 and anti-N-10 whole cell and by the anti-E-5 protein I
and anti-N-10 protein I antisera mixtures respectively. MOMP N-10
antigen was detected at two-fold higher levels.
The non-gonococcal Neisseria antigens detected ranged from
minimum concentrations of 3 x 1014 to 1 x 106 cfu and 6.3 x Hf to un¬
detectable at 1 x 106 cfu with the gonococcal anti-whole cell and anti-
protein I antisera mixtures respectively. Compared with detection
of the gonococcal antigens, these represented approximately 4 to 125-
fold higher levels of detection. However among the non-gonococcal
Neisseria there appears to be an antigenic order of relatedness. Antigen
from strains of N. lactamica and N. meningitidis were detected at lower
levels than antigen from the commensal Neisseria and therefore appear
to be more closely related antigenically to the gonococcal strain.
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Figures 18 and 19 demonstrate the typical reactions of antigen
from MOMP E-5 and N-10 and a commensal Neisseria N. pharyngis in
the dot-blot immunoassay with gonococcal anti-whole cell and anti-
protein I antisera respectively.
Antigens from seven of the eight non-neisserial organisms which
are commonly found in the urogenital tract were either not detected
at 1x106 cfu or were just detectable at high levels from 5 x 105 to 1 x 106
cfu. The exception was B. bivius which was detected at 6.25 x 104 and
2.5 x 105cfu with the gonococcal anti-whole cell and anti-protein I antisera
mixtures respectively.
3.10 Antigen detection using antisera absorbed with B. bivius
Table 33 shows the results of antigen detection in the dot-blot
immunoassay using gonococcal anti-whole cell and anti-protein I antisera
absorbed with B. bivius.
TABLE 33: Detection of antigen with anti-E-5 and anti-N-10 whole
cell and anti-E-5 and anti-N-10 protein I antisera mixtures
absorbed with B. bivius.
Minimum amount bf antigen (-cfu)
detected by absorbed:
anti-whole cell anti-protein I
Source of antigen antisera mixture antisera mixture
MOMP E-5 1.6 x 104 3.1 x 104
MOMP N-10 3.1 x 104 6.3 x 104
B. bivius 1 x 106 ND
B. in termedius ND ND
B. assacharolyticus ND ND
B. ureolyticus ND ND
N. meningitidis RAS10 6.3 x 104 2.5 x 105






ND - not detectable at 1 x 106 cfu; P - positive; N - negative.
FIGURE 18: Result of dot-blot immunoassays using a mixture of
anti-E-5 and anti-N-10 whole cell antisera for detection
of whole cell antigen from N. gonorrhoeae MOMP E-5 and
N-10 and N. pharyngis.
Strip A: MOMP E-5 antigen;
Strip B: MOMP N-10 antigen;
Strip C: N. pharyngis antigen.
Antigen was applied to strips in 1 pi amounts and ranged
from undiluted (spot 1) to a dilution of 1/1024 (spot 11)
( 1 x 10 6 - 9.76 x 102 cfu).
FIGURE 19: Result of dot-blot immunoassays using a mixture of anti-
E-5 and anti-N-10 protein I antisera for detection of whole
cell antigen from N. gonorrhoeae MOMP E-5 and N-10
and N. pharyngis.
Strip A: MOMP E-5 antigen;
Strip B: MOMP N-10 antigen;
Strip C: N. pharyngis antigen.
Antigen was applied to strips in 1 ul amounts and ranged
from undiluted (spot 1) to a dilution of 1/1024 (spot 11)
(1 x 106 to 9. 76 x 102 cfu).
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The minimum amount of MOMP E-5 antigen detected with the
absorbed whole cell and absorbed anti-protein I antisera was 1.6 x 104
and 3.1 x 104 cfu respectively. MOMP N-10 antigen was detected at
two-fold higher levels of 3.1 x 104 and 6.3 x 104 cfu. B. bivius antigen
was detected at 1 x 106 cfu by the absorbed anti-whole cell antisera
mixture but at this level was undetected by the absorbed anti-protein I
antisera mixture.
The B. bivius antigen was previously detected by unabsorbed
anti-whole cell and by unabsorbed anti-protein I antisera mixtures
at 6.3 x 104 and 2.5 x 105 cfu respectively (Table 32). Antigen from
B. intermedius, B. ureolyticus and B. asqccharolyticus was not detect¬
able with either of the absorbed antisera mixtures.
Although there was still some colour development on the dots,
two of the four male urethral clinical specimens (CS74 and 83) were
scored as negative in the dot-blot immunoassay with both the absorbed
whole cell and absorbed protein I antisera mixtures, one (CS32) was
scored positive with the absorbed whole cell antisera mixture and neg¬
ative with the absorbed anti-protein I mixture and one (CS31) was
scored positive with both of the absorbed antisera mixtures. All four
clinical specimens had previously given false positive results with the
unabsorbed whole cell antiserum, CS74 and CS83 were negative and
positive with unabsorbed anti-protein I antisera mixture respectively,
while specimens 31 and 32 were not tested with this antisera mixture.
3.11 Reduction of non-specific colour development by blocking with
bovine serum albumin
No difference was observed in the colour development on antigen
spots on the strip blocked with 3% BSA/TBS compared with the strip
blocked with the normal blocking solution of 3% gelatin/TBS.
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3.12 Testing of the anti-rabbit IgG conjugate for non-specific binding
to antigen and for endogenous peroxidase activity in urethral
clinical specimens
Non-specific binding of the conjugate to antigen
Some colour developed on the control spots containing undiluted
(107 cfu) MOMP E-5 and N-10 whole cell antigen and this was scored
+/-. A similar amount of colour developed on each of the three spots
containing the clinical specimens. The clinical specimens chosen had
given high background negative or false positive results when previously
tested in the complete dot-blot immunoassay. However although the
conjugate appears to react to some degree with the control antigen at
high concentrations and with the clinical specimens, the intensity of
colour which developed with these specimens in the complete immunoassay
suggests that the conjugate is not the major contributor to non-specific
colour development.
Endogenous peroxidase activity
No colour developed on the antigen spots on the strip incubated
with the substrate solution alone. This indicated that there was no
residual peroxidase activity in the clinical specimens.
4.0 Immunological identification of N. gonorrhoeae with monoclonal
and polyclonal antibody coagglutination reagents
Table 34 shows the results of polyclonal and monoclonal antibody
coagglutination reagents with boiled suspensions of clinical isolates
of neisseriae. The sensitivity and specificity of the monoclonal reagent
were 97.7% (86/88) and 96.4% (54/56), respectively, compared with
values of 100% (88/88) and 94.6% (53/56) for the polyclonal reagent.
The overall agreement with carbohydrate utilisation was 97.9% (141/144)
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for the polyclonal antibody reagent and 97.2% (140/144) for the monoclonal
reagent. These differences are not significant at the 5% level.
Whereas all 13 stock cultures of N. lactamica were negative with
the monoclonal reagent seven gave a positive result with the polyclonal
reagent. All five isolates of ^-lactamase producing B. catarrhalis were
negative with both reagents. When these results were combined with
those for clinical isolates of non-gonococcal neisseriae the agreement
with carbohydrate utilisation was 97.3% (72/74) for the monoclonal reagent
and 86.5% (64/74) for the polyclonal reagent. This is a significant
difference (xi = 4.5; p <0.05).
4.1 CoA using boiled gonococcal suspensions and an antigen releasing
agent
Results of the monoclonal reagent with bacterial suspensions
prepared by boiling and by treatment with antigen releasing agent
are given in Table 35. Suspensions prepared with releasing agent
tended to be stringy compared with the uniform suspensions obtained
by boiling (Figures 20 and 21). On many occasions the stringy nature
of the suspensions made it impossible to score results unequivocally
positive or negative. The overall correlation with carbohydrate utilisation
was 97.1% (166/171) for the test with boiled suspension and 80.7% (138/171)
when antigen releasing agent was used. This is a highly significant
difference (xi = 21.6; p <0.001). The difference in test performance
remains significant when gonococcal (p <0.01) and non-gonococcal neisseriae
(p <0.001) are considered separately.
Test Control
FIGURE 20: Reaction of the monoclonal reagents with boiled suspen¬
sions of neisserial isolates.
Row A: Reaction of N. gonorrhoeae strain 1, positive with test reagent;
Row B: Reactions of N. lactamica, negative with test reagent;
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FIGURE 21: Reaction of the monoclonal reagents with suspensions
of Neisseria prepared with the releasing agent.
Reaction of N. gonorrhoeae strain 1 positive with test reagent;
Reaction of N. lactamica, negative with test reagent;






























































































4. 2 Calculation of predictive values
The positive and negative predictive values of the polyclonal
and monoclonal reagents applied to Gram negative diplococci isolated
from various anatomical sites are given in Table 36. The values of
o (sensitivity), b (specificity), and p (prevalence) used in calculating
the predictive values given in Table 36 were derived as follows.
The sensitivity and specificity of the monoclonal reagent were
96.6% (198/205) and 98.2% (108/110) respectively; these figures repres¬
ent all clinical isolates tested by the boiled suspension method. The
sensitivity and specificity of the polyclonal reagent were 97.4% (406/417)
and 96.1% ( 173/180), respectively. Because of the small number of
isolates tested with the polyclonal reagent these are composite results
of the present and previous study, which gave a sensitivity of 96.7%
(318/329) and a specificity of 96.8% (120/124) with the same reagents
(Young and McMillan, 1982).
The values of p (the proportion of gonococcal Gram negative
diplococci within the total population of Gram negative diplococci from
various anatomical sites) as given in Table 36 were taken from the finding
that over a 4-year period N. gonorrhoeae accounted for 20.3% of 1204
throat isolates of Gram negative diplococci; and that of the gram negative
diplococci isolated over a 5-year period N. gonorrhoeae accounted for
99.6% of 1944 anogenital isolates from women, 99.7% of 2623 urethral
isolates from heterosexual men, 95.3% of 384 anogenital isolates, and
92.0% of 225 rectal isolates from homosexual men (Young and Bain, 1983;
Young, 1983).



























SECTION I: CHARACTERISATION OF GONOCOCCAL STRAINS
BY CoA SEROGROUPING AND CELL ENVELOPE PHENOTYPING
1.0 Characterisation by CoA serogrouping
The CoA W serogroups have been shown to be stable during
subculture, do not vary with colony morphology, and correlate with
antigenic differences in the protein I molecules of the gonococcal outer
membrane (Sandstrom and Danielsson, 1980a; Sandstrom et al. , 1982a,b).
CoA serogroups WI and WII correspond to antigenic differences in
protein IA and IB molecules respectively, while CoA serogroup Will
corresponds to a prominent antigenic variation in protein IB (Sandstrom
et al. , 1982a).
To date there is little or no information available about the distribu¬
tion of CoA serogroups among gonococcal strains isolated in the United
Kingdom. However Copley, Chiswell and Egglestone (1983) have exam¬
ined a number of typing systems including CoA W serogrouping in relation
to contact pairs. Most work concerning CoA W serogroups has been
carried out in Sweden and the United States.
1.1 Overall distribution of CoA W serogroups
The overall distribution of CoA serogroups among gonococcal
strains isolated from patients who acquired their infections in the
Edinburgh area was as follows: 41.8% WI, 49.9% WII, 8.2% WII/WIII and
0.1% Will. This is similar to the overall proportion of serogroups among
strains isolated in Stockholm, Sweden, in 1981 (Bygdeman, Danielsson
and Sandstrom, 1981a), where 41.9%, 55.9% and 2.2% of isolates belonged
to serogroups WI, WII and Will respectively. Bygdeman et al. (1981a)
found that there was a significantly higher proportion of CoA WI sero¬
group isolates among strains isolated in Orebro, a small town with
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adjacent rural area than in Stockholm, one of the major Swedish cities.
Of 130 strains isolated in Orebro, 54.6%, 44.6% and 0.8% belonged to
serogroup WI, WII and Will respectively. In Edinburgh there is a
significantly lower proportion of WI strains compared with isolates from
Orebro (xi = 6.94; p <0.01). A survey of gonococcal strains isolated
in 10 geographical areas in Sweden has confirmed the significant dif¬
ferences in the proportion of serogroups found in large cities with
urban populations compared with smaller towns surrounded primarily
by rural areas (Danielsson, Bygdeman and Kallings, 1983). In Stockholm
and Goteborg the two largest towns in Sweden, the incidence of WII
strains was 57.2% and 54.7% respectively, whereas in the small towns
with rural areas the number of WI strains accounted for approximately
80% of the strains: 78.8% in Gavle and 72.7% in Orebro. The proportions
of CoA serogroups among strains isolated from middle sized University
towns were representative for those for Sweden as a whole (Danielsson
et at. , 1983). In a recent study using CoA reagents prepared with
polyclonal antibodies and reagents prepared with monoclonal antibodies
to protein I it has been shown that serogroup WII predominates (60-70%
of strains) in major cities in Scandinavia (Bygdeman, Danielsson and
Sandstrom, 1983).
Within the four consecutive time periods of this study a number
of changes in the overall distribution of CoA serogroups has occurred.
Initially, no WII/Will strains (strains which react with both WII and
Will CoA reagents) were isolated from patients who had acquired their
infections in Edinburgh. However by the end of the fourth study period
a total of 61 WII/WIII strains had been isolated (p <0.001).
Overall the proportion of WI strains isolated remained constant
(44-46%) over the first three study periods. However, in the fourth
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period a significantly lower number of WI strains was isolated: 77/215
(35.8%) (p <0.05). A dramatic decrease in the number of WI strains
has been reported in parts of Stockholm (Bygdeman et al. , 1983). The
incidence of WI strains has dropped from 40.3% to 28%.
1. 2 CoA serogroups in relation to patient group and sites of isolation
Serogroup WII predominated among gonococcal strains isolated
from homosexual men: overall 94% (102/108) strains belonged to CoA
serogroup WII or WII/WIII (Table 6) compared with only 53% ( 151/283)
and 50.8% (180/354) of isolates from heterosexual men and women (p <0.001).
Serogroup WI strains were isolated from homosexual men only
during study period one, thereafter all strains belonged to serogroups
WII and WII/WIII (Table 7). This significant association of serogroup
WII with homosexually acquired gonococcal infection has been previously
reported in Stockholm and Seattle, United States (Bygdeman, 1981a;
Morse et al. , 1982). Bygdeman (1981a) in Stockholm and Morse et al.
( 1982) in Seattle, found that 76.9% (30/37) and 73.7 (42/57) of strains
isolated from homosexual men belonged respectively to CoA serogroup
WII. Therefore in Edinburgh a significantly higher proportion of male
homosexual isolates belong to serogroup WII than those from homosexual
men in Stockholm (p <0.05) and Seattle (p <0.001). It may be that
a proportion of bisexual men were included in the Stockholm and Seattle
studies. The association of serogroup WII with homosexually acquired
infection occurs regardless of the anatomical site of isolation (Table 8).
Overall there were no significant differences in the distribution
of CoA serogroups of strains isolated from heterosexual men and women
(p >0.5) (Table 6). However there were significant changes within
the four time periods.
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In the first study period the proportion of WI strains was higher
among heterosexual men than women: 66% compared with 53% (Table 7).
However this was not a significant difference. In the second study
period the proportion of WI strains was higher in women. In this period
the proportion of WI strains isolated from heterosexual men dropped
significantly to 41% (p <0.05). Whereas the proportion of WI strains
isolated from women was similar to that for period one. However, despite
this change in the proportion of WI strains there was no significant
difference between heterosexual men and women.
Over the next year the proportion of WI strains isolated from
heterosexual men remained constant. However, in the last six month
period (period four) the proportion of WI strains isolated from women
dropped by approximately 10% to 40.4%. Thus in the fourth study
period the proportion of WI strains isolated from heterosexual men and
women reached equilibrium.
Study period two encompassed the summer months when there
is a large influx of visitors to Edinburgh, particularly during August
and September. It was preceded by a period when there was a great
deal of publicity on the Acquired Immune Deficiency Syndrome (AIDS).
The drop in the proportion of WI strains isolated from heterosexual
men was initially attributed to an undisclosed number of homosexual
men being included among this group and/or to an influx of gonococcal
strains acquired outwith Edinburgh. However the decrease in the
number of WI strains isolated from heterosexual men may have represented
a change in selective pressure resulting in a reduction in the number of
serogroup WI strains among the gonococcal pool. This change is now
reflected, after a lag of approximately one year, in women.
229.
It has been reported that WI strains are more commonly isolated
from women than from men in all major Scandinavian cities except
Stockholm, Sweden (Bygdeman et at. , 1983). It was shown that overall
36.3% (202/557) and 29.2% (137/469) of strains isolated from women
and men belonged to serogroup WI respectively. A previous study
found that a significantly higher number of WI strains was found in
women than in men (Bygdeman, 1981b).
However because of the strong association of serogroup WII with
homosexually acquired gonococcal infections it is misleading to compare
women with men without reference to sexual preference. For example,
in this study if gonococcal strains isolated from women are compared
with those isolated from homosexual men and heterosexual men together
it is found that 48.9% ( 173/354) of isolates from women and 35% (138/391)
of isolates from all men belong to serogroup WI (Table 6). This is
a significant difference (xi = 13.5; p <0.001). However, as already
discussed (p. 227 ), there is no significant difference in the distribution
of CoA serogroups among heterosexual men and women.
Therefore it is recommended that where there is a known homo¬
sexual male element within a study population that the data for this
group be excluded in evaluating differences between women and men.
1. 3 Rise in the incidence of CoA serogroup WII/Will strains and sero¬
group of strains acquired outwith Edinburgh
CoA serogroup WII represents gonococcal strains with protein IB
molecules, whereas serogroup Will represents a prominent antigenic
variant of protein IB rather than a third distinct protein I molecule
(Sandstrom et at. , 1982a). Gonococcal strains which react with reagents
defining serogroup WII and with reagents defining serogroup Will (WII/
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Will strains) have been reported to occur occasionally (Sandstrom et al. ,
1982b).
The increase in WII/WIII strains observed in this study has occur¬
red to a similar degree in all three patient groups.
Although the CoA W reagents have been shown to represent dif¬
ferences in the protein I molecules it must be remembered that the
reagents are prepared with polyclonal antibodies which may also react
with other antigens such as LPS and minor proteins such as protein II.
These reactions may contribute to the reaction patterns obtained with
the CoA W reagents used in this study. However it is unlikely that
the cross-reactions observed with strains grouped as WII/WIII are as
a result of such reactions because no such cross-reactions were observed
with the CoA reagents and the frequently isolated WI and WII strains.
The WII/WIII strains may have resulted from such strains being
brought into the Edinburgh area and establishing themselves within
the endogenous gonococcal population. Three of 33 (9%) strains isolated
from infections acquired abroad either in Europe or in non-European
countries, belonged to this group (Table 12). WII/WIII strains may also
have been introduced during the summer months when there is a large
influx of visitors.
Alternatively these strains may have arisen as a result of a mutation
resulting in a hybrid protein IB molecule which has antigenic determin¬
ants recognised by the reagents defining serogroups WII and Will.
Such mutational events may occur and the survival and establishment of
N. gonorrhoeae containing such mutations within the gonococcal popula¬
tion will depend on the selective advantages conferred by changes in
the structure of protein I molecules.
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The functional role of gonococcal protein I is that of a porin
(Greco el o/. , 1980; Douglas etal., 1981; Young et al. , 1983).
Alterations in the structure of the porin may result in strains being
better able to compete for nutrients and being more resistant to anti¬
biotics. Such changes may also affect the pathogenic potential of
gonococci. Recent work has shown that gonococci of serogroup WI
are strongly associated with disseminated gonococcal infections (DGI)
(Cannon et al. , 1983). It has been shown that protein I can insert
into the membranes of red blood cells and it has been suggested that
protein I may be involved in stimulating the phagocytosis of gonococci
by host cells (Blake and Gotschlich, 1983).
A hybrid protein IB molecule of serogroup WII/WIII is unlikely
to occur as the result of genetic transformation between endogenous
serogroup WII and Will gonococcal strains because serogroup Will are
extremely rare in Edinburgh. Only one Will strain was isolated from
a patient who had contracted her infection in Edinburgh. Previous
studies have indicated that Will strains are rarely isolated in Sweden
(Bygdeman et al. , 1981a). These strains have been isolated primarily
from patients who have contracted their infections in Thailand and
other countries in the Far East (Bygdeman et al. , 1981b; Bygdeman,
1981c). The majority of isolates from such parts of the world belong
to serogroups WII and Will. Gonococcal strains from these areas have
been shown to be more resistant to antibiotics than corresponding isolates
from Sweden (Bygdeman, 1981c). Gonococcal strains of serogroup Will
and WII are more resistant than WI strains.
All of the 22 gonococcal strains isolated from patients who had
acquired their infections in non-European countries including Thailand,
the Far East, Africa and the East Indies belonged to CoA serogroups
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WII, WII/WIII and Will (Table 12). Gonococcal strains isolated from
patients who had acquired their infections in European countries encom¬
passed all serogroups.
1.4 Antigenic diversity within individual CoA serogroups
When the CoA serogrouping system was first developed, Sandstrom
and Danielsson (1980a) observed that different reaction patterns existed
within each individual W serogroup. They concluded that these differ¬
ences represented antigenic diversity among strains of each serogroup
and suggested that the potential existed for subdividing the individual
serogroups.
During the course of this study a total of five WI and 13 WII
and WII/WIII reaction patterns were obtained with the CoA reagents
prepared with polyclonal antibodies (Table 5): one serogroup WI reaction
pattern and one serogroup WII reaction pattern predominated.
Serogroup WI and WII have been shown to represent different
types of gonococcal protein I, protein IA and IB respectively (Sandstrom
et al. , 1982a,b). According to recent studies only a small part of the
protein IA molecule is exposed at the gonococcal surface, whereas protein
IB has a looped structure with the loop exposed on the exterior of the
gonococcal membrane (Figure 4) (Barrera and Swanson, 1984). There¬
fore one would expect that there would be fewer antigenic sites exposed
on protein IA than on protein IB molecules. This appears to be corrobor¬
ated by Bygdeman et al. ( 1983) in a recent study employing CoA reagents
prepared with monoclonal antibodies to gonococcal protein I (Tam et al. ,
1982). Bygdeman et al. ( 1983) obtained a total of 43 different reaction
patterns or serovars (12 WI, 29 WII and 2 Will serovars) using gonococcal
strains isolated from five major Scandinavian cities. Among WI strains
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isolated it was found that only three to five different WI serovars existed
in each city with one serovar predominating in all cities. This serovar
accounted for up to 94% of WI strains isolated with a range from 76%
in Copenhagen (Denmark) to 94% in Oslo (Norway). A much greater
variation in WII serovars was observed in each city with a range of
six WII serovars in Trondheim (Norway) to 17 in Oslo (Norway). No
particular WII serovar dominated in any area (Bygdeman et al. , 1983).
1. 5 Theories for the changes in distribution of CoA serogroups
A number of theories have been proposed to explain differences
in the distribution of CoA serogroups between men and women and
for differences found in large cities compared to small towns with adjoin¬
ing rural areas. These include a proposed association of serogroup WI
strains with asymptomatic infections in men, an immunological model
and selective pressure induced by antibiotics.
7. 5. 7 Association of CoA serogroup WI with asymptomatic gonococcal
infections in men
It has been hypothesised that the lower number of WI strains
isolated from men may be due to undetected asymptomatic gonococcal
infections (Bygdeman et al. , 1983). No actual studies have been con¬
ducted to examine asymptomatic infections in relation to the serogroup
of infecting strain either in heterosexual men or women.
In homosexual men asymptomatic gonococcal infections are common
(McMillan and Young, 1978) and this and other studies have indicated
that serogroup WII predominates in this group of patients (Bygdeman,
1981a; Morse et al. , 1982). The rate of asymptomatic infections in
women is approximately 60-70% (Robertson et al., 1980).
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During the course of this study the serogroup of infecting strain
was correlated with the presence or absence of symptoms for 64 women.
It was found that a higher proportion of WI strains were isolated from
women with symptoms compared with those women with asymptomatic
infections: 58% compared with 47%. This difference was not significant.
Therefore although this was a limited study it does not appear that
serogroup WI and asymptomatic infections are linked in women.
Despite Bygdeman's findings that serogroup WII predominates
among homosexual men (Bygdeman, 1981a) the major failing of most
Swedish studies has been that this group of patients is not considered
apart from the heterosexual population. In this study when homosexual
men are considered apart no significant differences in the proportion
of CoA serogroups are observed when heterosexual men are compared
with women.
7. 5. 2 Proposed immunological model
An immunological model has been proposed to account for the
differences in the distribution of WI and WII serogroup strains between
men and women and between large and small cities (Bygdeman et aI. ,
1983). The model is based on the hypothesis that patients infected
with a gonococcal strain with a particular protein I serovar produce
protective antibodies against the protein I antigens of this strain and
thus in the event of re-exposure only become infected with gonococci
possessing different protein I antigens. It has been proposed that
because there is a small number of WI serovars one of which predominates,
that the chances of being reinfected with a WI strain of a different
serovar is very small. Therefore with a build up of immunity within
the population the number of WI strains would decrease. However the
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chance of being reinfected with a different WII serovar is much greater
because there are many more WII serovars, none of which predominates
in any given area (Bygdeman et al. , 1983).
This theory is dependent upon two major factors, the production
of a protective localised antibody response to protein I and the re-
exposure rate within the sexually active population.
Localised antibody responses producing primarily anti-gonococcal
IgG and IgA have been shown to occur in both men and women (McMillan
et al., 1979a,b). However as yet it has not been shown that localised
antibody responses confer protection against subsequent infection by
N. gonorrhoeae. Buchanan et al. (1980) showed that women with pelvic
inflammatory disease (PID) produced antibodies which were protective
against subsequent attacks of PID by gonococci of the same protein I
serotype. However they were not protected against reinfection at local¬
ised genital sites by gonococci of the same protein I serotype. The
re-exposure rate among the sexually active population to N. gonorrhoeae
would play an important role in the dynamics of this model, thereby
determining whether a reduction in a particular serogroup would occur
within the various patient groups and within geographical areas. How¬
ever before an immunological model can be substantiated as a major
factor in altering the proportion of CoA serogroups observed, the host
immune response to N. gonorrhoeae must be clarified.
1. 5. 3 Selection of CoA serogroups WII and Will by antibiotics
The third theory proposed is that antibiotics select strains belong¬
ing to serogroups WII and Will. It has been shown that strains of
serogroup WI are much more sensitive to antibiotics such as benzyl
penicillin, cefuroxime and ampicillin than strains of serogroup WII and
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Will (Bygdeman, 1981c). The majority of the WI strains tested (93.5% -
95.7%) were sensitive to <0.06 Mg/ml of benzyl penicillin and cefuroxime,
and were sensitive to <0.125 Mg/ml of ampicillin. Higher concentrations
of antibiotics were required to inhibit WII strains: 28.8% of WII strains
were inhibited by SO. 25 Mg/ml of cefuroxime, 54.5% were inhibited by
SO. 125 Mg/ml of benzyl penicillin and 53% were inhibited by SO. 25 Mg/ml
of ampicillin. The differences in sensitivity between WI and WII, WI and
Will and WII and Will strains were significant for most antibiotics tested
(Bygdeman, 1981c).
It has been shown that 79% (56/71) of non-PPNG and 77% (53/69)
of PPNG strains isolated from infections acquired in Thailand and the
Far East belonged to CoA serogroup WII or Will. All of the WII non-
PPNG strains acquired in Thailand had sensitivities to penicillin and
ampicillin of SO. 125 Mg/ml and S0.25 Mg/ml respectively, and 82% had
sensitivities to cefuroxime of SO. 125 Mg/ml (Bygdeman, 1981c). Thus
strains of serogroup WII acquired in Thailand were shown to be signifi¬
cantly more resistant to antibiotics than corresponding WII strains
acquired in Sweden. It has subsequently been shown that antibiotic
resistance and specificity for serogroup WII are genetically linked
(Bygdeman et al. , 1982). A multiple antibiotic resistant WII strain was
used as a donor strain in transformation experiments. When WI recipient
strains were transformed to antibiotic resistance it was found that they
acquired the same protein I type and hence serogroup of the donor
strain. This genetic linkage between CoA serogroup WII and multi-
antibiotic resistance was different from the multi-antibiotic resistance
conferred by the previously described mtr mutation (Sparling et al. ,
1975; Guymon et al., 1978). Therefore antibiotics may have selected
gonococcal strains of serogroup WII and Will in areas such as the Far
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East and other non-European countries where there is little or no control
over their use. This may explain the observed differences in the distribu¬
tion of CoA serogroups in different geographical areas of Sweden.
In their survey of 10 different geographical areas in Sweden, Danielsson
et al. (1983) showed that strains isolated in the large cities of Stockholm
and Goteborg were significantly more resistant to antibiotics than strains
isolated from small towns with adjacent rural areas such as Orebro
and Ghvle. In Stockholm and Goteborg serogroup WII strains predomin¬
ated whereas in Orebro and Gavle serogroup WI strains predominated
(Danielsson et at. , 1983). A previous study has indicated that gonococcal
strains isolated from rural areas are much more sensitive to antibiotics
than strains isolated from patients in cities (Gump and Berry, 1973).
This may reflect greater use of antibiotics within certain populations
and may also explain the very strong association of serogroup WII with
homosexually acquired infections.
2.0 Characterisation of gonococcal isolates by cell envelope pheno-
typing
It has been shown that serogroup WII and the mtr mutation are
associated with homosexually acquired infections (Morse et al., 1982).
The mtr mutation confers resistance to a variety of hydrophobic com¬
pounds including antibiotics, dyes and detergents by decreasing the
permeability of the gonococcal outer membrane (Sparling et at., 1975;
Guymon et al. , 1978).
It has been hypothesised that the rectal environment which is
rich in hydrophobic compounds such as faecal lipids selects gonococcal
strains of the Mtr phenotype in homosexual men (Morse et al. , 1982).
However Morse et al. ( 1982) did not examine phenotype in relation to site
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of infection. This study was undertaken to increase our understanding
of the role of different anatomical sites on the selection of gonococcal
strains with particular outer membrane properties.
Overall 5%, 87% and 8% of 482 consecutive gonococcal strains isolated
from infections acquired in the Edinburgh area had an Env, wild type
and Mtr phenotype respectively (Table 13). Morse et al. (1982) found
that 7 (4.6%), 128 (82.9%) and 19 (12.5%) of gonococcal strains collected
in Seattle (United States) over a five year period were of the Env,
wild type and Mtr phenotype. Although the genotypes of the strains
phenotyped in this study were not confirmed by genetic transformation
experiments, the proportion of Env phenotypes is similar to the proportion
isolated in Seattle. Overall a lower number of Mtr phenotypes were
found in Edinburgh compared with Seattle. This is not a significant
difference (xi = 1.58; p >0.1).
The findings of this study confirm the significant association
of the Mtr phenotype with homosexually acquired infection: 36% (17/47)
of isolates from homosexual men had the Mtr phenotype compared with
5% (9/197) (p <0.001) and 6% (15/238) (p <0.001) of isolates from hetero¬
sexual men and women respectively. However the findings cast doubt
on the hypothesis that the rectal environment, essential for the trans¬
mission of gonococci within the homosexual population, exerts a selective
pressure favouring the emergence of the Mtr phenotype.
The Mtr phenotype was found considerably more often among
urethral and throat isolates from homosexual men. This difference
just failed to reach significance (xi = 3.57; 0.1>p>0.05). There
was no significant difference in the proportion of Mtr phenotypes among
male and female rectal isolates (p >0.1). The lack of association between
the Mtr phenotype and male rectal isolates was surprising since it seemed
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possible that hydrophobic environment of the rectum could be capable
of selecting gonococcal strains with reduced membrane permeability.
Eisenstein and Sparling (1978) reported that strains with an mtr mutation
consistently had reduced rates of exponential growth in enriched broth
cultures. The introduction to these strains of an env mutation by
transformation which results in the phenotypic inhibition of the mtr
mutation (Sarubbi et al., 1975) partially restored the normal growth
rates in vitro (Eisenstein and Sparling, 1978). Therefore the Mtr strains
may be less able to establish rectal infections since their poorer growth
characteristics could make them less capable of competing with the
complex microbial flora of the rectum.
2.1 Another selective force
It has been shown that CoA serogroup WII strains predominate
in homosexual men (Bygdeman, 1981a; Morse et al., 1982). This study
has indicated that serogroup WII strains predominate in homosexual
men regardless of the anatomical site of isolation. Morse et at. ( 1982)
showed that serogroup WII and the Mtr phenotype was strongly correlated
in homosexual men. Results presented here confirm these observations.
However CoA serogroup WII and the Mtr phenotype are also strongly
associated for gonococcal strains isolated from heterosexual patients
(Table 15). Morse et al. ( 1982) showed that the mtr locus and WII
phenotype were often co-transformed to recipient strains. The results
presented here suggest that the rectal environment is not responsible
for the selection of gonococcal strains with the Mtr phenotype. The
theory (Morse et al. , 1982) that the rectal environment selects gonococcal
strains with the Mtr phenotype was based upon observations that Mtr
strains isolated from homosexual men were significantly more resistant
A
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to faecal lipids than matched non-Mtr strains isolated from heterosexual
men. A more meaningful comparison would have been to examine the
faecal lipid sensitivity of all strains isolated from homosexual men and
heterosexual patients. The recent report of an Mtr-independent system
for resistance to faecal lipids also casts doubt in the role of the hydro¬
phobic rectal environment in selecting gonococcal strains of the Mtr
phenotype (McFarland et al., 1983). It is proposed that a more general
selective pressure common to all infected sites is the driving force
for selection of both the Mtr phenotype and CoA serogroup WII in homo¬
sexual men. Antibiotics would appear to be the major candidate for
this role. This hypothesis is corroborated by a number of studies
which show that there is a very strong association between serogroup
WII and multi-resistance to a number of antibiotics such as B-lactams,
tetracyclines and other antibiotics (Bygdemen, 1981c; Danielsson
et at., 1983; Bygdeman et al., 1982). Homosexual men experience
a wider spectrum and a higher rate of all sexually transmitted diseases
than heterosexual men (Fluker, 1976; Willcox, 1981). Although diffi¬
cult to prove, it would seem probable that antibiotic usage is greater
among homosexual men than among heterosexuals. Evidence to support
this was reported by Bygdeman (1981a) who found that all isolates
including serogroup WI strains from homosexual men were more resistant
to penicillin than strains isolated from heterosexual patients.
In areas of the world such as the Far East where there is very
little or no control over the use of antibiotics there is considerable
antibiotic resistance in many bacterial species including N. gonorrhoeae.
It has been shown that serogroups WII and Will predominate among
strains isolated from Thailand (Bygdeman et al., 1981b). Strains of
all serogroups isolated from Thailand and other countries in the Far East
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have been shown to be considerably more resistant to antibiotics than
gonococcal strains isolated in Sweden (Bygdeman, 1981c). Strains
of serogroup WII and Will are the most resistant. Strains of serogroup
WII isolated from infections acquired in Sweden are more resistant than
comparable serogroup WI strains (Bygdeman, 1981c). Antibiotic pressure
has been considered as a possible cause for the higher proportion of
WII strains in large Swedish cities compared with small towns encompassing
rural areas (Bygdeman et at. , 1983).
A small number of gonococcal strains isolated from infections
acquired in non-European countries were examined. It was found that
all of these strains belonged to CoA serogroup WII or WII/WIII (Table 16 ).
A significantly higher proportion of these strains had an Mtr phenotype
compared with endogenous gonococcal strains (p <0.001). When the
results were analysed further it was found that 75% (9/12) isolates
from heterosexual men who acquired their infections in non-European
countries (mostly in Thailand) had the Mtr phenotype. Only 5% (9/197)
of strains isolated from heterosexual men who had acquired their infec¬
tions in Edinburgh had this phenotype. This is a significant difference
(p <0.001). The proportion of Mtr phenotypic strains isolated from
heterosexual men who acquired their infections in non-European countries
was also significantly higher than the proportion of Mtr strains isolated
from homosexual men who had acquired their infections in Edinburgh
(p <0.05).
Further studies are required to determine the precise nature
of the relationship of the mtr locus and determinants for protein I.
One would suspect that the mtr locus is closely linked to the previously
described nmp loci determining protein I structure (Cannon et al.,
1980a,b) or possibly to another nmp locus yet to be described. The nmp
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loci (nmp-1 and nmp-2) were discovered by the change in protein I
type conferred by acquisition of the loci penB and sac which respec¬
tively conferred low level penicillin resistance and resistance to the
bactericidal activity of normal human sera in transformants (Guymon
et al., 1978a,b; Sparling et al. , 1978). Protein I forms pores in the
gonococcal membrane (Greco et al., 1980; Douglas et a!., 1981; Young
etal ., 1983) and it has been reported that protein IA and IB molecules
form pores of different sizes (Blake, personal communication, cited by
Barrera and Swanson, 1984).
Therefore the type of protein I molecule produced by a gonococcal
strain may also be directly involved in antibiotic resistance. Gonococcal
strains containing protein IB molecules (serogroups WII and Will) and
or mtr mutations are likely to have a selective advantage over other
gonococcal strains in areas and sub-populations of patients where there
is a selective pressure exerted by antibiotics. Hence under continued
selective pressure these strains are likely to survive and proliferate as
is observed in Thailand and among homosexual men.
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SECTION II: NON-CULTURAL DETECTION AND
IDENTIFICATION OF N. GONORRHOEAE
1.0 Preliminary studies on gonococcal antigen detection by an indirect
enzyme linked immunosorbent assay (ELISA) using wheatgerm
lectin for antigen capture
The indirect ELISA is an extremely useful technique for the detec¬
tion of both antibody and microbial antigens and has gained widespread
use in diagnosis and as a research tool. The laboratory diagnosis of
gonococcal infections is reliant upon culture and therefore depends
upon the maintenance of the viability of N. gonorrhoeae. Therefore
a non-cultural detection assay for gonococcal antigen in clinical specimens
remains a worthwhile goal. A suitable non-cultural method may have
a number of applications including detection of gonococcal antigen in
transported specimens and as an "on-the-spot" test to be employed
at the clinic at the time of the patient's examination. This is particularly
important for the diagnosis of gonorrhoea in women because the Gram
stain only detects between 55 and 60% of positive cases (Chipperfield
and Catterall, 1976; Barlow etal., 1976; Evans, 1976).
The immunological detection of microbial antigens in body fluids
poses a number of problems. The low numbers of organisms necessitate
the use of a method of antigen capture from clinical specimens. A specific
and sensitive antibody representative of the antigenic make up of the
local pool of gonococci is required for antigen detection. Therefore
a knowledge of the antigenic diversity of N. gonorrhoeae is also required.
Study of gonococcal strains isolated from patients who acquired their
infections in the Edinburgh area by CoA serogrouping (Section I) has
indicated that the majority 95.8- 99.6% of isolates are detected by two
CoA reagents prepared with antisera raised to MOMP N-10 and MOMP E-5
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respectively. These reagents define serogroups WII and WI. It was
considered that these antisera would be suitable for use in the develop¬
ment of a non-cultural detection system.
Initially wheatgerm (WG) lectin was examined for antigen capture
in an indirect ELISA using polystyrene beads as the solid phase. Most
gonococcal strains have been shown to agglutinate WG lectin (Schaeffer
et at., 1979). Preliminary experiments with slide agglutination as des¬
cribed by Curtis and Slack (1981) indicated that gonococcal reference
strain MOMP E-5 agglutinated WG lectin at lower concentrations of lectin
than reference strain MOMP N-10.
Assays utilising lectins have been considered unsatisfactory for
the differentiation of gonococcal from non-gonococcal neisseriae because
many meningococcal strains also agglutinate WG lectin (Frasch, 1980;
Curtis and Slack, 1981). However because N. meningitidis is rarely
isolated from uro-genital specimens it was thought WG lectin could be
utilised in the place of specific antibody for capture of gonococcal antigen.
The minimum amount of whole cell and sonicated MOMP E-5 antigen
detected by anti-MOMP E-5 antiserum, using polystyrene beads coated
with WG lectin at various concentrations in different buffers was deter¬
mined. Unarmed (control) polystyrene beads consistently detected
lower concentrations of both whole cell and sonicated MOMP E-5 antigen
than beads armed with various lectin concentrations (Tables 20 and 21).
Uncoated beads detected a minimum of 1.4 x 10s cfu (Table 20) and
0.12 |ig of protein (e 2.8 x 10k cfu) at an arbitrary cut off of OD 0.5.
Lectin armed beads detected whole cell and sonicated antigen in the
ranges of 2 x 105 - 1 x 10 7 cfu and 0.18-0.8 ag of protein respectively.
In an indirect ELISA using mouse and rabbit antiserum raised
against N. gonorrhoeae strain 9 for capture and detection of strain 9
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respectively, Sarafian and Young ( 1982) were able to detect 48 ng of
outer membrane complex from strain 9 and from 48-92 ng of outer membrane
complex from 10 clinical gonococcal isolates. This was approximately
3 to 6-fold lower than the amount of sonicated MOMP E-5 antigen detected
using uncoated control beads and 8 to 16-fold lower than the minimum
amount of sonicated antigen detected by beads coated with 200 pg/ml of
lectin, at the cut off point of OD 1.0. The ELISA of Sarafian and Young
preferentially detected protein antigens (Sarafian and Young, 1982).
In a simulated clinical specimen the ELISA of Sarafian and Young (1982)
was able to detect whole cell strain 9 antigen at 6.6 x 103 cfu. This
number is approximately 100 and 150-1500 times lower than the minimum
amount of whole cell antigen detected at an OD of 1.0 by uncoated control
beads and by beads armed with various concentrations of lectin (Table
20; bead set one).
The ELISA of Sarafian and Young ( 1982) was used to detect antigen
in cervical and vaginal washings from 37 women (Young et at., 1983).
Specimens from 12 (60%) of the 20 women with culture proven gonorrhoea
gave positive ELISA results. Specimens from 2/17 (11.7%) of patients
with no clinical or microbiological evidence of gonorrhoea also gave
positive results. Therefore the ELISA of Sarafian and Young had a
similar sensitivity to that of the Gram stain which detects up to 60% of
women with gonorrhoea. The number of gonococci recovered from cervical
aspirates varied within a range of 5 x 103 to 8 x 106 cfu/ml with a mean
of 1 x 106cfu/ml; the corresponding figures for vaginal aspirates
were 1 x 102 to 1 x 106 cfu/ml with a mean of 8.4 x 101* cfu/ml (Young
et al. , 1983). Lowe and Kraus (1976) found that the numbers of gonococci
in cervico-vaginal aspirates from 52 women with gonorrhoea ranged
from 40 - 1.8 x 106 cfu/ml (mean 1.45 x 104 cfu/ml).
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It was concluded that gonococcal antigen detection by homologous
antiserum in the ELISA system utilising lectin armed polystyrene beads
for antigen capture was less sensitive than that of the ELISA of Sarafian
and Young (1982) and that no advantage could be gained by using
this system for detection of gonococcal components in clinical specimens.
Therefore an alternative method for the detection of gonococcal antigen
in clinical specimens was evaluated.
2.0 Gonococcal antigen detection on nitrocellulose by an indirect enzyme
linked immunosorbent assay (dot-blot immunoassay)
The dot-blot immunoassay is based upon the non-covalent binding
of proteins to nitrocellulose membranes. Towbin, Staehlin and Gordon
(1979) first described this technique for the electrophoretic transfer
of ribosomal proteins from polyacrylamide gels to nitrocellulose membranes.
Antigen can also be applied directly to nitrocellulose membranes in the
form of dots (Hawkes, Niday and Gordon, 1982). Antigen bound to
the nitrocellulose can be detected using immunoassays, the nitrocellulose
taking the place of conventional solid phases such as polystyrene wells
or beads. Towbin and Gordon (1984) have reviewed many of the applica¬
tions of this technique. It has been used primarily for either the charac¬
terisation of the antigen profile of microorganisms or for characterisation
of both polyclonal and monoclonal antibodies to many microorganisms
(Towbin and Gordon, 1984).
Immunoblotting (electrophoretic transfer followed by immunoassay)
has been used to examine the antibody response to the pili and protein
II of gonococci isolated from individual patients within contact groups
(Duckworth et al., 1983; Zak eta!., 1984). To my knowledge, there
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has only been one report of the use of the dot-blot immunoassay for
detection of microbial antigens in clinical specimens (Brooks, Sharma
and Remington, 1985). Brooks et al. ( 1985) used this technique to
detect Toxoplasma gondii antigen in laboratory infected mice and in
the serum and cerebrospinal fluid of six infants infected with T. gondii.
Preliminary studies using unabsorbed whole cell antigonococcal
antisera raised to MOMP E-5 and N-10 indicated that MOMP E-5 and
N-10 boiled whole cell antigen could be detected at levels of 1.6- 3.2
x 10** cfu (Tables 22 and 23). The absorbed anti-E-5 and anti-N-10
used for preparing CoA serogrouping reagents were less sensitive
than the unabsorbed antisera. The absorbed antisera detected their
homologous whole cell boiled antigen at 3.2-6.5 x lO1* cfu (Tables 25
and 26). Interestingly, absorbed anti-E-5 and anti-N-10 detected
heterologous antigen in the dot-blot immunoassay, whereas no cross-
reactions were observed with CoA reagents prepared with these antisera
and their respective heterologous strains.
A mixture of antisera raised against protein I purified from MOMP
E-5 and N-10 detected MOMP E-5 boiled whole cell antigen at 4-8 x lO4
cfu and MOMP N-10 antigen at 1.6 x lO4 cfu (Tables 27 and 28). There¬
fore the anti protein I antisera was less sensitive than the antisera
raised against whole cell MOMP E-5 and N-10. The unabsorbed whole
cell antiserum mixture detected 1 ng of purified protein I from MOMP E-5
and N-10 whereas the mixture of anti-E-5 and anti-N-10 protein I antisera
detected protein I antigen from these strains at 5 ng. The conventional
ELISA of Sarafian and Young (1982) detected 48-92 ng of outer membrane
complex which was mostly protein in nature.
The amount of homologous whole cell gonococcal antigen detected
in the dot-blot immunoassay was approximately two-fold higher than that
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detected by the conventional ELISA of Sarafian and Young which detected
strain 9 at 6.6 x 103 cfu with homologous whole cell antiserum (Sarafian
and Young, 1982). Therefore because the dot-blot immunoassay detected
similar levels of antigen as the conventional ELISA of Sarafian and
Young ( 1982) and had the major advantage of being able to apply antigen
directly to the solid phase (nitrocellulose) without the necessity for an
antibody for antigen capture, this method was considered promising
for evaluation for antigen detection in clinical specimens. Other advan¬
tages of the dot-blot immunoassay were the ease of handling materials
and incubation at room temperature.
2.1 Detection of gonococcal antigen in 95 male urethral specimens
by antigonococcal antisera in the dot-blot immunoassay
Urethral specimens were obtained from 95 men with urethritis.
All 95 specimens were tested with the whole cell antisera mixture and
45 were also tested with the protein I antisera mixture. The dot-blot
results were correlated with culture results.
The dot-blot immunoassay using the anti-whole cell antisera mixture
for antigen detection had a sensitivity and specificity of 91.5% and
89.6% respectively. There were four false negative and five false positive
results. The sensitivity and specificity of the assay for the 45 specimens
tested with the anti-protein I antisera mixture was 84% and 85% respec¬
tively. The sensitivity and specificity of the assay using the whole cell
antisera was identical for these 45 specimens. This was because all
the false negative and most of the false positive results occurred in
this part of the study.
A number of groups have evaluated the commercially available
Gonozyme ELISA (Abbot Diagnostic Laboratories) for the detection of
249.
N. gonorrhoeae in genitourinary specimens (Aardoom et al., 1982;
Papasian eta!., 1984; Stamm eta!., 1984). The Gonozyme assay is
a conventional ELISA using polystyrene beads coated in some way to
aid antigen capture. All three groups found that Gonozyme correlated
well with cultural results for men with urethritis: Aardoom et al. ( 1982)
found that Gonozyme and culture results were in complete agreement
for specimens from 52 men with urethritis; Papasian et al. (1984) found
that Gonozyme had a sensitivity and specificity of 97.3% and 95.8% respec¬
tively for 208 male urethral specimens, whereas Stamm et al. (1984),
who tested 1171 male urethral specimens, found that Gonozyme had
a sensitivity and specificity of 94% and 98% respectively. Stamm et al.
(1984) found that the Gonozyme had a similar sensitivity to the Gram
stain for diagnosis of gonorrhoea in male urethral specimens. Positive
predictive values (PV+) of 90% and 96.5% and negative predictive values
(PV~) of 96.8% and 99% were obtained by two of the groups (Stamm et al.,
1984; Papasian et al. , 1984).
In a comparison of specimens from men with urethral discharge
with those from men without discharge it was found that the Gonozyme
ELISA detected significantly fewer cases of gonorrhoea among the asympto¬
matic group of patients: sensitivity and specificity were 67% and 98%
respectively (Stamm et al., 1984). Small numbers of infecting organisms
have been hypothesised as the reason for the poor results for specimens
from asymptomatic men. The dot-blot immunoassay, which was scored
subjectively, had a PV+ of 89.6% and a PV~ of 91.5%.
There are a number of drawbacks associated with comparing
a non-cultural detection method with culture results. It is possible
that specimens positive with non-cultural detection but culture negative
may represent true infections where viable organisms cannot be grown.
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This could be due to prior antibiotic treatment, exposure to gonococci
but successful killing of the infecting gonococci by the host but leaving
detectable antigen and failure of the culture system to grow some isolates,
e.g. vancomycin sensitive strains.
Four false negative specimens were obtained with the dot-blot
immunoassay. All specimens for analysis by dot-blot immunoassay were
obtained from patients after specimens had been taken for routine Gram-
staining and culture. It was observed that there was very little material
on the swabs obtained from two of the patients who gave false negative
results. Determination of the minimal amount of antigen detected and
serogrouping of gonococcal strains isolated from nine patients from
whom specimens were taken for testing in the dot-blot immunoassay
indicated that heterologous whole cell antigen could be detected to
similar levels as MOMP E-5 and N-10 antigen. All isolates were sero-
groupable. Two of these isolates were from patients whose dot-blot
immunoassay results were negative: one isolate (strain 4) could be
detected at comparable amounts of antigen as other strains, whereas the
second isolate (strain 9) required more antigen for detection and belonged
to serogroup WII/WIII. The urethral swab obtained from this patient
had very little material on it. Therefore the amount of antigen available
in specimens obtained from patients is likely to affect the assay results.
However, because all false negative results occurred when the dilution
of the antisera mixture was increased, it seems probable that the higher
antibody dilution was a contributory factor to false negative results.
Therefore the dilution of the antisera used may require reevaluation,
particularly when the assay is used for detection of gonococcal antigen
in female genital specimens.
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Aardoom et al. ( 1982) examined Gonozyme results for "high" and
"lower" risk groups of female patients: prostitutes attending for routine
screening for sexually transmitted diseases and women who were contacts
of patients suspected of having gonococcal infections. The sensitivity
and specificity of the Gonozyme ELISA was higher for prostitutes ("high"
risk group) than for specimens from women among the "lower" riskjcontact
group. However the results were considerably poorer than those obtained
with male urethral specimens. Papasian et at. (1984) and Stamm et al.
(1984) found sensitivities and specificities of 79.2% and 87.2%, and 78%
and 98% respectively. These were considerably lower than those obtained
with male urethral specimens. Stamm et al. (1984) reported that with
a sensitivity of 78% the Gonozyme ELISA offered a considerable improve¬
ment over gram stained smears for the diagnosis of gonorrhoea in women.
They found that the Gram stain had a sensitivity of 48%. However
the sensitivity of the Gram stain for diagnosis of gonorrhoea in women
can range from 40-70% in different laboratories and is dependent upon
the experience of the technical staff screening stained smears (Lossick
et al. , 1982). Therefore to offer any real improvement, the sensitivity
of any method for antigen detection must be above 70%. Poor sensitivity
of Gonozyme for women may be attributed to a proportion of women
with infections with very low numbers of gonococci. Lowe and Kraus
( 1976) detected as few as 43 cfu in cervico-vaginal specimens from women.
None of the Gonozyme studies differentiated between women with
symptomatic and women with asymptomatic infections. However as the
majority of women (60%) have asymptomatic infections any test must
be able to detect antigen in this group. Papasian et al. (1984) suggested
that the complex microbial flora found in the female genital tract may
mask the presence of gonococcal antigen by competing for binding sites
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on the polystyrene beads thus reducing the sensitivity of the Gonozyme
assay.
In the dot-blot immunoassay some of the negative clinical specimens
were observed to develop background colour. No endogenous peroxidase
activity was detected when a number of high background negative and
false positive specimens were tested with the peroxidase colour developer.
Endogenous peroxidase activity from PMNs has been reported to be a
problem in direct staining techniques applied to clinical specimens
(McMillan, personal communication).
The peroxidase conjugate reacted with these specimens to give
faint non-specific colour development. This was considered unlikely to
be high enough for specimens to be scored positive. However it may be
necessary to examine anti-rabbit IgG peroxidase conjugate from another
source.
Five specimens gave false positive results in the dot-blot immuno¬
assay. Two of these specimens gave very strong reactions in the assay
(deep purple) and it is possible that these patients may have had gonococcal
infections where no viable gonococci were detected. Alternatively all
five false positives may have resulted from cross-reactions of the anti-
gonococcal antisera with antigen from some other genital pathogen or
commensal organism.
The reaction in the dot-blot assay of both the antigonococcal
whole cell and protein I antisera mixtures with a variety commensal
and pathogenic non-gonococcal neisseriae and a variety of organisms
commonly found in the urogenital tract of both men and women was
investigated.
Non-gonococcal neisserial antigens were detected at 4 to 125-fold
higher levels than antigen from N. gonorrhoeae (Table 32). Strains of
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N. meningitidis appear to be antigenically most closely related to N.
gonorrhoeae. The majority of the non-gonococcal neisseriae including
Branhamella sp. are found in the upper respiratory tract and oro¬
pharynx of man. The exceptions are N. can is, N. caviae, N. ovis and
N. cuniculi which are isolated from dogs, guinea pigs, sheep and rabbits
respectively (Bdvre, 1984). However N. meningitidis are occasionally
isolated from ano-genital sites, particularly in homosexual men (McMillan
and Young, 1978), whereas N. lactamica are rarely isolated from these
sites (Telfer Brunton„ Young and Fraser, 1980). The mixture of anti-
gonococcal protein I antisera was more specific than the whole cell antisera
mixture.
Examination of G. vaganalis, C. albicans, group B streptococci
and lactobacilli, four species commonly found in the urogenital tract
indicated that none except C. vaganalis were detectable at the highest
antigen concentration of 1 x 106 cfu. However, B. bivius was detected
at 6.25 x 104 and 2.5 x 105 cfu with the whole cell and protein I antisera
mixtures respectively. None of the three other Bacteroides species
were detected with the protein I antisera mixture but were detected in
the range of 5 x 105 - 1 x 106 cfu with the whole cell antisera mixture.
A recent study has indicated that B. asticcharolyticus, B. intermedius,
B. ureolyticus and B. bivius are commonly isolated from men with non¬
specific urethritis and Balanoposthitis (Masfari, Kinghorn and Duerden,
1983). These species have also been isolated from the urethras of 21%
of healthy men. Other species commonly isolated from healthy men are
coagulase-negative staphylococci, coryneforms and a and 6 haemolytic
streptococci. These species and lactobacilli, C. vaganalis and C. albicans
are also isolated from patients with urethritis (Masfari et al., 1983).
A greater range of bacteria are isolated from women. The most prevalent
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aerobes are E. coli, enterococci, g-haemolytic streptococci and yeasts
(Hamman, 1982). Anaerobic bacteria were cultured from a total of
34% (72/212) of vaginal swabs. B. bivius was the most commonly isolated
Bacteroides spp. followed by B. oralis (Hamman., 1982).
The possibility that cross-reaction of the antigonococcal antisera
with B. bivius gave rise to false positive and high background reactions
in the dot-blot immunoassay, was investigated. The antisera mixtures
used for detection of antigen in the dot-blot immunoassay were absorbed
with B. bivius. Absorption with B. bivius resulted in reduction in
the sensitivity of the antisera in detecing homologous gonococcal strains
MOMP E-5 and N-10. No cross-reactions were observed with B. assacharo-
lyticus, B. intermedius or B. ureolyticus. However B. bivius was still
detectable at 1 x 106 cfu with antigonococcal whole cell antiserum mixture
(Table 33).
Four clinical specimens which had given false positive results
when first tested in the dot-blot immunoassay were retested with the
absorbed antiserum mixtures. Although there was still some colour
development on the dots when compared with the controls two of these
specimens were scored negative with both the absorbed antisera mixtures,
one was scored negative with the absorbed protein I antisera mixture
and positive with the absorbed whole cell antisera mixture, and one
was scored positive with both of the absorbed antisera mixtures. There¬
fore it is possible that at least two of these specimens may have given
false positive results because of cross reactions of the unabsorbed
antisera with B. bivius or related organisms.
The cross reactions may have resulted from two possible sources;
the rabbits used to raise antigonococcal antisera may have been previously
exposed to B. bivius or the antigonococcal antiserum contained antibodies
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to antigens which are common to gram negative bacteria. Unfortunately
the pre-immune sera from the rabbits used here were not available
for testing against B. bivius. However it seems more likely that the
antigonococcal antisera contains antibodies which react to antigens
common to other gram negative bacteria. The most likely candidate
for this is lipopolysaccharide (LPS). Whole cell untreated gonococci
were used to raise antisera against MOMP E-5 and N-10 whereas a purified
outer membrane antigen preparation was used to raise antisera against
MOMP E-5 and N-10 protein I. One would expect with the whole cell
antigen that an immune response would be mounted to many antigens
including LPS. Gel electrophoresis showed that a small amount of con¬
taminating protein II and LPS was present in the purified protein I
antigens. On the gel stained for LPS with silver stain there were bands
corresponding to protein I and two or three minor staining bands of
low molecular weight. According to the method of James and Heckels
(1981) column chromatography should have separated protein I, protein
II and LPS into distinct fractions. However the protein I and protein II
peaks were not well separated during column chromatography using
a column approximately half the length of that used by James and Heckels
(1981). Therefore it is possible that some LPS was fractionated with
the protein. Alternatively some LPS could still be covalently bound to
the proteins.
3.0 Immunological identification of N. gonorrhoeae with coagglutination
reagents prepared with polyclonal and monoclonal antibodies
The advent of monoclonal antibodies raises the possibility of
improved and more widely applied immunological methods of identifying
microorganisms. In this "in use" evaluation, however, there was no
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significant difference in the sensitivity and specificity of monoclonal
and polyclonal antibody reagents for the routine identification of clinical
isolates of N. gonorrhoeae. Although factors such as sensitivity and
specificity are important in evaluating new methods the utility of a
test result (the predictive value) depends upon the prevalence of gonococci
among the total population of gram negative diplococci tested. As shown
in Table 36, the predictive values vary greatly depending on the anatomical
site of isolation. Sound recommendations regarding the application of
immunological methods for the laboratory identification of N. gonorrhoeae
can be made from these results. Coagglutination testing with either
polyclonal or monoclonal reagents can be recommended for the identification
of gonococci from an anogenital site. However reliability is less in the
case of isolates from homosexual men when 1 to 3 per 1000 positive tests
will be false positives. The corresponding false positive rate for ano¬
genital specimens from heterosexual patients is 1 to 2 per 10,000 positive
tests. A positive coagglutination result on an isolate from the throat is
less reliable than in the case of anogenital isolates; there will be 7 false
positives per 100 positive tests with the monoclonal reagent, and 14 false
positives per 100 positive tests with the polyclonal reagent. Although
this difference is not significant at the 5% level with 100 positive results,
it becomes significant with 200 positive tests (xi = 4.49; p <0.05).
The Phadebact Gonococcus test has previously been reported to react
with N. lactamica (Anand and Kadis, 1980).
The negative predictive values are of much more use than positive
predictive values for throat isolates; 7 negative tests will be false
negatives per 1000 negative tests with the polyclonal reagent compared
with 9 per 1000 negative tests with the monoclonal reagent. N. gonor¬
rhoeae accounts for only 20.3% of throat cultures which yield GNDC
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compared with N. meningitidis and N. lactamica which respectively
account for 74.2% and 3.7% of throat cultures yielding GNDC (Young
and Bain, 1983). Therefore a negative coagglutination result with
either the polyclonal or monoclonal reagent is a reliable indicator of
non-gonococcal neisseriae in throat cultures. However because of the
extremely rare occurrence of meningococci in anogenital specimens from
heterosexual patients a negative coagglutination result is not a reliable
indicator of non-gonococcal neisseriae: approximately 9 of 10 negative
results will be false negatives and gonococcal infection could pass un¬
diagnosed.
In preliminary investigations of the same monoclonal reagents,
Philip, Ison and Easmon ( 1984) and Lawton and Battaglioli ( 1983) respec¬
tively found that all 27 and 57 non-gonococcal neisseriae tested gave
negative reactions. Although a larger study is required the results
of this study suggest that monoclonal coagglutination reagents are
likely to achieve a level of specificity such that the predictive value
of a positive test result is a reliable indicator of pharyngeal gonorrhoea
in patients attending a clinic for sexually transmitted diseases. Because
of its slightly greater sensitivity the negative predictive value of the
polyclonal reagent is marginally better than that of the monoclonal
reagent. However a sensitivity of 99.99% would be required to give
a negative predictive value of 97.5% for anogenital isolates from hetero¬
sexual patients; a sensitivity of 99.9% would give a negative predictive
value of only 79.7%. It will obviously be difficult to achieve a sensitivity
of greater than 99.90% given that the sensitivity of the monoclonal reagent
in this study was 96.6% ( 198/205) and is comparable to the figure of
96% (48/50) reported by Philip et at. ( 1984). However, a sensitivity
of 99.09% (109/110) was reported by Lawton and Battaglioli ( 1983) who
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conducted their study in New York (United States). GonoGen which
is manufactured in the United States may therefore be lacking reactivity




CoA serogrouping has provided valuable information concerning
the variation in gonococcal strains within different geographical locations
and within specific patient groups. It has also provided an additional
means of surveying antibiotic resistance in N. gonorrhoeae.
This study has provided useful data concerning the antigenic
pool of N. gonorrhoeae in the Edinburgh area. CoA serogrouping has
shown that this pool is not static but dynamic and changing. It has
provided us with a means of monitoring the influx of new gonococcal
strains from outwith Edinburgh and may help identify new strains which
arise from mutation of the protein I structure.
The CoA serogrouping and phenotyping results presented here
suggest that antibiotics may have a major role in the selection of gonococci
belonging to serogroup WII. Careful monitoring of changes in the distribu¬
tion within a given area, may give additional warning of changes in the
antibiotic sensitivity of N. gonorrhoeae.
Gonococcal research has long awaited an acceptable serological
means of typing N. gonorrhoeae and CoA serogrouping based on the
protein I molecules appears to have fulfilled this role. The advent
of monoclonal antibodies to protein I (Tarn et al., 1982) should make
investigation of specific subgroups of gonococci particularly those causing
complicated and disseminated infections easier. They may also help in
the study of the host response to gonococcal infections. CoA serogroup¬
ing in conjunction with auxotyping is now being used by many groups.
The experience now exists for further studies to be carried out using
the newly available monoclonal antibodies.
Continued surveillance of the gonococcal pool is of importance for
the diagnosis of gonorrhoea. Serological identification by commercially
available CoA reagents forms an integral part of the laboratory identification
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of N. gonorrhoeae and constant surveillance will be required to ensure
that these reagents remain effective.
The CoA serogrouping study has allowed the rational choice of
antisera to be employed in the development of a non-cultural detection
method. The sentisitivity and the specificity of the dot-blot immuno¬
assay is acceptable at present but could be improved. Limitations of
the assay could become more apparent when clinical specimens from
women are evaluated. However the means exist to improve both the
sensitivity and specificity of this assay. It has been reported that
polyethylene glycol (PEG) enhances the ability of the second antibody
reaction step in conventional phase ELISAs for the detection of human
antibody to a variety of viruses and microorganisms (Salonen and Vaheri,
1981). The use of PEG considerably reduced the incubation period
required for the binding of anti-human IgG conjugate to antibody bound
to antigen attached to the solid phase. PEG could be incorporated into
the diluent buffers of the dot-blot immunoassay to increase the binding
of the peroxidase anti-rabbit conjugate with the anti-gonococcal antisera.
Reduction in the incubation periods may therefore be possible.
An ELISA using monoclonal antibody directed against meningococcal
pili has been developed to detect meningococcal antigen in the CSF of
patients with meningitis (Sugasawara, Prato and Sippel, 1984). In
25 patients with meningitis, antigen was detected in the CSF in 21 patients
by ELISA and in 16 patients by crossed immunoelectrophoresis.
Monoclonal antibodies to protein I are now becoming available
and may improve the specificity of the dot-blot immunoassay. However
monoclonal antibodies have been criticised because their high specificity
may reduce the sensitivity of assays. A pool of monoclonal antibodies
would be required to detect most gonococcal strains.
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The sensitivity of the dot-blot immunoassay could be improved
by using steps to amplify the antibody reactions. The interaction of
avidin with biotin has been described for amplification of immunoassays
(Guesdon, Ternynck and Avrameas, 1979; Yolken etal., 1983; Kendall,
Ionescu-Matiu and Dreesman, 1983). Avidin is a basic glycoprotein
(MWt 68,000) which has an extremely high affinity for biotin. "Each
avidin molecule can bind four biotin molecules (Guesdon et al., 1979).
Guesdon et al. (1979) covalently bound biotin to antibody to a high
specific activity without affecting the antigen binding capacity of the
antibody. The biotin-labelled antibody was incubated with avidin
followed by incubation with enzyme-labelled biotin. Alternatively biotin-
labelled antibody could be incubated directly with enzyme-labelled avidin.
These methods were used in immunohistochemically staining procedures
(Guesdon et al., 1979).
Yolken et al. (1983) developed an ELISA for the detection of
antigen from Haemophilus influenzae and Streptococcus pneumoniae using
the avidin-biotin system. They found that biotin-labelled antibody-
avidin-peroxidase-labelled biotin detected antigen most efficiently:
0.16 ng/ml and 0.8 ng/ml of Haemophilus and streptococcal antigen
respectively could be detected. However they also found that good
sensitivity could be obtained using unlabelled specific antibody-biotin
labelled anti-rabbit IgG-avidin-enzyme-labelled biotin. Kendall et al.
( 1983) used the avidin-biotin system to amplify the sensitivity of an
ELISA for the detection of antibody against hepatitis B surface antigen
(HBsAg) in mice. They found that the amplified ELISA was more sensi¬
tive than a commercially available radioimmunoassay (AUSAB, Abbot
Laboratories) for the detection of antibody to HBsAg. They found very
little background activity using avidin-biotin systems.
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Although the dot-blot immunoassay is in its preliminary stages
of development it offers certain advantages over conventional ELISAs:
antigen can be applied quickly and directly to nitrocellulose which
takes the place of conventional solid phases, ease of handling and all
incubation steps are at room temperature. It is unlikely that this assay
could be used as an "on-the-spot" diagnostic test. However it may
prove useful for the detection of gonococcal antigen in transported
specimens and possibly also for the detection of antigen in specimens
from cases of DGI.
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